"diuretics. this classification denotes agents or substances that promote excretion of urine by influencing human kidney function, commonly known as diuretics. the major diuretic types include osmotic (diuretics that increase urine volume by increasing osmotically-active urine solute); potassium sparing (diuretics that limit potassium secretion in urine); sodium chloride symporter inhibitors; and sodium potassium chloride symporter inhibitors. diuretics, that is, operate by stimulating he nervous system, by alleviating kidney congestion, by increasing blood pressure, or by increasing or improving liquid transport.. . "
"diuretics. this classification denotes agents or substances that promote excretion of urine by influencing human kidney function, commonly known as diuretics. the major diuretic types include osmotic (diuretics that increase urine volume by increasing osmotically-active urine solute); potassium sparing (diuretics that limit potassium secretion in urine); sodium chloride symporter inhibitors; and sodium potassium chloride symporter inhibitors. diuretics, that is, operate by stimulating he nervous system, by alleviating kidney congestion, by increasing blood pressure, or by increasing or improving liquid transport.. chlorothiazide. this classification denotes a thiazide diuretic with the molecular formula c7h6cln3o4s2, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 77w477j15h, chemically known as 6-chloro-7-sulfamoyl-2h-1,2,4-benzothiadiazine 1,1-dioxide but generally known as chlorothiazide, which bears us nih compound identifier 2720. european medicines agency schedules chlorothiazide in its extended eudravigilance medicinal product dictionary or xevmpd under index sub06198mig. the term chlorothiazide is an international non-proprietary name or inn (see who inn reference publication, volume 16, no. 3 1962, list 4). world health organization schedules chlorothiazide in its anatomical therapeutic chemical (atc) classification. chlorothiazide is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule chlorothiazide under hs 29350090 and sitc 51580. as of q4 2014, chlorothiazide remains the us fda preferred term for this commodity. chlorothiazide bears us nlm identifiers umls id c0008273 and nci concept code c28924. smiles: clc1c(s(=o)(=o)n)cc2s(=o)(=o)n=cnc2c1.. "
"diuretics. this classification denotes agents or substances that promote excretion of urine by influencing human kidney function, commonly known as diuretics. the major diuretic types include osmotic (diuretics that increase urine volume by increasing osmotically-active urine solute); potassium sparing (diuretics that limit potassium secretion in urine); sodium chloride symporter inhibitors; and sodium potassium chloride symporter inhibitors. diuretics, that is, operate by stimulating he nervous system, by alleviating kidney congestion, by increasing blood pressure, or by increasing or improving liquid transport.. chlortalidone or chlorthalidone. this classification denotes a thiazide diuretic with the molecular formula c14h11cln2o4s, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier q0mqd1073q, chemically known as 2-chloro-5-(2,3-dihydro-1-hydroxy-3-oxo-1h-isoindol-1-yl)benzenesulfonamide but generally known as chlortalidone, which bears us nih compound identifier 2732. european medicines agency schedules chlortalidone in its extended eudravigilance medicinal product dictionary or xevmpd under index sub06212mig. the term chlortalidone is an international non-proprietary name or inn (see who inn reference publication, volume 19 1975, list 5). world health organization schedules chlortalidone in its anatomical therapeutic chemical (atc) classification. chlortalidone is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. as of q4 2014, chlorthalidone remains the us fda preferred term for this commodity. chlorthalidone bears us nlm identifiers umls id c0008294 and nci concept code c47449. smiles: clc1c(s(=o)(=o)n)cc(c2(o)nc(=o)c3c2cccc3)cc1.. "
"diuretics. this classification denotes agents or substances that promote excretion of urine by influencing human kidney function, commonly known as diuretics. the major diuretic types include osmotic (diuretics that increase urine volume by increasing osmotically-active urine solute); potassium sparing (diuretics that limit potassium secretion in urine); sodium chloride symporter inhibitors; and sodium potassium chloride symporter inhibitors. diuretics, that is, operate by stimulating he nervous system, by alleviating kidney congestion, by increasing blood pressure, or by increasing or improving liquid transport.. metolazone. this classification denotes a thiazide diuretic with the molecular formula c16h16cln3o3s, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier tz7v40x7vx, chemically known as 7-chloro-2-methyl-3-(2-methylphenyl)-4-oxo-1,2-dihydroquinazoline-6-sulfonamide but generally known as metolazone, which bears us nih compound identifier 4170. european medicines agency schedules metolazone in its extended eudravigilance medicinal product dictionary or xevmpd under index sub08906mig. the term metolazone is an international non-proprietary name or inn (see who inn reference publication, volume 23, no. 10 1969, list 9). world health organization schedules metolazone in its anatomical therapeutic chemical (atc) classification. metolazone is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule metolazone under hs 29350090 and sitc 51580. as of q4 2014, metolazone remains the us fda preferred term for this commodity. metolazone bears us nlm identifiers umls id c0025854 and nci concept code c650. smiles: clc1cc2nc(n(c(=o)c2cc1s(=o)(=o)n)c1c(cccc1)c)c.. "
"diuretics. this classification denotes agents or substances that promote excretion of urine by influencing human kidney function, commonly known as diuretics. the major diuretic types include osmotic (diuretics that increase urine volume by increasing osmotically-active urine solute); potassium sparing (diuretics that limit potassium secretion in urine); sodium chloride symporter inhibitors; and sodium potassium chloride symporter inhibitors. diuretics, that is, operate by stimulating he nervous system, by alleviating kidney congestion, by increasing blood pressure, or by increasing or improving liquid transport.. bumetanide. this classification denotes a loop diuretic with the molecular formula c17h20n2o5s, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 0y2s3xuq5h, chemically known as benzoic acid, 3-(butylamino)-4-phenoxy-5-sulfamoyl- but generally known as bumetanide, which bears us nih compound identifier 2471. european medicines agency schedules bumetanide in its extended eudravigilance medicinal product dictionary or xevmpd under index sub05971mig. the term bumetanide is an international non-proprietary name or inn (see who inn reference publication, volume 25 , no. 10 1971, list 11). world health organization schedules bumetanide in its anatomical therapeutic chemical (atc) classification. bumetanide is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule bumetanide under hs 29350090 and sitc 51580. as of q4 2014, bumetanide remains the us fda preferred term for this commodity. bumetanide bears us nlm identifiers umls id c0701009 and nci concept code c28875. smiles: s(=o)(=o)(n)c1c(oc2ccccc2)c(ncccc)cc(c1)c(=o)o.. "
"diuretics. this classification denotes agents or substances that promote excretion of urine by influencing human kidney function, commonly known as diuretics. the major diuretic types include osmotic (diuretics that increase urine volume by increasing osmotically-active urine solute); potassium sparing (diuretics that limit potassium secretion in urine); sodium chloride symporter inhibitors; and sodium potassium chloride symporter inhibitors. diuretics, that is, operate by stimulating he nervous system, by alleviating kidney congestion, by increasing blood pressure, or by increasing or improving liquid transport.. ethacrynate sodium. this classification denotes a loop diuretic with the molecular formula c13h11cl2o4.na, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier k41myv7mpm, chemically known as sodium (2,3-dichloro-4-(2-methylenebutyryl)phenoxy)acetate but generally known as ethacrynate sodium, which bears us nih compound identifier 23003. as of q4 2014, ethacrynate sodium remains the us fda preferred term for this commodity. ethacrynate sodium bears us nlm identifiers umls id c0014962 and nci concept code c47993. smiles: ccc(=c)c(=o)c1=c(c(=c(c=c1)occ(=o)[o-])cl)cl.[na+].. "
"diuretics. this classification denotes agents or substances that promote excretion of urine by influencing human kidney function, commonly known as diuretics. the major diuretic types include osmotic (diuretics that increase urine volume by increasing osmotically-active urine solute); potassium sparing (diuretics that limit potassium secretion in urine); sodium chloride symporter inhibitors; and sodium potassium chloride symporter inhibitors. diuretics, that is, operate by stimulating he nervous system, by alleviating kidney congestion, by increasing blood pressure, or by increasing or improving liquid transport.. amiloride. this classification denotes a potassium-sparing diuretic and intercalating agent with the molecular formula c6h8cln7o, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 7dzo8eb0z3, chemically known as 3,5-diamino-n-(aminoiminomethyl)-6-chloropyrazinecarboxamide but generally known as amiloride, which bears us nih compound identifier 16231. amiloride most often comes in caproate, chloride, hydrochloride, hydrochloride dihydrate, and hydrochloride-hydrochlorothiazide forms. european medicines agency schedules amiloride in its extended eudravigilance medicinal product dictionary or xevmpd under index sub05433mig. the term amiloride is an international non-proprietary name or inn (see who inn reference publication, volume 22, no. 10, 1968, list 8). world health organization schedules amiloride in its anatomical therapeutic chemical (atc) classification. amiloride is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule amiloride under hs 29339990 and sitc 51577. as of q4 2014, amiloride remains the us fda preferred term for this commodity. amiloride bears us nlm identifiers umls id c0002502 and nci concept code c61633. smiles: c1(c(nc(c(n1)cl)n)n)c(=o)nc(=n)n.. "
"diuretics. this classification denotes agents or substances that promote excretion of urine by influencing human kidney function, commonly known as diuretics. the major diuretic types include osmotic (diuretics that increase urine volume by increasing osmotically-active urine solute); potassium sparing (diuretics that limit potassium secretion in urine); sodium chloride symporter inhibitors; and sodium potassium chloride symporter inhibitors. diuretics, that is, operate by stimulating he nervous system, by alleviating kidney congestion, by increasing blood pressure, or by increasing or improving liquid transport.. spironolactone. this classification denotes a potassium-sparing diuretic with the molecular formula c24h32o4s, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 27o7w4t232, chemically known as pregn-4-ene-21-carboxylic acid, 7-(acetylthio)-17-hydroxy-3-oxo-, .gamma.-lactone, (7.alpha.,17.alpha.)- but generally known as spironolactone, which bears us nih compound identifier 5267. european medicines agency schedules spironolactone in its extended eudravigilance medicinal product dictionary or xevmpd under index sub10631mig. the term spironolactone is an international non-proprietary name or inn (see who inn reference publication, volume 19 1975, list 5). world health organization schedules spironolactone in its anatomical therapeutic chemical (atc) classification. as of q4 2014, spironolactone remains the us fda preferred term for this commodity. spironolactone bears us nlm identifiers umls id c0037982 and nci concept code c840. smiles: s(c1c2c3c(c4(oc(=o)cc4)cc3)(ccc2c2(c(=cc(=o)cc2)c1)c)c)c(=o)c.. "
"diuretics. this classification denotes agents or substances that promote excretion of urine by influencing human kidney function, commonly known as diuretics. the major diuretic types include osmotic (diuretics that increase urine volume by increasing osmotically-active urine solute); potassium sparing (diuretics that limit potassium secretion in urine); sodium chloride symporter inhibitors; and sodium potassium chloride symporter inhibitors. diuretics, that is, operate by stimulating he nervous system, by alleviating kidney congestion, by increasing blood pressure, or by increasing or improving liquid transport.. triamterene. this classification denotes a potassium-sparing diuretic with the molecular formula c12h11n7, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier ws821z52lq, chemically known as 2,4,7-triamino-6-phenylpteridine but generally known as triamterene, which bears us nih compound identifier 5546. european medicines agency schedules triamterene in its extended eudravigilance medicinal product dictionary or xevmpd under index sub11256mig. the term triamterene is an international non-proprietary name. world health organization schedules triamterene in its anatomical therapeutic chemical (atc) classification. triamterene is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule triamterene under hs 29335995 and sitc 51576. as of q4 2014, triamterene remains the us fda preferred term for this commodity. triamterene bears us nlm identifiers umls id c0040869 and nci concept code c29519. smiles: c1=cc=c(c=c1)c2=nc3=c(n=c2n)n=c(n=c3n)n.. "
"diuretics. this classification denotes agents or substances that promote excretion of urine by influencing human kidney function, commonly known as diuretics. the major diuretic types include osmotic (diuretics that increase urine volume by increasing osmotically-active urine solute); potassium sparing (diuretics that limit potassium secretion in urine); sodium chloride symporter inhibitors; and sodium potassium chloride symporter inhibitors. diuretics, that is, operate by stimulating he nervous system, by alleviating kidney congestion, by increasing blood pressure, or by increasing or improving liquid transport.. mannitol. this classification denotes an osmotic diuretic with the molecular formula c6h14o6, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 3owl53l36a, chemically known as 1,2,3,4,5,6-hexanehexol but generally known as mannitol, which bears us nih compound identifier 453. european medicines agency schedules mannitol in its extended eudravigilance medicinal product dictionary or xevmpd under index sub03087mig. world health organization schedules mannitol in its anatomical therapeutic chemical (atc) classification. mannitol is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule mannitol under hs 29054300 and sitc 51224. as of q4 2014, mannitol remains the us fda preferred term for this commodity. mannitol bears us nlm identifiers umls id c0024730 and nci concept code c625. smiles: oc(c(o)c(o)co)c(o)co.. "
"diuretics. this classification denotes agents or substances that promote excretion of urine by influencing human kidney function, commonly known as diuretics. the major diuretic types include osmotic (diuretics that increase urine volume by increasing osmotically-active urine solute); potassium sparing (diuretics that limit potassium secretion in urine); sodium chloride symporter inhibitors; and sodium potassium chloride symporter inhibitors. diuretics, that is, operate by stimulating he nervous system, by alleviating kidney congestion, by increasing blood pressure, or by increasing or improving liquid transport.. canrenoate potassium or canrenone or potassium canrenoate. this classification denotes a potassium-sparing diuretic with the molecular formula c22h28o3, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 78o20x9j0u, chemically known as 17-hydroxy-3-oxo-17alpha-pregna-4,6-diene-21-carboxylic acid gamma-lactone but generally known as canrenone, which bears us nih compound identifier 13789. european medicines agency schedules canrenone in its extended eudravigilance medicinal product dictionary or xevmpd under index sub06076mig. the term canrenone is an international non-proprietary name. world health organization schedules canrenone in its anatomical therapeutic chemical (atc) classification. canrenone is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. as of q4 2014, canrenoate potassium remains the us fda preferred term for this commodity. canrenoate potassium bears us nlm identifiers umls id c0006881 and nci concept code c81161. smiles: o1c2(c3(c(c4c(cc3)c3(c(=cc(=o)cc3)c=c4)c)cc2)c)ccc1=o.. "
"diuretics. this classification denotes agents or substances that promote excretion of urine by influencing human kidney function, commonly known as diuretics. the major diuretic types include osmotic (diuretics that increase urine volume by increasing osmotically-active urine solute); potassium sparing (diuretics that limit potassium secretion in urine); sodium chloride symporter inhibitors; and sodium potassium chloride symporter inhibitors. diuretics, that is, operate by stimulating he nervous system, by alleviating kidney congestion, by increasing blood pressure, or by increasing or improving liquid transport.. hydrochlorothiazide. this classification denotes a thiazide diuretic with the molecular formula c7h8cln3o4s2, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 0j48lph2th, chemically known as 6-chloro-7-sulfamoyl-2h-1,2,4-benzothiadiazine 1,1-dioxide but generally known as hydrochlorothiazide, which bears us nih compound identifier 2720. european medicines agency schedules hydrochlorothiazide in its extended eudravigilance medicinal product dictionary or xevmpd under index sub08062mig. the term hydrochlorothiazide is an international non-proprietary name or inn (see who inn reference publication, volume 16, no. 3 1962, list 4). world health organization schedules hydrochlorothiazide in its anatomical therapeutic chemical (atc) classification. hydrochlorothiazide is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule hydrochlorothiazide under hs 29350090 and sitc 51580. as of q4 2014, hydrochlorothiazide remains the us fda preferred term for this commodity. hydrochlorothiazide bears us nlm identifiers umls id c0020261 and nci concept code c29098. smiles: clc1c(s(=o)(=o)n)cc2s(=o)(=o)n=cnc2c1.. "
"diuretics. this classification denotes agents or substances that promote excretion of urine by influencing human kidney function, commonly known as diuretics. the major diuretic types include osmotic (diuretics that increase urine volume by increasing osmotically-active urine solute); potassium sparing (diuretics that limit potassium secretion in urine); sodium chloride symporter inhibitors; and sodium potassium chloride symporter inhibitors. diuretics, that is, operate by stimulating he nervous system, by alleviating kidney congestion, by increasing blood pressure, or by increasing or improving liquid transport.. hydroflumethiazide. this classification denotes a thiazide diuretic with the molecular formula c8h8f3n3o4s2, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 501cfl162r, chemically known as benzoic acid, 5-(aminosulfonyl)-4-chloro-2-((2-furanylmethyl)amino)- but generally known as hydroflumethiazide, which bears us nih compound identifier 3440. european medicines agency schedules hydroflumethiazide in its extended eudravigilance medicinal product dictionary or xevmpd under index sub08067mig. the term hydroflumethiazide is an international non-proprietary name or inn (see who inn reference publication, volume 16, no. 3 1962, list 4). world health organization schedules hydroflumethiazide in its anatomical therapeutic chemical (atc) classification. hydroflumethiazide is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule hydroflumethiazide under hs 29350090 and sitc 51580. as of q4 2014, hydroflumethiazide remains the us fda preferred term for this commodity. hydroflumethiazide bears us nlm identifiers umls id c0020273 and nci concept code c47557. smiles: clc1c(s(=o)(=o)n)cc(c(ncc2occc2)c1)c(=o)o.. "
"diuretics. this classification denotes agents or substances that promote excretion of urine by influencing human kidney function, commonly known as diuretics. the major diuretic types include osmotic (diuretics that increase urine volume by increasing osmotically-active urine solute); potassium sparing (diuretics that limit potassium secretion in urine); sodium chloride symporter inhibitors; and sodium potassium chloride symporter inhibitors. diuretics, that is, operate by stimulating he nervous system, by alleviating kidney congestion, by increasing blood pressure, or by increasing or improving liquid transport.. isosorbide. this classification denotes a vasodilating agent with the molecular formula c6h10o4, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier wxr179l51s, chemically known as 1,4-dianhydrosorbitol but generally known as isosorbide, which bears us nih compound identifier 12597. european medicines agency schedules isosorbide in its extended eudravigilance medicinal product dictionary or xevmpd under index sub08334mig. the term isosorbide is an international non-proprietary name or inn (see who inn reference publication, volume 4, no. 3 1990, list 30). isosorbide is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule isosorbide under hs 29329985 and sitc 51569. as of q4 2014, isosorbide remains the us fda preferred term for this commodity. isosorbide bears us nlm identifiers umls id c0022251 and nci concept code c60773. smiles: o1c2c(occ2o)c(o)c1.. "
"diuretics. this classification denotes agents or substances that promote excretion of urine by influencing human kidney function, commonly known as diuretics. the major diuretic types include osmotic (diuretics that increase urine volume by increasing osmotically-active urine solute); potassium sparing (diuretics that limit potassium secretion in urine); sodium chloride symporter inhibitors; and sodium potassium chloride symporter inhibitors. diuretics, that is, operate by stimulating he nervous system, by alleviating kidney congestion, by increasing blood pressure, or by increasing or improving liquid transport.. methyclothiazide. this classification denotes a thiazide diuretic with the molecular formula c9h11cl2n3o4s2, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier l3h46uac61, chemically known as 6-chloro-3-(chloromethyl)-3,4-dihydro-2-methyl-2h-1,2,4-benzothiadiazine-7-sulfonamide 1,1-dioxide but generally known as methyclothiazide, which bears us nih compound identifier 4121. european medicines agency schedules methyclothiazide in its extended eudravigilance medicinal product dictionary or xevmpd under index sub08861mig. the term methyclothiazide is an international non-proprietary name or inn (see who inn reference publication, volume 19 1975, list 5). world health organization schedules methyclothiazide in its anatomical therapeutic chemical (atc) classification. methyclothiazide is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule methyclothiazide under hs 29350090 and sitc 51580. as of q4 2014, methyclothiazide remains the us fda preferred term for this commodity. methyclothiazide bears us nlm identifiers umls id c0025696 and nci concept code c47614. smiles: clcc1n(s(=o)(=o)c2c(n1)cc(cl)c(s(=o)(=o)n)c2)c.. "
"diuretics. this classification denotes agents or substances that promote excretion of urine by influencing human kidney function, commonly known as diuretics. the major diuretic types include osmotic (diuretics that increase urine volume by increasing osmotically-active urine solute); potassium sparing (diuretics that limit potassium secretion in urine); sodium chloride symporter inhibitors; and sodium potassium chloride symporter inhibitors. diuretics, that is, operate by stimulating he nervous system, by alleviating kidney congestion, by increasing blood pressure, or by increasing or improving liquid transport.. pamabrom. this classification denotes a diuretic with the molecular formula c7h7brn4o2.c4h11no, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier ua8u0kjm72, chemically known as 8-bromo-3,7-dihydro-1,3-dimethyl-1h-purine-2,6-dione compound with 2-amino-2-methyl-1-propanol (1:1) but generally known as pamabrom, which bears us nih compound identifier 11806. european medicines agency schedules pamabrom in its extended eudravigilance medicinal product dictionary or xevmpd under index sub14745mig. as of q4 2014, pamabrom remains the us fda preferred term for this commodity. pamabrom bears us nlm identifiers umls id c0135166 and nci concept code c81076. smiles: brc1[nh]c2c(n(c(=o)n(c2=o)c)c)n1.occ(n)(c)c.. "
"diuretics. this classification denotes agents or substances that promote excretion of urine by influencing human kidney function, commonly known as diuretics. the major diuretic types include osmotic (diuretics that increase urine volume by increasing osmotically-active urine solute); potassium sparing (diuretics that limit potassium secretion in urine); sodium chloride symporter inhibitors; and sodium potassium chloride symporter inhibitors. diuretics, that is, operate by stimulating he nervous system, by alleviating kidney congestion, by increasing blood pressure, or by increasing or improving liquid transport.. polythiazide. this classification denotes a thiazide diuretic with the molecular formula c11h13clf3n3o4s3, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 36780apv5n, chemically known as 6-chloro-3,4-dihydro-2-methyl-7-sulphamoyl-3-(2,2,2-trifluoroethylthiomethyl)-2h-benzo-1,2,4-thiadiazine 1,1-dioxide but generally known as polythiazide, which bears us nih compound identifier 4870. european medicines agency schedules polythiazide in its extended eudravigilance medicinal product dictionary or xevmpd under index sub09976mig. the term polythiazide is an international non-proprietary name or inn (see who inn reference publication, volume 19 1975, list 5). world health organization schedules polythiazide in its anatomical therapeutic chemical (atc) classification. polythiazide is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule polythiazide under hs 29350090 and sitc 51580. as of q4 2014, polythiazide remains the us fda preferred term for this commodity. polythiazide bears us nlm identifiers umls id c0032613 and nci concept code c47676. smiles: cn1c(nc2=cc(=c(c=c2s1(=o)=o)s(=o)(=o)n)cl)cscc(f)(f)f.. "
"diuretics. this classification denotes agents or substances that promote excretion of urine by influencing human kidney function, commonly known as diuretics. the major diuretic types include osmotic (diuretics that increase urine volume by increasing osmotically-active urine solute); potassium sparing (diuretics that limit potassium secretion in urine); sodium chloride symporter inhibitors; and sodium potassium chloride symporter inhibitors. diuretics, that is, operate by stimulating he nervous system, by alleviating kidney congestion, by increasing blood pressure, or by increasing or improving liquid transport.. urea osmotic diuretic. this classification denotes an osmotic diuretic with the molecular formula ch4n2o, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 8w8t17847w, chemically known as urea, homopolymer but generally known as carbamide, which bears us nih compound identifier 1176. carbamide most often comes in base, perhydrate, peroxide, phenylacetate, and resin forms. european medicines agency schedules urea in its extended eudravigilance medicinal product dictionary or xevmpd under index sub15662mig. world health organization schedules carbamide in its anatomical therapeutic chemical (atc) classification. smiles: o=c(n)n.. "
"diuretics. this classification denotes agents or substances that promote excretion of urine by influencing human kidney function, commonly known as diuretics. the major diuretic types include osmotic (diuretics that increase urine volume by increasing osmotically-active urine solute); potassium sparing (diuretics that limit potassium secretion in urine); sodium chloride symporter inhibitors; and sodium potassium chloride symporter inhibitors. diuretics, that is, operate by stimulating he nervous system, by alleviating kidney congestion, by increasing blood pressure, or by increasing or improving liquid transport.. amisometradine. this classification denotes a diuretic with the molecular formula c9h13n3o2, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 30973n61zf, chemically known as 2,4(1h,3h)-pyrimidinedione, 6-amino-3-methyl-1-(2-methyl-2-propenyl)- (9ci) but generally known as amisometradine, which bears us nih compound identifier 11071. european medicines agency schedules amisometradine in its extended eudravigilance medicinal product dictionary or xevmpd under index sub05457mig. the term amisometradine is an international non-proprietary name or inn (see who inn reference publication, volume 13, no. 12, 1959, list 3). amisometradine is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule amisometradine under hs 29335995 and sitc 51576. as of q4 2014, amisometradine remains the us fda preferred term for this commodity. amisometradine bears us nlm identifiers umls id c0301545 and nci concept code c76646. smiles: o=c1n(cc(=c)c)c(n)cc(=o)n1c.. "
"diuretics. this classification denotes agents or substances that promote excretion of urine by influencing human kidney function, commonly known as diuretics. the major diuretic types include osmotic (diuretics that increase urine volume by increasing osmotically-active urine solute); potassium sparing (diuretics that limit potassium secretion in urine); sodium chloride symporter inhibitors; and sodium potassium chloride symporter inhibitors. diuretics, that is, operate by stimulating he nervous system, by alleviating kidney congestion, by increasing blood pressure, or by increasing or improving liquid transport.. aditeren. this classification denotes a diuretic with the molecular formula c13h17n5o2, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier l4f80m873g, chemically known as 2,4-diamino-5-(4-amino-3,5-dimethoxybenzyl)pyrimidine but generally known as aditeren, which bears us nih compound identifier 176875. european medicines agency schedules aditeren in its extended eudravigilance medicinal product dictionary or xevmpd under index sub05274mig. the term aditeren is an international non-proprietary name or inn (see who inn reference publication, volume 35, no. 5 1981, list 21). aditeren is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule aditeren under hs 29335995 and sitc 51576. as of q4 2014, aditeren remains the us fda preferred term for this commodity. aditeren bears us nlm identifiers umls id c2700367 and nci concept code c74259. smiles: o(c1cc(cc2c(nc(nc2)n)n)cc(oc)c1n)c.. "
"diuretics. this classification denotes agents or substances that promote excretion of urine by influencing human kidney function, commonly known as diuretics. the major diuretic types include osmotic (diuretics that increase urine volume by increasing osmotically-active urine solute); potassium sparing (diuretics that limit potassium secretion in urine); sodium chloride symporter inhibitors; and sodium potassium chloride symporter inhibitors. diuretics, that is, operate by stimulating he nervous system, by alleviating kidney congestion, by increasing blood pressure, or by increasing or improving liquid transport.. alipamide. this classification denotes a diuretic with the molecular formula c9h12cln3o3s, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier pe8925k9ey, chemically known as 4-chloro-3-sulfamoylbenzoic acid 2,2-dimethylhydrazide but generally known as alipamide, which bears us nih compound identifier 18520. european medicines agency schedules alipamide in its extended eudravigilance medicinal product dictionary or xevmpd under index sub05331mig. the term alipamide is an international non-proprietary name or inn (see who inn reference publication, volume 22, no. 10, 1968, list 8). alipamide is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule alipamide under hs 29350090 and sitc 51580. as of q4 2014, alipamide remains the us fda preferred term for this commodity. alipamide bears us nlm identifiers umls id c2825440 and nci concept code c81071. smiles: clc1c(s(=o)(=o)n)cc(cc1)c(=o)nn(c)c.. "
"diuretics. this classification denotes agents or substances that promote excretion of urine by influencing human kidney function, commonly known as diuretics. the major diuretic types include osmotic (diuretics that increase urine volume by increasing osmotically-active urine solute); potassium sparing (diuretics that limit potassium secretion in urine); sodium chloride symporter inhibitors; and sodium potassium chloride symporter inhibitors. diuretics, that is, operate by stimulating he nervous system, by alleviating kidney congestion, by increasing blood pressure, or by increasing or improving liquid transport.. althiazide or altizide. this classification denotes a thiazide diuretic with the molecular formula c11h14cln3o4s3, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier gi8cb72b0d, chemically known as 6-chloro-3,4-dihydro-3-((2-propenylthio)methyl)-2h-1,2,4-benzothiadiazine-7-sulfonamide but generally known as althiazide, which bears us nih compound identifier 2122. european medicines agency schedules althiazide in its extended eudravigilance medicinal product dictionary or xevmpd under index sub05379mig. althiazide or altizide bears us nlm identifiers umls id c0051500 and nci concept code c80838. smiles: c=ccscc1nc2=cc(=c(c=c2s(=o)(=o)n1)s(=o)(=o)n)cl.. "
"diuretics. this classification denotes agents or substances that promote excretion of urine by influencing human kidney function, commonly known as diuretics. the major diuretic types include osmotic (diuretics that increase urine volume by increasing osmotically-active urine solute); potassium sparing (diuretics that limit potassium secretion in urine); sodium chloride symporter inhibitors; and sodium potassium chloride symporter inhibitors. diuretics, that is, operate by stimulating he nervous system, by alleviating kidney congestion, by increasing blood pressure, or by increasing or improving liquid transport.. amanozine. this classification denotes a diuretic with the molecular formula c9h9n5, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier x43w7jda8l, chemically known as 1,3,5-triazine-2,4-diamine, n-phenyl-, monohydrochloride but generally known as amanozine, which bears us nih compound identifier 10832. amanozine most often comes in base and hydrochloride forms. european medicines agency schedules amanozine in its extended eudravigilance medicinal product dictionary or xevmpd under index sub05388mig. the term amanozine is an international non-proprietary name or inn (see who inn reference publication, volume 16, no. 3 1962, list 4). amanozine is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule amanozine under hs 29336980 and sitc 51576. as of q4 2014, amanozine remains the us fda preferred term for this commodity. amanozine bears us nlm identifiers umls id c2698079 and nci concept code c74253. smiles: n(c1ccccc1)c1nc(ncn1)n.. "
"diuretics. this classification denotes agents or substances that promote excretion of urine by influencing human kidney function, commonly known as diuretics. the major diuretic types include osmotic (diuretics that increase urine volume by increasing osmotically-active urine solute); potassium sparing (diuretics that limit potassium secretion in urine); sodium chloride symporter inhibitors; and sodium potassium chloride symporter inhibitors. diuretics, that is, operate by stimulating he nervous system, by alleviating kidney congestion, by increasing blood pressure, or by increasing or improving liquid transport.. aminometradine. this classification denotes a diuretic with the molecular formula c9h13n3o2, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier ppm8sx5q3v, chemically known as 6-amino-3-ethyl-1-(2-propenyl)-2,4(1h,3h-)-pyrimidinedione but generally known as aminometradine, which bears us nih compound identifier 12551. european medicines agency schedules aminometradine in its extended eudravigilance medicinal product dictionary or xevmpd under index sub05441mig. the term aminometradine is an international non-proprietary name or inn (see who inn reference publication, volume 13, no. 12, 1959, list 3). aminometradine is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule aminometradine under hs 29335995 and sitc 51576. as of q4 2014, aminometradine remains the us fda preferred term for this commodity. aminometradine bears us nlm identifiers umls id c0301544 and nci concept code c76645. smiles: o=c1n(cc)c(=o)cc(n1cc=c)n.. "
"diuretics. this classification denotes agents or substances that promote excretion of urine by influencing human kidney function, commonly known as diuretics. the major diuretic types include osmotic (diuretics that increase urine volume by increasing osmotically-active urine solute); potassium sparing (diuretics that limit potassium secretion in urine); sodium chloride symporter inhibitors; and sodium potassium chloride symporter inhibitors. diuretics, that is, operate by stimulating he nervous system, by alleviating kidney congestion, by increasing blood pressure, or by increasing or improving liquid transport.. azolimine. this classification denotes a diuretic with the molecular formula c10h11n3o, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier des29595kx, chemically known as 4-imidazolidinone, 2-imino-3-methyl-1-phenyl- but generally known as azolimine, which bears us nih compound identifier 38684. european medicines agency schedules azolimine in its extended eudravigilance medicinal product dictionary or xevmpd under index sub05662mig. the term azolimine is an international non-proprietary name or inn (see who inn reference publication, volume 29, no. 10 1975, list 15). azolimine is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule azolimine under hs 29332990 and sitc 51573. as of q4 2014, azolimine remains the us fda preferred term for this commodity. azolimine bears us nlm identifiers umls id c0604541 and nci concept code c77555. smiles: cn1c(=o)cn(c1=n)c2=cc=cc=c2.. "
"diuretics. this classification denotes agents or substances that promote excretion of urine by influencing human kidney function, commonly known as diuretics. the major diuretic types include osmotic (diuretics that increase urine volume by increasing osmotically-active urine solute); potassium sparing (diuretics that limit potassium secretion in urine); sodium chloride symporter inhibitors; and sodium potassium chloride symporter inhibitors. diuretics, that is, operate by stimulating he nervous system, by alleviating kidney congestion, by increasing blood pressure, or by increasing or improving liquid transport.. bemitradine. this classification denotes a diuretic with the molecular formula c15h17n5o, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier lt9004d9n0, chemically known as 8-(2-ethoxyethyl)-7-phenyl-(1,2,4)triazolo(1,5-c)pyrimidin-5-amine but generally known as bemitradine, which bears us nih compound identifier 55784. european medicines agency schedules bemitradine in its extended eudravigilance medicinal product dictionary or xevmpd under index sub05694mig. the term bemitradine is an international non-proprietary name or inn (see who inn reference publication, volume 40, no. 6, 1986, list 26). bemitradine is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule bemitradine under hs 29335995 and sitc 51576. as of q4 2014, bemitradine remains the us fda preferred term for this commodity. bemitradine bears us nlm identifiers umls id c0165297 and nci concept code c77556. smiles: o(ccc1c(nc(n2ncnc12)n)c1ccccc1)cc.. "
"diuretics. this classification denotes agents or substances that promote excretion of urine by influencing human kidney function, commonly known as diuretics. the major diuretic types include osmotic (diuretics that increase urine volume by increasing osmotically-active urine solute); potassium sparing (diuretics that limit potassium secretion in urine); sodium chloride symporter inhibitors; and sodium potassium chloride symporter inhibitors. diuretics, that is, operate by stimulating he nervous system, by alleviating kidney congestion, by increasing blood pressure, or by increasing or improving liquid transport.. benzthiazide. this classification denotes a thiazide diuretic with the molecular formula c15h14cln3o4s3, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 1td8j48l61, chemically known as 6-chloro-7-sulfamoyl-3-benzylthiomethyl-2h-1,2,4-benzothiadiazine 1,1-dioxide but generally known as benzthiazide, which bears us nih compound identifier 2343. european medicines agency schedules benzthiazide in its extended eudravigilance medicinal product dictionary or xevmpd under index sub05769mig. the term benzthiazide is an international non-proprietary name or inn (see who inn reference publication, volume 16, no. 3 1962, list 4). benzthiazide is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule benzthiazide under hs 29350090 and sitc 51580. as of q4 2014, benzthiazide remains the us fda preferred term for this commodity. benzthiazide bears us nlm identifiers umls id c0053245 and nci concept code c65254. smiles: clc1c(s(=o)(=o)n)cc2s(=o)(=o)n=c(nc2c1)cscc1ccccc1.. "
"diuretics. this classification denotes agents or substances that promote excretion of urine by influencing human kidney function, commonly known as diuretics. the major diuretic types include osmotic (diuretics that increase urine volume by increasing osmotically-active urine solute); potassium sparing (diuretics that limit potassium secretion in urine); sodium chloride symporter inhibitors; and sodium potassium chloride symporter inhibitors. diuretics, that is, operate by stimulating he nervous system, by alleviating kidney congestion, by increasing blood pressure, or by increasing or improving liquid transport.. besulpamide. this classification denotes a diuretic with the molecular formula c15h16cln3o3s, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 048uj2mm65, chemically known as 1-((4-chloro-3-sulfamoylbenzoyl)amino)-2,4,6-trimethylpyridinium hydroxide, inner salt but generally known as besulpamide, which bears us nih compound identifier 9571085. european medicines agency schedules besulpamide in its extended eudravigilance medicinal product dictionary or xevmpd under index sub05789mig. the term besulpamide is an international non-proprietary name or inn (see who inn reference publication, volume 39, no. 5, 1985, list 25). besulpamide is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule besulpamide under hs 29350090 and sitc 51580. as of q4 2014, besulpamide remains the us fda preferred term for this commodity. besulpamide bears us nlm identifiers umls id c0053356 and nci concept code c74254. smiles: clc1c(s(=o)(=o)n)cc(c(=n\\[n]2c(cc(cc2c)c)c)\\o)cc1.. "
"diuretics. this classification denotes agents or substances that promote excretion of urine by influencing human kidney function, commonly known as diuretics. the major diuretic types include osmotic (diuretics that increase urine volume by increasing osmotically-active urine solute); potassium sparing (diuretics that limit potassium secretion in urine); sodium chloride symporter inhibitors; and sodium potassium chloride symporter inhibitors. diuretics, that is, operate by stimulating he nervous system, by alleviating kidney congestion, by increasing blood pressure, or by increasing or improving liquid transport.. brocrinat. this classification denotes a diuretic with the molecular formula c15h9brfno4, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 6esf2z39vz, chemically known as acetic acid, ((7-bromo-3-(2-fluorophenyl)-1,2-benzisoxazol-6-yl)oxy)- but generally known as brocrinat, which bears us nih compound identifier 51603. european medicines agency schedules brocrinat in its extended eudravigilance medicinal product dictionary or xevmpd under index sub05897mig. the term brocrinat is an international non-proprietary name or inn (see who inn reference publication, volume 38, no. 6, 1984, list 24). brocrinat is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule brocrinat under hs 29349990 and sitc 51579. as of q4 2014, brocrinat remains the us fda preferred term for this commodity. brocrinat bears us nlm identifiers umls id c2825442 and nci concept code c81073. smiles: brc1c2onc(c2ccc1occ(=o)o)c1c(f)cccc1.. "
"diuretics. this classification denotes agents or substances that promote excretion of urine by influencing human kidney function, commonly known as diuretics. the major diuretic types include osmotic (diuretics that increase urine volume by increasing osmotically-active urine solute); potassium sparing (diuretics that limit potassium secretion in urine); sodium chloride symporter inhibitors; and sodium potassium chloride symporter inhibitors. diuretics, that is, operate by stimulating he nervous system, by alleviating kidney congestion, by increasing blood pressure, or by increasing or improving liquid transport.. chlormerodrin. this classification denotes a loop diuretic with the molecular formula c5h11clhgn2o2, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 99t5two621, chemically known as urea, (3-(chloromercurio)-2-methoxypropyl)- but generally known as chlormerodrin, which bears us nih compound identifier 2716. european medicines agency schedules chlormerodrin in its extended eudravigilance medicinal product dictionary or xevmpd under index sub06184mig. the term chlormerodrin is an international non-proprietary name. chlormerodrin is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule chlormerodrin under hs 28444030 and sitc 52519. as of q4 2014, chlormerodrin remains the us fda preferred term for this commodity. chlormerodrin bears us nlm identifiers umls id c0008217 and nci concept code c65315. smiles: [hg]1(cl)[o]=c(ncc(oc)c1)n.. "
"diuretics. this classification denotes agents or substances that promote excretion of urine by influencing human kidney function, commonly known as diuretics. the major diuretic types include osmotic (diuretics that increase urine volume by increasing osmotically-active urine solute); potassium sparing (diuretics that limit potassium secretion in urine); sodium chloride symporter inhibitors; and sodium potassium chloride symporter inhibitors. diuretics, that is, operate by stimulating he nervous system, by alleviating kidney congestion, by increasing blood pressure, or by increasing or improving liquid transport.. dehydrocholic acid. this classification denotes a cholagogue or choleretic agent with the molecular formula c24h34o5, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier nh5000009i, chemically known as cholan-24-oic acid, 3,7,12-trioxo-, (5.beta.)- but generally known as dehydrocholic acid, which bears us nih compound identifier 2975. european medicines agency schedules dehydrocholic acid in its extended eudravigilance medicinal product dictionary or xevmpd under index sub06945mig. the term dehydrocholic acid is an international non-proprietary name. most nations schedule dehydrocholic acid under hs 29183000 and sitc 51395. as of q4 2014, dehydrocholic acid remains the us fda preferred term for this commodity. dehydrocholic acid bears us nlm identifiers umls id c0011182 and nci concept code c76605. smiles: o=c1c2(c(c3c(c4(c(cc3=o)cc(=o)cc4)c)c1)ccc2c(ccc(=o)o)c)c.. "
"diuretics. this classification denotes agents or substances that promote excretion of urine by influencing human kidney function, commonly known as diuretics. the major diuretic types include osmotic (diuretics that increase urine volume by increasing osmotically-active urine solute); potassium sparing (diuretics that limit potassium secretion in urine); sodium chloride symporter inhibitors; and sodium potassium chloride symporter inhibitors. diuretics, that is, operate by stimulating he nervous system, by alleviating kidney congestion, by increasing blood pressure, or by increasing or improving liquid transport.. cicletanine. this classification denotes a diuretic with the molecular formula c14h12clno2, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier chg7qc509w, chemically known as win 90,000 but generally known as cicletanine, which bears us nih compound identifier 54910. european medicines agency schedules cicletanine in its extended eudravigilance medicinal product dictionary or xevmpd under index sub06237mig. the term cicletanine is an international non-proprietary name. world health organization schedules cicletanine in its anatomical therapeutic chemical (atc) classification. cicletanine is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule cicletanine under hs 29349990 and sitc 51579. as of q4 2014, cicletanine remains the us fda preferred term for this commodity. cicletanine bears us nlm identifiers umls id c0056686 and nci concept code c77557. smiles: clc1ccc(c2occ3c2cnc(c3o)c)cc1.. "
"diuretics. this classification denotes agents or substances that promote excretion of urine by influencing human kidney function, commonly known as diuretics. the major diuretic types include osmotic (diuretics that increase urine volume by increasing osmotically-active urine solute); potassium sparing (diuretics that limit potassium secretion in urine); sodium chloride symporter inhibitors; and sodium potassium chloride symporter inhibitors. diuretics, that is, operate by stimulating he nervous system, by alleviating kidney congestion, by increasing blood pressure, or by increasing or improving liquid transport.. clazolimine. this classification denotes a diuretic with the molecular formula c10h10cln3o, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier c3xsg3dlpa, chemically known as 4-imidazolidinone, 1-(4-chlorophenyl)-2-imino-3-methyl- but generally known as clazolimine, which bears us nih compound identifier 38683. european medicines agency schedules clazolimine in its extended eudravigilance medicinal product dictionary or xevmpd under index sub06644mig. the term clazolimine is an international non-proprietary name or inn (see who inn reference publication, volume 29, no. 10 1975, list 15). clazolimine is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule clazolimine under hs 29332100 and sitc 51572. as of q4 2014, clazolimine remains the us fda preferred term for this commodity. clazolimine bears us nlm identifiers umls id c2699341 and nci concept code c77558. smiles: cn1c(=o)cn(c1=n)c2=cc=c(c=c2)cl.. "
"diuretics. this classification denotes agents or substances that promote excretion of urine by influencing human kidney function, commonly known as diuretics. the major diuretic types include osmotic (diuretics that increase urine volume by increasing osmotically-active urine solute); potassium sparing (diuretics that limit potassium secretion in urine); sodium chloride symporter inhibitors; and sodium potassium chloride symporter inhibitors. diuretics, that is, operate by stimulating he nervous system, by alleviating kidney congestion, by increasing blood pressure, or by increasing or improving liquid transport.. clofenamide. this classification denotes a diuretic with the molecular formula c6h7cln2o4s2, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 582iln204b, chemically known as 1,3-benzenedisulfonamide, 4-chloro- but generally known as clofenamide, which bears us nih compound identifier 69594. european medicines agency schedules clofenamide in its extended eudravigilance medicinal product dictionary or xevmpd under index sub06697mig. the term clofenamide is an international non-proprietary name or inn (see who inn reference publication, volume 19 1975, list 5). world health organization schedules clofenamide in its anatomical therapeutic chemical (atc) classification. clofenamide is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule clofenamide under hs 29350090 and sitc 51580. as of q4 2014, clofenamide remains the us fda preferred term for this commodity. clofenamide bears us nlm identifiers umls id c2699364 and nci concept code c77559. smiles: clc1c(s(=o)(=o)n)cc(s(=o)(=o)n)cc1.. "
"diuretics. this classification denotes agents or substances that promote excretion of urine by influencing human kidney function, commonly known as diuretics. the major diuretic types include osmotic (diuretics that increase urine volume by increasing osmotically-active urine solute); potassium sparing (diuretics that limit potassium secretion in urine); sodium chloride symporter inhibitors; and sodium potassium chloride symporter inhibitors. diuretics, that is, operate by stimulating he nervous system, by alleviating kidney congestion, by increasing blood pressure, or by increasing or improving liquid transport.. clopamide. this classification denotes a diuretic with the molecular formula c14h20cln3o3s, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 17s83won0i, chemically known as 4-chloro-n-(2,6-dimethyl-piperidin-1-yl)-3-sulfamoyl-benzamide but generally known as clopamide, which bears us nih compound identifier 2804. european medicines agency schedules clopamide in its extended eudravigilance medicinal product dictionary or xevmpd under index sub06735mig. the term clopamide is an international non-proprietary name or inn (see who inn reference publication, volume 19 1975, list 5). world health organization schedules clopamide in its anatomical therapeutic chemical (atc) classification. clopamide is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule clopamide under hs 29350090 and sitc 51580. as of q4 2014, clopamide remains the us fda preferred term for this commodity. clopamide bears us nlm identifiers umls id c0009025 and nci concept code c81074. smiles: clc1c(s(=o)(=o)n)cc(c(=o)nn2c(cccc2c)c)cc1.. "
"diuretics. this classification denotes agents or substances that promote excretion of urine by influencing human kidney function, commonly known as diuretics. the major diuretic types include osmotic (diuretics that increase urine volume by increasing osmotically-active urine solute); potassium sparing (diuretics that limit potassium secretion in urine); sodium chloride symporter inhibitors; and sodium potassium chloride symporter inhibitors. diuretics, that is, operate by stimulating he nervous system, by alleviating kidney congestion, by increasing blood pressure, or by increasing or improving liquid transport.. clorexolone. this classification denotes a diuretic with the molecular formula c14h17cln2o3s, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier q2plt3fs05, chemically known as 6-chloro-2-cyclohexyl-2,3-dihydro-3-oxo-1h-isoindole-5-sulfonamide but generally known as clorexolone, which bears us nih compound identifier 16473. european medicines agency schedules clorexolone in its extended eudravigilance medicinal product dictionary or xevmpd under index sub06754mig. the term clorexolone is an international non-proprietary name or inn (see who inn reference publication, volume 14, no. 1, 2000, list 43). world health organization schedules clorexolone in its anatomical therapeutic chemical (atc) classification. clorexolone is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule clorexolone under hs 29350090 and sitc 51580. as of q4 2014, clorexolone remains the us fda preferred term for this commodity. clorexolone bears us nlm identifiers umls id c0055938 and nci concept code c81075. smiles: clc1cc2cn(c3ccccc3)c(=o)c2cc1s(=o)(=o)n.. "
"diuretics. this classification denotes agents or substances that promote excretion of urine by influencing human kidney function, commonly known as diuretics. the major diuretic types include osmotic (diuretics that increase urine volume by increasing osmotically-active urine solute); potassium sparing (diuretics that limit potassium secretion in urine); sodium chloride symporter inhibitors; and sodium potassium chloride symporter inhibitors. diuretics, that is, operate by stimulating he nervous system, by alleviating kidney congestion, by increasing blood pressure, or by increasing or improving liquid transport.. cyclopenthiazide. this classification denotes a thiazide diuretic with the molecular formula c13h18cln3o4s2, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier vx4s2n85f5, chemically known as 6-chloro-3-(cyclopentylmethyl)-3,4-dihydro-2h-1,2, 4-benzothiadiazine-7-sulfonamide 1,1-dioxide but generally known as cyclopenthiazide, which bears us nih compound identifier 2904. european medicines agency schedules cyclopenthiazide in its extended eudravigilance medicinal product dictionary or xevmpd under index sub06857mig. the term cyclopenthiazide is an international non-proprietary name or inn (see who inn reference publication, volume 19 1975, list 5). world health organization schedules cyclopenthiazide in its anatomical therapeutic chemical (atc) classification. cyclopenthiazide is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule cyclopenthiazide under hs 29350090 and sitc 51580. as of q4 2014, cyclopenthiazide remains the us fda preferred term for this commodity. cyclopenthiazide bears us nlm identifiers umls id c0010581 and nci concept code c80839. smiles: clc1cc2nc(ns(=o)(=o)c2cc1s(=o)(=o)n)cc1cccc1.. "
"diuretics. this classification denotes agents or substances that promote excretion of urine by influencing human kidney function, commonly known as diuretics. the major diuretic types include osmotic (diuretics that increase urine volume by increasing osmotically-active urine solute); potassium sparing (diuretics that limit potassium secretion in urine); sodium chloride symporter inhibitors; and sodium potassium chloride symporter inhibitors. diuretics, that is, operate by stimulating he nervous system, by alleviating kidney congestion, by increasing blood pressure, or by increasing or improving liquid transport.. cyclothiazide. this classification denotes a thiazide diuretic with the molecular formula c14h16cln3o4s2, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier p71u09g5bw, chemically known as 6-chloro-3,4-dihydro-3-(norbornen-2-yl)-2h-1,2,4-benzothiadiazine-7-sulfonamide 1,1-dioxide but generally known as cyclothiazide, which bears us nih compound identifier 2910. european medicines agency schedules cyclothiazide in its extended eudravigilance medicinal product dictionary or xevmpd under index sub06864mig. the term cyclothiazide is an international non-proprietary name or inn (see who inn reference publication, volume 19 1975, list 5). world health organization schedules cyclothiazide in its anatomical therapeutic chemical (atc) classification. cyclothiazide is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule cyclothiazide under hs 29350090 and sitc 51580. as of q4 2014, cyclothiazide remains the us fda preferred term for this commodity. cyclothiazide bears us nlm identifiers umls id c0056831 and nci concept code c65358. smiles: clc1cc2nc(ns(=o)(=o)c2cc1s(=o)(=o)n)c1c2cc(c1)c=c2.. "
"diuretics. this classification denotes agents or substances that promote excretion of urine by influencing human kidney function, commonly known as diuretics. the major diuretic types include osmotic (diuretics that increase urine volume by increasing osmotically-active urine solute); potassium sparing (diuretics that limit potassium secretion in urine); sodium chloride symporter inhibitors; and sodium potassium chloride symporter inhibitors. diuretics, that is, operate by stimulating he nervous system, by alleviating kidney congestion, by increasing blood pressure, or by increasing or improving liquid transport.. epithiazide or epitizide. this classification denotes a thiazide diuretic with the molecular formula c10h11clf3n3o4s3, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 5b266b85j1, chemically known as 6-chloro-3, 4-dihydro-7-sulfamoyl-3-(2,2,2-trifluoroethylthiomethyl)-2h-1,2, 4-benzothiadiazine 1,1-dioxide but generally known as epithiazide, which bears us nih compound identifier 15671. european medicines agency schedules epitizide in its extended eudravigilance medicinal product dictionary or xevmpd under index sub06573mig. the term epitizide is an international non-proprietary name or inn (see who inn reference publication, volume 19 1975, list 5). epithiazide or epitizide bears us nlm identifiers umls id c2700005 and nci concept code c77141. smiles: c1=c2c(=cc(=c1cl)s(=o)(=o)n)s(=o)(=o)nc(n2)cscc(f)(f)f.. "
"diuretics. this classification denotes agents or substances that promote excretion of urine by influencing human kidney function, commonly known as diuretics. the major diuretic types include osmotic (diuretics that increase urine volume by increasing osmotically-active urine solute); potassium sparing (diuretics that limit potassium secretion in urine); sodium chloride symporter inhibitors; and sodium potassium chloride symporter inhibitors. diuretics, that is, operate by stimulating he nervous system, by alleviating kidney congestion, by increasing blood pressure, or by increasing or improving liquid transport.. etacrynic acid or ethacrynic acid. this classification denotes a loop diuretic with the molecular formula c13h12cl2o4, a preparation that us fda recognizes as an active ingredient or moiety under unique ingredient identifier m5dp350vzv, chemically known as 2,3-dichloro-4-(2-methylenebutyryl)phenoxy acetic acid but more generally known as etacrynic acid, which bears us nih compound identifier 3278. european medicines agency schedules etacrynic acid in its extended eudravigilance medicinal product dictionary or xevmpd under index sub07255mig. the term etacrynic acid is an international non-proprietary name world health organization schedules etacrynic acid in its anatomical therapeutic chemical (atc) classification. ethacrynic acid bears us nlm identifiers umls id c0014963 and nci concept code c485. smiles: clc1c(c(=o)c(=c)cc)ccc(occ(=o)o)c1cl.. "
"diuretics. this classification denotes agents or substances that promote excretion of urine by influencing human kidney function, commonly known as diuretics. the major diuretic types include osmotic (diuretics that increase urine volume by increasing osmotically-active urine solute); potassium sparing (diuretics that limit potassium secretion in urine); sodium chloride symporter inhibitors; and sodium potassium chloride symporter inhibitors. diuretics, that is, operate by stimulating he nervous system, by alleviating kidney congestion, by increasing blood pressure, or by increasing or improving liquid transport.. ethiazide. this classification denotes a thiazide diuretic with the molecular formula c9h12cln3o4s2, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier ek9lsw731r, chemically known as 6-chloro-3-ethyl-3,4-dihydro-2h-1,2,4-benzothiadiazine-7-sulfonamide 1,1-dioxide but generally known as ethiazide, which bears us nih compound identifier 15763. european medicines agency schedules ethiazide in its extended eudravigilance medicinal product dictionary or xevmpd under index sub07275mig. the term ethiazide is an international non-proprietary name. ethiazide is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule ethiazide under hs 29350090 and sitc 51580. as of q4 2014, ethiazide remains the us fda preferred term for this commodity. ethiazide bears us nlm identifiers umls id c0873164 and nci concept code c80840. smiles: clc1cc2nc(ns(=o)(=o)c2cc1s(=o)(=o)n)cc.. "
"diuretics. this classification denotes agents or substances that promote excretion of urine by influencing human kidney function, commonly known as diuretics. the major diuretic types include osmotic (diuretics that increase urine volume by increasing osmotically-active urine solute); potassium sparing (diuretics that limit potassium secretion in urine); sodium chloride symporter inhibitors; and sodium potassium chloride symporter inhibitors. diuretics, that is, operate by stimulating he nervous system, by alleviating kidney congestion, by increasing blood pressure, or by increasing or improving liquid transport.. fenquizone. this classification denotes a thiazide diuretic with the molecular formula c14h12cln3o3s, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier lj1u13r8ik, chemically known as 6-quinazolinesulfonamide, 7-chloro-1,2,3,4-tetrahydro-4-oxo-2-phenyl-, (+-)- but generally known as fenquizone, which bears us nih compound identifier 68548. european medicines agency schedules fenquizone in its extended eudravigilance medicinal product dictionary or xevmpd under index sub07594mig. the term fenquizone is an international non-proprietary name or inn (see who inn reference publication, volume 28, no. 10 1974, list 14). world health organization schedules fenquizone in its anatomical therapeutic chemical (atc) classification. fenquizone is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule fenquizone under hs 29350090 and sitc 51580. as of q4 2014, fenquizone remains the us fda preferred term for this commodity. fenquizone bears us nlm identifiers umls id c0060196 and nci concept code c65670. smiles: clc1c(s(=o)(=o)n)cc2c(nc(nc2=o)c2ccccc2)c1.. "
"diuretics. this classification denotes agents or substances that promote excretion of urine by influencing human kidney function, commonly known as diuretics. the major diuretic types include osmotic (diuretics that increase urine volume by increasing osmotically-active urine solute); potassium sparing (diuretics that limit potassium secretion in urine); sodium chloride symporter inhibitors; and sodium potassium chloride symporter inhibitors. diuretics, that is, operate by stimulating he nervous system, by alleviating kidney congestion, by increasing blood pressure, or by increasing or improving liquid transport.. frusemide or furosemide. this classification denotes a loop diuretic with the molecular formula c12h11cln2o5s, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 7lxu5n7zo5, chemically known as benzoic acid, 5-(aminosulfonyl)-4-chloro-2-((2-furanylmethyl)amino)- but generally known as furosemide, which bears us nih compound identifier 3440. european medicines agency schedules furosemide in its extended eudravigilance medicinal product dictionary or xevmpd under index sub07849mig. the term furosemide is an international non-proprietary name. world health organization schedules furosemide in its anatomical therapeutic chemical (atc) classification. furosemide is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. frusemide or furosemide bears us nlm identifiers umls id c0016860 and nci concept code c515. smiles: c1=coc(=c1)cnc2=cc(=c(c=c2c(=o)o)s(=o)(=o)n)cl.. "
"diuretics. this classification denotes agents or substances that promote excretion of urine by influencing human kidney function, commonly known as diuretics. the major diuretic types include osmotic (diuretics that increase urine volume by increasing osmotically-active urine solute); potassium sparing (diuretics that limit potassium secretion in urine); sodium chloride symporter inhibitors; and sodium potassium chloride symporter inhibitors. diuretics, that is, operate by stimulating he nervous system, by alleviating kidney congestion, by increasing blood pressure, or by increasing or improving liquid transport.. furterene. this classification denotes a diuretic with the molecular formula c10h9n7o, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier ty1x1wg26a, chemically known as 2,4,7-triamino-6-(2-furyl)pteridine but generally known as furterene, which bears us nih compound identifier 71852. european medicines agency schedules furterene in its extended eudravigilance medicinal product dictionary or xevmpd under index sub07853mig. the term furterene is an international non-proprietary name. furterene is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule furterene under hs 29349990 and sitc 51579. as of q4 2014, furterene remains the us fda preferred term for this commodity. furterene bears us nlm identifiers umls id c1880876 and nci concept code c65791. smiles: c1=coc(=c1)c2=nc3=c(n=c2n)n=c(n=c3n)n.. "
"diuretics. this classification denotes agents or substances that promote excretion of urine by influencing human kidney function, commonly known as diuretics. the major diuretic types include osmotic (diuretics that increase urine volume by increasing osmotically-active urine solute); potassium sparing (diuretics that limit potassium secretion in urine); sodium chloride symporter inhibitors; and sodium potassium chloride symporter inhibitors. diuretics, that is, operate by stimulating he nervous system, by alleviating kidney congestion, by increasing blood pressure, or by increasing or improving liquid transport.. mebutizide. this classification denotes a thiazide diuretic with the molecular formula c13h20cln3o4s2, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 7738as8324, chemically known as 6-chloro-3,4-dihydro-3-(1,2-dimethylbutyl)-2h-1,2,4-benzothiadiazine-7-sulfonamide 1,1-dioxide but generally known as mebutizide, which bears us nih compound identifier 71652. european medicines agency schedules mebutizide in its extended eudravigilance medicinal product dictionary or xevmpd under index sub08669mig. the term mebutizide is an international non-proprietary name. world health organization schedules mebutizide in its anatomical therapeutic chemical (atc) classification. mebutizide is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule mebutizide under hs 29350090 and sitc 51580. as of q4 2014, mebutizide remains the us fda preferred term for this commodity. mebutizide bears us nlm identifiers umls id c0603520 and nci concept code c83910. smiles: clc1cc2nc(ns(=o)(=o)c2cc1s(=o)(=o)n)c(c(cc)c)c.. "
"diuretics. this classification denotes agents or substances that promote excretion of urine by influencing human kidney function, commonly known as diuretics. the major diuretic types include osmotic (diuretics that increase urine volume by increasing osmotically-active urine solute); potassium sparing (diuretics that limit potassium secretion in urine); sodium chloride symporter inhibitors; and sodium potassium chloride symporter inhibitors. diuretics, that is, operate by stimulating he nervous system, by alleviating kidney congestion, by increasing blood pressure, or by increasing or improving liquid transport.. hydroxindasate. this classification denotes a diuretic, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier u8687j667p. european medicines agency schedules hydroxindasate in its extended eudravigilance medicinal product dictionary or xevmpd under index sub08072mig. hydroxindasate generally arises in the molecular formula c21h24n2o3. the term hydroxindasate is an international non-proprietary name or inn. hydroxindasate is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule hydroxindasate under hs 29339990 and sitc 51577. as of q4 2014, hydroxindasate remains the us fda preferred term for this commodity. hydroxindasate bears us nlm identifiers umls id c1881075 and nci concept code c65866. smiles: o(c1cc2c(c(n(c2cc1)cc1ccc(oc)cc1)c)ccn)c(=o)c.. "
"diuretics. this classification denotes agents or substances that promote excretion of urine by influencing human kidney function, commonly known as diuretics. the major diuretic types include osmotic (diuretics that increase urine volume by increasing osmotically-active urine solute); potassium sparing (diuretics that limit potassium secretion in urine); sodium chloride symporter inhibitors; and sodium potassium chloride symporter inhibitors. diuretics, that is, operate by stimulating he nervous system, by alleviating kidney congestion, by increasing blood pressure, or by increasing or improving liquid transport.. indapamide. this classification denotes a thiazide diuretic with the molecular formula c16h16cln3o3s, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier f089i0511l, chemically known as 4-chloro-n-(2-methyl-2,3-dihydroindol-1-yl)-3-sulfamoyl-benzamide but generally known as indapamide, which bears us nih compound identifier 3702. european medicines agency schedules indapamide in its extended eudravigilance medicinal product dictionary or xevmpd under index sub08169mig. the term indapamide is an international non-proprietary name or inn (see who inn reference publication, volume 27, no. 10 1973, list 13). world health organization schedules indapamide in its anatomical therapeutic chemical (atc) classification. indapamide is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule indapamide under hs 29350090 and sitc 51580. as of q4 2014, indapamide remains the us fda preferred term for this commodity. indapamide bears us nlm identifiers umls id c0021186 and nci concept code c29119. smiles: clc1c(s(=o)(=o)n)cc(c(=o)nn2c(cc3c2cccc3)c)cc1.. "
"diuretics. this classification denotes agents or substances that promote excretion of urine by influencing human kidney function, commonly known as diuretics. the major diuretic types include osmotic (diuretics that increase urine volume by increasing osmotically-active urine solute); potassium sparing (diuretics that limit potassium secretion in urine); sodium chloride symporter inhibitors; and sodium potassium chloride symporter inhibitors. diuretics, that is, operate by stimulating he nervous system, by alleviating kidney congestion, by increasing blood pressure, or by increasing or improving liquid transport.. isosorbide dinitrate. this classification denotes a vasodilating agent with the molecular formula c6h8n2o8, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier ia7306519n, chemically known as 1,4:3,6-dianhydrosorbitol 2, 5-dinitrate but generally known as isosorbide dinitrate, which bears us nih compound identifier 3780. european medicines agency schedules isosorbide dinitrate in its extended eudravigilance medicinal product dictionary or xevmpd under index sub08335mig. the term isosorbide dinitrate is an international non-proprietary name or inn (see who inn reference publication, volume 19 1975, list 5). world health organization schedules isosorbide dinitrate in its anatomical therapeutic chemical (atc) classification. most nations schedule isosorbide dinitrate under hs 29329985 and sitc 51569. as of q4 2014, isosorbide dinitrate remains the us fda preferred term for this commodity. isosorbide dinitrate bears us nlm identifiers umls id c0022252 and nci concept code c29134. smiles: o1c2c(occ2o[n](=o)o)c(o[n](=o)o)c1.. "
"diuretics. this classification denotes agents or substances that promote excretion of urine by influencing human kidney function, commonly known as diuretics. the major diuretic types include osmotic (diuretics that increase urine volume by increasing osmotically-active urine solute); potassium sparing (diuretics that limit potassium secretion in urine); sodium chloride symporter inhibitors; and sodium potassium chloride symporter inhibitors. diuretics, that is, operate by stimulating he nervous system, by alleviating kidney congestion, by increasing blood pressure, or by increasing or improving liquid transport.. isosorbide mononitrate. this classification denotes a vasodilating agent with the molecular formula c6h9no6, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier lx1oh63030, chemically known as 1,4:3,6-dianhydro-d-glucitol 5-nitrate but generally known as isosorbide mononitrate, which bears us nih compound identifier 27661. european medicines agency schedules isosorbide mononitrate in its extended eudravigilance medicinal product dictionary or xevmpd under index sub08336mig. the term isosorbide mononitrate is an international non-proprietary name or inn (see who inn reference publication, volume 39, no. 5, 1985, list 25). world health organization schedules isosorbide mononitrate in its anatomical therapeutic chemical (atc) classification. most nations schedule isosorbide mononitrate under hs 29329985 and sitc 51569. as of q4 2014, isosorbide mononitrate remains the us fda preferred term for this commodity. isosorbide mononitrate bears us nlm identifiers umls id c0064079 and nci concept code c47575. smiles: o1c2c(occ2o)c(o[n](=o)o)c1.. "
"diuretics. this classification denotes agents or substances that promote excretion of urine by influencing human kidney function, commonly known as diuretics. the major diuretic types include osmotic (diuretics that increase urine volume by increasing osmotically-active urine solute); potassium sparing (diuretics that limit potassium secretion in urine); sodium chloride symporter inhibitors; and sodium potassium chloride symporter inhibitors. diuretics, that is, operate by stimulating he nervous system, by alleviating kidney congestion, by increasing blood pressure, or by increasing or improving liquid transport.. lemidosul. this classification denotes a loop diuretic, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 98c3qm4d0p. european medicines agency schedules lemidosul in its extended eudravigilance medicinal product dictionary or xevmpd under index sub08427mig. lemidosul generally arises in the molecular formula c12h19no3s. the term lemidosul is an international non-proprietary name or inn (see who inn reference publication, volume 39, no. 5, 1985, list 25.) lemidosul is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule lemidosul under hs 29309085 and sitc 51549. as of q4 2014, lemidosul remains the us fda preferred term for this commodity. lemidosul bears us nlm identifiers umls id c2825392 and nci concept code c80957. smiles: s(=o)(=o)(c1cc(c(c)(c)c)cc(c1o)cn)c.. "
"diuretics. this classification denotes agents or substances that promote excretion of urine by influencing human kidney function, commonly known as diuretics. the major diuretic types include osmotic (diuretics that increase urine volume by increasing osmotically-active urine solute); potassium sparing (diuretics that limit potassium secretion in urine); sodium chloride symporter inhibitors; and sodium potassium chloride symporter inhibitors. diuretics, that is, operate by stimulating he nervous system, by alleviating kidney congestion, by increasing blood pressure, or by increasing or improving liquid transport.. prorenoate. this classification denotes a potassium-sparing diuretic, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier wet36j3301. european medicines agency schedules prorenoate in its extended eudravigilance medicinal product dictionary or xevmpd under index sub10129mig. prorenoate generally arises in the molecular formula c23h31o4.k. the term prorenoate is an international non-proprietary name or inn (see who inn reference publication, volume 29, no. 10 1975, list 15.) as of q4 2014, prorenoate remains the us fda preferred term for this commodity. prorenoate bears us nlm identifiers umls id cl412716 and nci concept code c84117. smiles: cc12ccc(=o)c=c1c3cc3c4c2ccc5(c4ccc5(ccc(=o)o)o)c.. "
"diuretics. this classification denotes agents or substances that promote excretion of urine by influencing human kidney function, commonly known as diuretics. the major diuretic types include osmotic (diuretics that increase urine volume by increasing osmotically-active urine solute); potassium sparing (diuretics that limit potassium secretion in urine); sodium chloride symporter inhibitors; and sodium potassium chloride symporter inhibitors. diuretics, that is, operate by stimulating he nervous system, by alleviating kidney congestion, by increasing blood pressure, or by increasing or improving liquid transport.. mefruside. this classification denotes a diuretic with the molecular formula c13h19cln2o5s2, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier x1ns9sns92, chemically known as 1,3-benzenedisulfonamide, 4-chloro-n(sup 1)-methyl-n(sup 1)-((tetrahydro-2-methyl-2-furanyl)methyl)- but generally known as mefruside, which bears us nih compound identifier 4047. european medicines agency schedules mefruside in its extended eudravigilance medicinal product dictionary or xevmpd under index sub08710mig. world health organization schedules mefruside in its anatomical therapeutic chemical (atc) classification. mefruside is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule mefruside under hs 29350090 and sitc 51580. as of q4 2014, mefruside remains the us fda preferred term for this commodity. smiles: clc1c(s(=o)(=o)n)cc(s(=o)(=o)n(cc2(occc2)c)c)cc1.. "
"diuretics. this classification denotes agents or substances that promote excretion of urine by influencing human kidney function, commonly known as diuretics. the major diuretic types include osmotic (diuretics that increase urine volume by increasing osmotically-active urine solute); potassium sparing (diuretics that limit potassium secretion in urine); sodium chloride symporter inhibitors; and sodium potassium chloride symporter inhibitors. diuretics, that is, operate by stimulating he nervous system, by alleviating kidney congestion, by increasing blood pressure, or by increasing or improving liquid transport.. mersalyl. this classification denotes a diuretic with the molecular formula c13h15hgno5.na.ho, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 5x1io031v8, chemically known as mercury, 3-(alpha-carboxy-o-anisamido)-2-methoxypropyl hydroxy-, monosodium salt but generally known as mersalyl, which bears us nih compound identifier 10293. european medicines agency schedules mersalyl in its extended eudravigilance medicinal product dictionary or xevmpd under index sub08779mig. the term mersalyl is an international non-proprietary name. world health organization schedules mersalyl in its anatomical therapeutic chemical (atc) classification. mersalyl is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. as of q4 2014, mersalyl remains the us fda preferred term for this commodity. mersalyl bears us nlm identifiers umls id c0025446 and nci concept code c77560. smiles: [hg]([oh2])cc(oc)cnc(=o)c1c(occ(=o)o)cccc1.[na].. "
"diuretics. this classification denotes agents or substances that promote excretion of urine by influencing human kidney function, commonly known as diuretics. the major diuretic types include osmotic (diuretics that increase urine volume by increasing osmotically-active urine solute); potassium sparing (diuretics that limit potassium secretion in urine); sodium chloride symporter inhibitors; and sodium potassium chloride symporter inhibitors. diuretics, that is, operate by stimulating he nervous system, by alleviating kidney congestion, by increasing blood pressure, or by increasing or improving liquid transport.. methazolamide. this classification denotes a diuretic and carbonic anhydrase inhibitor with the molecular formula c5h8n4o3s2, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier w733b0s9sd, chemically known as 5-acetylimino-4-methyl-delta(sup 2)-1,3,4-thiadiazoline-2-sulfonamide but generally known as methazolamide, which bears us nih compound identifier 4100. european medicines agency schedules methazolamide in its extended eudravigilance medicinal product dictionary or xevmpd under index sub08843mig. the term methazolamide is an international non-proprietary name or inn (see who inn reference publication, volume 16, no. 3 1962, list 4). world health organization schedules methazolamide in its anatomical therapeutic chemical (atc) classification. methazolamide is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule methazolamide under hs 29350090 and sitc 51580. as of q4 2014, methazolamide remains the us fda preferred term for this commodity. methazolamide bears us nlm identifiers umls id c0025631 and nci concept code c61318. smiles: s(=o)(=o)(n)c1s/c(=n\\c(=o)c)n(n1)c.. "
"diuretics. this classification denotes agents or substances that promote excretion of urine by influencing human kidney function, commonly known as diuretics. the major diuretic types include osmotic (diuretics that increase urine volume by increasing osmotically-active urine solute); potassium sparing (diuretics that limit potassium secretion in urine); sodium chloride symporter inhibitors; and sodium potassium chloride symporter inhibitors. diuretics, that is, operate by stimulating he nervous system, by alleviating kidney congestion, by increasing blood pressure, or by increasing or improving liquid transport.. meticrane. this classification denotes a thiazide diuretic with the molecular formula c10h13no4s2, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier i7ekn1924q, chemically known as 3,4-dihydro-6-methyl-2h-1-benzothiopyran-7-sulfonamide 1,1-dioxide but generally known as meticrane, which bears us nih compound identifier 4165. european medicines agency schedules meticrane in its extended eudravigilance medicinal product dictionary or xevmpd under index sub08886mig. the term meticrane is an international non-proprietary name or inn (see who inn reference publication, volume 21 no. 12 1967, list 7). world health organization schedules meticrane in its anatomical therapeutic chemical (atc) classification. meticrane is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule meticrane under hs 29350090 and sitc 51580. as of q4 2014, meticrane remains the us fda preferred term for this commodity. meticrane bears us nlm identifiers umls id c0873165 and nci concept code c66125. smiles: cc1=c(c=c2c(=c1)cccs2(=o)=o)s(=o)(=o)n.. "
"diuretics. this classification denotes agents or substances that promote excretion of urine by influencing human kidney function, commonly known as diuretics. the major diuretic types include osmotic (diuretics that increase urine volume by increasing osmotically-active urine solute); potassium sparing (diuretics that limit potassium secretion in urine); sodium chloride symporter inhibitors; and sodium potassium chloride symporter inhibitors. diuretics, that is, operate by stimulating he nervous system, by alleviating kidney congestion, by increasing blood pressure, or by increasing or improving liquid transport.. triflocin. this classification denotes a diuretic with the molecular formula c13h9f3n2o2, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier s01b3a38sk, chemically known as 4-(alpha,alpha,alpha-trifluoro-m-toluidino)nicotinic acid but generally known as triflocin, which bears us nih compound identifier 25969. european medicines agency schedules triflocin in its extended eudravigilance medicinal product dictionary or xevmpd under index sub11284mig. the term triflocin is an international non-proprietary name or inn (see who inn reference publication, volume 14, no. 1, 2000, list 43). triflocin is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule triflocin under hs 29333999 and sitc 51574. as of q4 2014, triflocin remains the us fda preferred term for this commodity. triflocin bears us nlm identifiers umls id c0244851 and nci concept code c76648. smiles: fc(f)(f)c1cc(nc2c(cncc2)c(=o)o)ccc1.. "
"diuretics. this classification denotes agents or substances that promote excretion of urine by influencing human kidney function, commonly known as diuretics. the major diuretic types include osmotic (diuretics that increase urine volume by increasing osmotically-active urine solute); potassium sparing (diuretics that limit potassium secretion in urine); sodium chloride symporter inhibitors; and sodium potassium chloride symporter inhibitors. diuretics, that is, operate by stimulating he nervous system, by alleviating kidney congestion, by increasing blood pressure, or by increasing or improving liquid transport.. quincarbate. this classification denotes a thiazide diuretic with the molecular formula c17h18clno6, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier u40q9ge876, chemically known as ethyl 10-chloro-3-(ethoxymethyl)-2,3,6,9-tetrahydro-9-oxo-p-dioxino(2,3-g)quinoline-8-carboxylate but generally known as quincarbate, which bears us nih compound identifier 323967. european medicines agency schedules quincarbate in its extended eudravigilance medicinal product dictionary or xevmpd under index sub10205mig. the term quincarbate is an international non-proprietary name. quincarbate is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule quincarbate under hs 29349990 and sitc 51579. as of q4 2014, quincarbate remains the us fda preferred term for this commodity. quincarbate bears us nlm identifiers umls id c2698927 and nci concept code c74410. smiles: clc1c2occ(oc2cc2[nh]cc(c(=o)c12)c(=o)occ)cocc.. "
"diuretics. this classification denotes agents or substances that promote excretion of urine by influencing human kidney function, commonly known as diuretics. the major diuretic types include osmotic (diuretics that increase urine volume by increasing osmotically-active urine solute); potassium sparing (diuretics that limit potassium secretion in urine); sodium chloride symporter inhibitors; and sodium potassium chloride symporter inhibitors. diuretics, that is, operate by stimulating he nervous system, by alleviating kidney congestion, by increasing blood pressure, or by increasing or improving liquid transport.. quinethazone. this classification denotes a thiazide diuretic with the molecular formula c10h12cln3o3s, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 455e0s048w, chemically known as 7-chloro-2-ethyl-6-sulfamoyl-1,2,3,4-tetrahydro-4-quinazolinone but generally known as quinethazone, which bears us nih compound identifier 6307. european medicines agency schedules quinethazone in its extended eudravigilance medicinal product dictionary or xevmpd under index sub10213mig. the term quinethazone is an international non-proprietary name or inn (see who inn reference publication, volume 19 1975, list 5). world health organization schedules quinethazone in its anatomical therapeutic chemical (atc) classification. quinethazone is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule quinethazone under hs 29350090 and sitc 51580. as of q4 2014, quinethazone remains the us fda preferred term for this commodity. quinethazone bears us nlm identifiers umls id c0164608 and nci concept code c66501. smiles: ccc1nc2=cc(=c(c=c2c(=o)n1)s(=o)(=o)n)cl.. "
"diuretics. this classification denotes agents or substances that promote excretion of urine by influencing human kidney function, commonly known as diuretics. the major diuretic types include osmotic (diuretics that increase urine volume by increasing osmotically-active urine solute); potassium sparing (diuretics that limit potassium secretion in urine); sodium chloride symporter inhibitors; and sodium potassium chloride symporter inhibitors. diuretics, that is, operate by stimulating he nervous system, by alleviating kidney congestion, by increasing blood pressure, or by increasing or improving liquid transport.. sitalidone. this classification denotes a diuretic, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 06h9kwb6ib. european medicines agency schedules sitalidone in its extended eudravigilance medicinal product dictionary or xevmpd under index sub10540mig. sitalidone generally arises in the molecular formula c23h29cln2o5s. the term sitalidone is an international non-proprietary name or inn (see who inn reference publication, volume 3, no. 3, 1989, list 29.) most nations schedule sitalidone under hs 29350090 and sitc 51580. as of q4 2014, sitalidone remains the us fda preferred term for this commodity. sitalidone bears us nlm identifiers umls id c2699304 and nci concept code c74251. smiles: clc1c(s(=o)(=o)nc2cc(c(c)c)c(o)c(c(c)c)c2)cc(c2(o)n(c(=o)cc2)c)cc1.. "
"diuretics. this classification denotes agents or substances that promote excretion of urine by influencing human kidney function, commonly known as diuretics. the major diuretic types include osmotic (diuretics that increase urine volume by increasing osmotically-active urine solute); potassium sparing (diuretics that limit potassium secretion in urine); sodium chloride symporter inhibitors; and sodium potassium chloride symporter inhibitors. diuretics, that is, operate by stimulating he nervous system, by alleviating kidney congestion, by increasing blood pressure, or by increasing or improving liquid transport.. sodium acetate. this classification denotes an electrolyte replacement agent with the molecular formula c2h3o2.na.3h2o, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 4550k0sc9b, chemically known as mercury acetate, hg (oac)2, compd. with 1,4-dihydroanthracene (1:1) but generally known as sodium acetate, which bears us nih compound identifier 176. european medicines agency schedules sodium acetate in its extended eudravigilance medicinal product dictionary or xevmpd under index sub12576mig. world health organization schedules sodium acetate in its anatomical therapeutic chemical (atc) classification. most nations schedule sodium acetate under hs 29152900 and sitc 51371. as of q4 2014, sodium acetate remains the us fda preferred term for this commodity. sodium acetate bears us nlm identifiers umls id c0142785 and nci concept code c47720. smiles: oc(=o)c.. "
"diuretics. this classification denotes agents or substances that promote excretion of urine by influencing human kidney function, commonly known as diuretics. the major diuretic types include osmotic (diuretics that increase urine volume by increasing osmotically-active urine solute); potassium sparing (diuretics that limit potassium secretion in urine); sodium chloride symporter inhibitors; and sodium potassium chloride symporter inhibitors. diuretics, that is, operate by stimulating he nervous system, by alleviating kidney congestion, by increasing blood pressure, or by increasing or improving liquid transport.. sulosemide. this classification denotes a diuretic with the molecular formula c17h16n2o7s2, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier cy351d07gj, chemically known as benzenesulfonic acid, 2-(furfurylamino)-4-phenoxy-5-sulfanoyl- but generally known as sulosemide, which bears us nih compound identifier 213033. european medicines agency schedules sulosemide in its extended eudravigilance medicinal product dictionary or xevmpd under index sub10755mig. the term sulosemide is an international non-proprietary name or inn (see who inn reference publication, volume 37, no. 6, 1983, list 23). sulosemide is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule sulosemide under hs 29350090 and sitc 51580. as of q4 2014, sulosemide remains the us fda preferred term for this commodity. sulosemide bears us nlm identifiers umls id c2699723 and nci concept code c74250. smiles: s(=o)(=o)(n)c1c(oc2ccccc2)cc(ncc2occc2)c(s(=o)(=o)o)c1.. "
"diuretics. this classification denotes agents or substances that promote excretion of urine by influencing human kidney function, commonly known as diuretics. the major diuretic types include osmotic (diuretics that increase urine volume by increasing osmotically-active urine solute); potassium sparing (diuretics that limit potassium secretion in urine); sodium chloride symporter inhibitors; and sodium potassium chloride symporter inhibitors. diuretics, that is, operate by stimulating he nervous system, by alleviating kidney congestion, by increasing blood pressure, or by increasing or improving liquid transport.. theobromide or theobromine or xantheose. this classification denotes a bronchodilator with the molecular formula c7h8n4o2, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier obd445wz5p, chemically known as 3,7-dimethylxanthine but generally known as theobromine, which bears us nih compound identifier 5429. european medicines agency schedules theobromine in its extended eudravigilance medicinal product dictionary or xevmpd under index sub15511mig. world health organization schedules theobromine in its anatomical therapeutic chemical (atc) classification. smiles: o=c1[nh]c(=o)n(c2ncn(c12)c)c. smiles: o=c1[nh]c(=o)n(c2ncn(c12)c)c.. "
"diuretics. this classification denotes agents or substances that promote excretion of urine by influencing human kidney function, commonly known as diuretics. the major diuretic types include osmotic (diuretics that increase urine volume by increasing osmotically-active urine solute); potassium sparing (diuretics that limit potassium secretion in urine); sodium chloride symporter inhibitors; and sodium potassium chloride symporter inhibitors. diuretics, that is, operate by stimulating he nervous system, by alleviating kidney congestion, by increasing blood pressure, or by increasing or improving liquid transport.. tizolemide. this classification denotes a diuretic, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier p60k8qk3aa. european medicines agency schedules tizolemide in its extended eudravigilance medicinal product dictionary or xevmpd under index sub11130mig. tizolemide generally arises in the molecular formula c11h14cln3o3s2. the term tizolemide is an international non-proprietary name or inn (see who inn reference publication, volume 30, no. 10 1976, list 16.) tizolemide is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule tizolemide under hs 29350090 and sitc 51580. as of q4 2014, tizolemide remains the us fda preferred term for this commodity. tizolemide bears us nlm identifiers umls id c0076749 and nci concept code c90838. smiles: cn=c1n(c(cs1)(c2=cc(=c(c=c2)cl)s(=o)(=o)n)o)c.. "
"diuretics. this classification denotes agents or substances that promote excretion of urine by influencing human kidney function, commonly known as diuretics. the major diuretic types include osmotic (diuretics that increase urine volume by increasing osmotically-active urine solute); potassium sparing (diuretics that limit potassium secretion in urine); sodium chloride symporter inhibitors; and sodium potassium chloride symporter inhibitors. diuretics, that is, operate by stimulating he nervous system, by alleviating kidney congestion, by increasing blood pressure, or by increasing or improving liquid transport.. xipamide. this classification denotes a diuretic with the molecular formula c15h15cln2o4s, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 4s9ey0nuec, chemically known as 4-chloro-5-sulfamoyl-2,6-salicyloxylidide but generally known as xipamide, which bears us nih compound identifier 26618. european medicines agency schedules xipamide in its extended eudravigilance medicinal product dictionary or xevmpd under index sub00116mig. the term xipamide is an international non-proprietary name or inn (see who inn reference publication, volume 24, no. 11 1970, list 10). world health organization schedules xipamide in its anatomical therapeutic chemical (atc) classification. xipamide is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule xipamide under hs 29350090 and sitc 51580. as of q4 2014, xipamide remains the us fda preferred term for this commodity. xipamide bears us nlm identifiers umls id c0043355 and nci concept code c87708. smiles: clc1c(s(=o)(=o)n)cc(c(=o)nc2c(cccc2c)c)c(o)c1.. "
"diuretics. this classification denotes agents or substances that promote excretion of urine by influencing human kidney function, commonly known as diuretics. the major diuretic types include osmotic (diuretics that increase urine volume by increasing osmotically-active urine solute); potassium sparing (diuretics that limit potassium secretion in urine); sodium chloride symporter inhibitors; and sodium potassium chloride symporter inhibitors. diuretics, that is, operate by stimulating he nervous system, by alleviating kidney congestion, by increasing blood pressure, or by increasing or improving liquid transport.. zidapamide. this classification denotes a diuretic, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier f7ku1miy58. european medicines agency schedules zidapamide in its extended eudravigilance medicinal product dictionary or xevmpd under index sub00151mig. zidapamide generally arises in the molecular formula c16h16cln3o3s. the term zidapamide is an international non-proprietary name or inn (see who inn reference publication, volume 38, no. 6, 1984, list 24.) zidapamide is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule zidapamide under hs 29350090 and sitc 51580. as of q4 2014, zidapamide remains the us fda preferred term for this commodity. zidapamide bears us nlm identifiers umls id c2826075 and nci concept code c82267. smiles: clc1c(s(=o)(=o)n)cc(c(=o)nn2c(c3c(c2)cccc3)c)cc1.. "
"diuretics. this classification denotes agents or substances that promote excretion of urine by influencing human kidney function, commonly known as diuretics. the major diuretic types include osmotic (diuretics that increase urine volume by increasing osmotically-active urine solute); potassium sparing (diuretics that limit potassium secretion in urine); sodium chloride symporter inhibitors; and sodium potassium chloride symporter inhibitors. diuretics, that is, operate by stimulating he nervous system, by alleviating kidney congestion, by increasing blood pressure, or by increasing or improving liquid transport.. amiloride hydrochloride. this classification denotes a potassium-sparing diuretic and intercalating agent with the molecular formula c6h8cln7o.clh.2h2o, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier fzj37245uc, chemically known as pyrazinecarboxamide, n-amidino-3,5-diamino-6-chloro-, monohydrochloride but more generally known as amiloride hydrochloride, which bears us nih compound identifier 16230. european medicines agency schedules amiloride hydrochloride in its extended eudravigilance medicinal product dictionary or xevmpd under index sub00445mig. most nations, for tariff and trade purposes, schedule amiloride hydrochloride under hs 29339990 and sitc 51577. as of q4 2014, amiloride hydrochloride remains us fdas preferred term for this commodity. amiloride hydrochloride bears us nlm identifiers umls id c0026054 and nci concept code c47390. smiles: c1(c(nc(c(n1)cl)n)n)c(=o)nc(=n)n.o.o.cl.. "
"diuretics. this classification denotes agents or substances that promote excretion of urine by influencing human kidney function, commonly known as diuretics. the major diuretic types include osmotic (diuretics that increase urine volume by increasing osmotically-active urine solute); potassium sparing (diuretics that limit potassium secretion in urine); sodium chloride symporter inhibitors; and sodium potassium chloride symporter inhibitors. diuretics, that is, operate by stimulating he nervous system, by alleviating kidney congestion, by increasing blood pressure, or by increasing or improving liquid transport.. amiloride hydrochloride anhydrous. this classification denotes the anhydrous form of a potassium-sparing diuretic and intercalating agent with the molecular formula c6h8cln7o.clh.2h2o, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier fzj37245uc, chemically known as pyrazinecarboxamide, n-amidino-3,5-diamino-6-chloro-, monohydrochloride but more generally known as amiloride hydrochloride, which bears us nih compound identifier 16230. european medicines agency schedules amiloride hydrochloride in its extended eudravigilance medicinal product dictionary or xevmpd under index sub00445mig. most nations, for tariff and trade purposes, schedule amiloride hydrochloride anhydrous under hs 29339990. as of q4 2014, amiloride hydrochloride anhydrous remains us fdas preferred term for this commodity. smiles: c1(c(nc(c(n1)cl)n)n)c(=o)nc(=n)n.cl.. "
"diuretics. this classification denotes agents or substances that promote excretion of urine by influencing human kidney function, commonly known as diuretics. the major diuretic types include osmotic (diuretics that increase urine volume by increasing osmotically-active urine solute); potassium sparing (diuretics that limit potassium secretion in urine); sodium chloride symporter inhibitors; and sodium potassium chloride symporter inhibitors. diuretics, that is, operate by stimulating he nervous system, by alleviating kidney congestion, by increasing blood pressure, or by increasing or improving liquid transport.. chlorothiazide sodium. this classification denotes a thiazide diuretic with the molecular formula c7h4cln3o4s2.h+.na, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier sn86fg7n2k, chemically known as 6-chloro-2h-1,2,4-benzothiadiazine-7-sulfonamide, 1,1-dioxide, monosodium salt but more generally known as chlorothiazide sodium, which bears us nih compound identifier 23490. european medicines agency schedules chlorothiazide sodium in its extended eudravigilance medicinal product dictionary or xevmpd under index sub21994. most nations, for tariff and trade purposes, schedule chlorothiazide sodium under hs 29350090 and sitc 51580. as of q4 2014, chlorothiazide sodium remains us fdas preferred term for this commodity. chlorothiazide sodium bears us nlm identifiers umls id c0304489 and nci concept code c65319. smiles: c1c2c(cc(c1cl)s(=o)(=o)n)s(=o)(=o)[n-]c=n2.[na+].. "
"diuretics. this classification denotes agents or substances that promote excretion of urine by influencing human kidney function, commonly known as diuretics. the major diuretic types include osmotic (diuretics that increase urine volume by increasing osmotically-active urine solute); potassium sparing (diuretics that limit potassium secretion in urine); sodium chloride symporter inhibitors; and sodium potassium chloride symporter inhibitors. diuretics, that is, operate by stimulating he nervous system, by alleviating kidney congestion, by increasing blood pressure, or by increasing or improving liquid transport.. cicletanine hydrochloride. this classification denotes a diuretic with the molecular formula c14h12clno2.clh, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier t0sy6373oq, chemically known as furo(3,4-c)pyridin-7-ol, 3-(4-chlorophenyl)-1,3-dihydro-6-methyl-, hydrochloride but more generally known as cicletanine hydrochloride, which bears us nih compound identifier 54909. european medicines agency schedules cicletanine hydrochloride in its extended eudravigilance medicinal product dictionary or xevmpd under index sub01291mig. most nations, for tariff and trade purposes, schedule cicletanine hydrochloride under hs 29349990 and sitc 51579. as of q4 2014, cicletanine hydrochloride remains us fdas preferred term for this commodity. cicletanine hydrochloride bears us nlm identifiers umls id c1530416 and nci concept code c101534. smiles: cc1c(c2c(cn1)c(oc2)c3ccc(cc3)cl)o.cl.. "
"diuretics. this classification denotes agents or substances that promote excretion of urine by influencing human kidney function, commonly known as diuretics. the major diuretic types include osmotic (diuretics that increase urine volume by increasing osmotically-active urine solute); potassium sparing (diuretics that limit potassium secretion in urine); sodium chloride symporter inhibitors; and sodium potassium chloride symporter inhibitors. diuretics, that is, operate by stimulating he nervous system, by alleviating kidney congestion, by increasing blood pressure, or by increasing or improving liquid transport.. furosemide sodium. this classification denotes a loop diuretic with the molecular formula c12h10cln2o5s.na, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 101em454s7. european medicines agency schedules furosemide sodium in its extended eudravigilance medicinal product dictionary or xevmpd under index sub02287mig. most nations, for tariff and trade purposes, schedule furosemide sodium under hs 29350090. as of q4 2014, furosemide sodium remains us fdas preferred term for this commodity. smiles: c1cc(oc1)cnc2cc(c(cc2c(=o)[o-])s(=o)(=o)n)cl.[na+].. "
"diuretics. this classification denotes agents or substances that promote excretion of urine by influencing human kidney function, commonly known as diuretics. the major diuretic types include osmotic (diuretics that increase urine volume by increasing osmotically-active urine solute); potassium sparing (diuretics that limit potassium secretion in urine); sodium chloride symporter inhibitors; and sodium potassium chloride symporter inhibitors. diuretics, that is, operate by stimulating he nervous system, by alleviating kidney congestion, by increasing blood pressure, or by increasing or improving liquid transport.. furosemide xantinol. this classification denotes a loop diuretic c13h21n5o4.c12h11cln2o5s, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier y1p3p1md0g, chemically known as benzoic acid, 5-(aminosulfonyl)-4-chloro-2-((2-furanylmethyl)amino)-, compd. with 3,7-dihydro-7-(2-hydroxy-3-((2-hydroxyethyl)methylamino)propyl)-1,3-dimethyl-1h-purine-2,6-dione (1:1), but more generally known as furosemide xantinol, which bears us nih compound identifier 71587213. european medicines agency schedules furosemide xantinol in its extended eudravigilance medicinal product dictionary or xevmpd under index sub02288mig. most nations, for tariff and trade purposes, schedule furosemide xantinol under hs 29350090 and sitc 51580. as of q4 2014, furosemide xantinol remains us fdas preferred term for this commodity. smiles: cn1c2c(c(=o)n(c1=o)c)n(cn2)cc(cn(c)cco)o.c1cc(oc1)cnc2cc(c(cc2c(=o)o)s(=o)(=o)n)cl.. "
"diuretics. this classification denotes agents or substances that promote excretion of urine by influencing human kidney function, commonly known as diuretics. the major diuretic types include osmotic (diuretics that increase urine volume by increasing osmotically-active urine solute); potassium sparing (diuretics that limit potassium secretion in urine); sodium chloride symporter inhibitors; and sodium potassium chloride symporter inhibitors. diuretics, that is, operate by stimulating he nervous system, by alleviating kidney congestion, by increasing blood pressure, or by increasing or improving liquid transport.. mannitol myleran. this classification denotes an osmotic diuretic with the molecular formula c8h18o10s2, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 6sto1p091f, chemically known as cb-2511, but more generally known as mannitol myleran, which bears us nih compound identifier 14464. european medicines agency schedules mannitol myleran or its base in its extended eudravigilance medicinal product dictionary or xevmpd under index sub03087mig. most nations, for tariff purposes, schedule mannitol myleran under hs 29054300. smiles: cs(=o)(=o)oc[c@h]([c@h]([c@@h]([c@@h](cos(=o)(=o)c)o)o)o)o.. "
"diuretics. this classification denotes agents or substances that promote excretion of urine by influencing human kidney function, commonly known as diuretics. the major diuretic types include osmotic (diuretics that increase urine volume by increasing osmotically-active urine solute); potassium sparing (diuretics that limit potassium secretion in urine); sodium chloride symporter inhibitors; and sodium potassium chloride symporter inhibitors. diuretics, that is, operate by stimulating he nervous system, by alleviating kidney congestion, by increasing blood pressure, or by increasing or improving liquid transport.. mersalyl sodium. this classification denotes a diuretic with the molecular formula c13h15hgno5.na.ho, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 5x1io031v8, chemically known as mercury, 3-(alpha-carboxy-o-anisamido)-2-methoxypropyl hydroxy-, monosodium salt but more generally known as mersalyl, which bears us nih compound identifier 10293. european medicines agency schedules mersalyl in its extended eudravigilance medicinal product dictionary or xevmpd under index sub08779mig. the term mersalyl is an international non-proprietary name. world health organization schedules mersalyl in its anatomical therapeutic chemical (atc) classification. mersalyl is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations, for tariff and trade purposes, schedule mersalyl sodium under hs 29310095. smiles: coc(cnc(=o)c1ccccc1occ(=o)[o-])c[hg+].[oh-].[na+].. "
"diuretics. this classification denotes agents or substances that promote excretion of urine by influencing human kidney function, commonly known as diuretics. the major diuretic types include osmotic (diuretics that increase urine volume by increasing osmotically-active urine solute); potassium sparing (diuretics that limit potassium secretion in urine); sodium chloride symporter inhibitors; and sodium potassium chloride symporter inhibitors. diuretics, that is, operate by stimulating he nervous system, by alleviating kidney congestion, by increasing blood pressure, or by increasing or improving liquid transport.. prorenoate potassium. this classification denotes a potassium-sparing diuretic, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier t2d4xus623. european medicines agency schedules prorenoate potassium in its extended eudravigilance medicinal product dictionary or xevmpd under index sub10129mig. prorenoate potassium generally arises in the molecular formula c23h31o4.k. the term prorenoate potassium is an international non-proprietary name or inn (see world health organization inn reference publication, volume 29, no. 10 1975, list 15.) most nations, for tariff and trade purposes, schedule prorenoate potassium under hs 29372900 and sitc 54153. as of q4 2014, prorenoate potassium remains us fdas preferred term for this commodity. prorenoate potassium bears us nlm identifiers umls id c0072213 and nci concept code c84118. smiles: c[c@]12ccc(=o)c=c1[c@@h]3c[c@@h]3[c@@h]4[c@@h]2cc[c@]5([c@h]4cc[c@]5(ccc(=o)[o-])o)c.[k+].. "
"diuretics. this classification denotes agents or substances that promote excretion of urine by influencing human kidney function, commonly known as diuretics. the major diuretic types include osmotic (diuretics that increase urine volume by increasing osmotically-active urine solute); potassium sparing (diuretics that limit potassium secretion in urine); sodium chloride symporter inhibitors; and sodium potassium chloride symporter inhibitors. diuretics, that is, operate by stimulating he nervous system, by alleviating kidney congestion, by increasing blood pressure, or by increasing or improving liquid transport.. theobromine magnesium oleate. this classification denotes a bronchodilator c18h33o2.c7h7n4o2.mg, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 3l7il2rtm6, chemically known as magnesium 3,7-dimethylxanthine oleate, but more generally known as theobromine magnesium oleate, which bears us nih compound identifier 57352542. european medicines agency schedules theobromine magnesium oleate in its extended eudravigilance medicinal product dictionary or xevmpd under index sub15513mig. most nations, for tariff and trade purposes, schedule theobromine magnesium oleate under hs 29399990 and sitc 54149. as of q4 2014, theobromine magnesium oleate remains us fdas preferred term for this commodity. smiles: cccccccc/c=c\\cccccccc(=o)[o-].cn1cnc2c1c(=o)[n-]c(=o)n2c.[mg+2].. "
"diuretics. this classification denotes agents or substances that promote excretion of urine by influencing human kidney function, commonly known as diuretics. the major diuretic types include osmotic (diuretics that increase urine volume by increasing osmotically-active urine solute); potassium sparing (diuretics that limit potassium secretion in urine); sodium chloride symporter inhibitors; and sodium potassium chloride symporter inhibitors. diuretics, that is, operate by stimulating he nervous system, by alleviating kidney congestion, by increasing blood pressure, or by increasing or improving liquid transport.. theobromine sodium salicylate. this classification denotes a bronchodilator with the molecular structure c7h7n4o2.c7h5o3.2na.h2o, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier, p6vr6p4a5v chemically known as equimolar mixture of sodium theobromine, sodium salicylate and water, but more commonly known as theobromine sodium salicylate, which bears us nih compound identifier 24700. european medicines agency schedules theobromine sodium salicylate in its extended eudravigilance medicinal product dictionary or xevmpd under index sub15514mig. most nations, for tariff and trade purposes, schedule theobromine sodium salicylate under hs 29399990. smiles: cn1cnc2c1c(=o)[nh]c(=o)n2c.c1ccc(c(c1)c(=o)[o-])[o-].o.[na+].[na+].. "
"diuretics. this classification denotes agents or substances that promote excretion of urine by influencing human kidney function, commonly known as diuretics. the major diuretic types include osmotic (diuretics that increase urine volume by increasing osmotically-active urine solute); potassium sparing (diuretics that limit potassium secretion in urine); sodium chloride symporter inhibitors; and sodium potassium chloride symporter inhibitors. diuretics, that is, operate by stimulating he nervous system, by alleviating kidney congestion, by increasing blood pressure, or by increasing or improving liquid transport.. triflocin sodium. this classification denotes the sodium form of a diuretic with the molecular formula c13h9f3n2o2, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier s01b3a38sk, chemically known as 4-(alpha,alpha,alpha-trifluoro-m-toluidino)nicotinic acid but more generally known as triflocin, which bears us nih compound identifier 25969. european medicines agency schedules triflocin in its extended eudravigilance medicinal product dictionary or xevmpd under index sub11284mig. the term triflocin is an international non-proprietary name or inn (see world health organization inn reference publication, volume 14, no. 1, 2000, list 43). triflocin is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations, for tariff and trade purposes, schedule triflocin sodium under hs 29333999. as of q4 2014, triflocin sodium remains us fdas preferred term for this commodity. smiles: c1cc(cc(c1)nc2ccncc2c(=o)[o-])c(f)(f)f.[na+].. "
"diuretics. this classification denotes agents or substances that promote excretion of urine by influencing human kidney function, commonly known as diuretics. the major diuretic types include osmotic (diuretics that increase urine volume by increasing osmotically-active urine solute); potassium sparing (diuretics that limit potassium secretion in urine); sodium chloride symporter inhibitors; and sodium potassium chloride symporter inhibitors. diuretics, that is, operate by stimulating he nervous system, by alleviating kidney congestion, by increasing blood pressure, or by increasing or improving liquid transport.. indapamide + perindopril terbutylamine. perindopril works by inhibiting the formation of hormones that raise blood pressure (ace inhibitor), while indapamide increases the elimination of salt and water through the kidneys.. "
"electrolytes. . "
"electrolytes.  sodium chloride electrolytes. this classification denotes an electrolyte solution, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 451w47iq8x, chemically known as sodium;chloride, more generally known as sodium chloride or saline, us nih compound identifier 5234. european medicines agency schedules sodium chloride in its extended eudravigilance medicinal product dictionary or xevmpd under index sub12581mig. sodium chloride generally arises in the molecular formula clna. the term sodium chloride is an fda designation, but the term compound solution of sodium chloride is an international non-proprietary name or inn (see who inn reference publication, 1955, 9, 185-194, list 1.) smiles: [na+].[cl-].. "
"electrolytes.  total parenteral alimentation or total parenteral nutrition tpn. this classification denotes intravenous preparations that deliver minerals and vitamins necessary to proper electrolyte functioning. these typically come in plastic or polymer bags, and attach to a drip, which flushes substances into the patients bloodstream or system.. "
"electrolytes.  lactated ringers solution. this classification denotes an isotonic solution with the molecular formula c3h9cacl2kna2o6, chemicaly known as calcium;potassium;disodium;(2s)-2-hydroxypropanoate;dichloride; dihydroxide;hydrate but generally known as lactated ringers solution or ringer lactate solution, which bears us nih compound identifier european medicines agency schedules lactated ringers solution in its extended eudravigilance medicinal product dictionary or xevmpd under indices 56841910. sub32409, sub33298, and sub33359. smiles: cc(c(=o)[o-])o.o.[oh-].[oh-].[na+].[na+].[cl-].[cl-].[k+].[ca+2].. "
"electrolytes.  sterile water for injection. this classification denotes an electrolyte-active substance, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 059qf0ko0r. european medicines agency schedules water in its extended eudravigilance medicinal product dictionary or xevmpd under index sub15717mig. water generally arises in the molecular formula h2o. the term water is a united states homeopathic pharmacopoeia name designation. smiles: o.. "
"electrolytes.  cupric chloride. this classification denotes an electrolyte replacement agent with the molecular formula 2cl.cu, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier p484053j2y, chemically known as dichlorocopper but generally known as cupric chloride, which bears us nih compound identifier 24014. the term cupric chloride anhydrous is a hazardous substances data bank designation. as of q4 2014, cupric chloride remains the us fda preferred term for this commodity. cupric chloride bears us nlm identifiers umls id c0056593 and nci concept code c61692. smiles: cl[cu]cl.. "
"electrolytes.  dextrose usp solution for injection. a substance used to treat low blood sugar (hypoglycemia), insulin shock, or dehydration (fluid loss).. "
"electrolytes.  amino acid injection. amino acids solutions. "
"alkalinizing agents. this classification denotes drugs or other substances that raise blood ph levels.. . "
"alkalinizing agents. this classification denotes drugs or other substances that raise blood ph levels.. trometamol or tromethamine. this classification denotes an organic carcinogen with the molecular formula c4h11no3, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 023c2whx2v, chemically known as 1,1,1-tris(hydroxymethyl)methanamine but generally known as trometamol, which bears us nih compound identifier 6503. european medicines agency schedules trometamol in its extended eudravigilance medicinal product dictionary or xevmpd under index sub11336mig. the term trometamol is an international non-proprietary name. world health organization schedules trometamol in its anatomical therapeutic chemical (atc) classification. trometamol is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule tromethamine under hs 29221990 and sitc 51461. as of q4 2014, tromethamine remains the us fda preferred term for this commodity. tromethamine bears us nlm identifiers umls id c0041175 and nci concept code c47775. smiles: occ(n)(co)co.. "
"alkalinizing agents. this classification denotes drugs or other substances that raise blood ph levels.. multiple electrolyte solutions. this classification denotes alkalinizing agents composed of mixtures of substances that dissociate into two or more ions, to some extent, in water.. "
"alkalinizing agents. this classification denotes drugs or other substances that raise blood ph levels.. citric acid and potassium citrate combination. this classification denotes an alkalinizing agent combination drug. the first component of this drug is a carboxylic acid with the molecular formula c6h8o7.h2o, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 2968phw8qpm, and which is called citric acid. european medicines agency schedules citric acid monohydrate in its extended eudravigilance medicinal product dictionary or xevmpd under index sub12482mig. the term citrate is a u.s. fda designation. smiles: oc(cc(=o)o)(cc(=o)o)c(=o)o. the second component of this drug is an an electrolyte replacement agent with the molecular formula c6h5o7.3k.h2o, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier ee90oni6ff, chemically known as 1,2,3-propanetricarboxylic acid, 2-hydroxy-, tripotassium salt but generally known as potassium citrate, which bears us nih compound identifier 13344. european medicines agency schedules potassium citrate in its extended eudravigilance medicinal product dictionary or xevmpd under index sub14973mig. world health organization schedules potassium citrate in its anatomical therapeutic chemical (atc) classification.. "
"alkalinizing agents. this classification denotes drugs or other substances that raise blood ph levels.. citric acid and sodium citrate combination. this classification denotes an alkalinizing agent combination drug. the first component of this drug is a carboxylic acid with the molecular formula c6h8o7.h2o, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 2968phw8qpm, and which is called citric acid. european medicines agency schedules citric acid monohydrate in its extended eudravigilance medicinal product dictionary or xevmpd under index sub12482mig. the term citrate is a u.s. fda designation. smiles: oc(cc(=o)o)(cc(=o)o)c(=o)o. the second component of this drug is an electrolyte replacement agent and anticoagulant agent, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 1q73q2julr. european medicines agency schedules sodium citrate in its extended eudravigilance medicinal product dictionary or xevmpd under index sub12582mig. sodium citrate generally arises in the molecular formula c6h5na3o7. the term sodium citrate is a u.s. pharmacopeial convention designation.. "
"alkalinizing agents. this classification denotes drugs or other substances that raise blood ph levels.. trometamol or tromethamine hydrochloride. this classification denotes an organic carcinogen with the molecular formula c4h11no3.clh, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 383v75m34e. european medicines agency schedules tromethamine hydrochloride in its extended eudravigilance medicinal product dictionary or xevmpd under index sub32380. most nations, for tariff and trade purposes, schedule tromethamine hydrochloride under hs 29221990. as of q4 2014, tromethamine hydrochloride remains us fdas preferred term for this commodity. smiles: c(c(co)(co)n)o.cl.. "
"potassium salts. this classification denotes inorganic compounds that contain potassium as an integral part of the molecule.. . "
"potassium salts. this classification denotes inorganic compounds that contain potassium as an integral part of the molecule.. potassium chloride. this classification denotes an electrolyte replacement agent, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 660yq98i10. european medicines agency schedules potassium chloride in its extended eudravigilance medicinal product dictionary or xevmpd under index sub12559mig. potassium chloride generally arises in the molecular formula clk. the term potassium chloride is a united states homeopathic pharmacopoeia name designation. as of q4 2014, potassium chloride remains the us fda preferred term for this commodity. potassium chloride bears us nlm identifiers umls id c0032825 and nci concept code c47679. smiles: [cl-].[k+].. "
"potassium salts. this classification denotes inorganic compounds that contain potassium as an integral part of the molecule.. potassium acetate. this classification denotes an electrolyte replacement agent, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier m911911u02. european medicines agency schedules potassium acetate in its extended eudravigilance medicinal product dictionary or xevmpd under index sub14962mig. potassium acetate generally arises in the molecular formula c2h4o2.k. the term potassium acetate is a united states homeopathic pharmacopoeia name designation. most nations schedule potassium acetate under hs 29152900 and sitc 51371. as of q4 2014, potassium acetate remains the us fda preferred term for this commodity. potassium acetate bears us nlm identifiers umls id c0137984 and nci concept code c47677. smiles: cc(=o)[o-].[k+].. "
"potassium salts. this classification denotes inorganic compounds that contain potassium as an integral part of the molecule.. potassium citrate. this classification denotes an electrolyte replacement agent with the molecular formula c6h5o7.3k.h2o, a preparation that us fda recognizes as an active ingredient or moiety under unique ingredient identifier ee90oni6ff, chemically known as 1,2,3-propanetricarboxylic acid, 2-hydroxy-, tripotassium salt but more generally known as potassium citrate, which bears u.s. nih compound identifier 13344. european medicines agency schedules potassium citrate in its extended eudravigilance medicinal product dictionary or xevmpd under index sub14973mig. world health organization schedules potassium citrate in its anatomical therapeutic chemical (atc) classification and its who-dd or drug dictionary.. "
"nutritional therapy products. this classification denotes products in capsule, tablet or liquid form that provide essential nutrients, such as a vitamin, an essential mineral, a protein, an herb, or similar nutritional substance.. . "
"nutritional therapy products. this classification denotes products in capsule, tablet or liquid form that provide essential nutrients, such as a vitamin, an essential mineral, a protein, an herb, or similar nutritional substance.. phospholipids. this classification denotes lipids containing one or more phosphate groups, particularly those derived from either glycerol or sphingosine, polar lipids that are of great importance for the structure and function of cell membranes and the most abundant of membrane lipids, although not stored in large amounts in the system.. "
"nutritional therapy products. this classification denotes products in capsule, tablet or liquid form that provide essential nutrients, such as a vitamin, an essential mineral, a protein, an herb, or similar nutritional substance.. thiamine. this classification denotes a b vitamin with the molecular formula c12h17n4os.cl, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier x66nso3n35, chemically known as 67-03-8 (chloride, hcl) but generally known as thiamine, which bears us nih compound identifier 1130. european medicines agency schedules thiamine in its extended eudravigilance medicinal product dictionary or xevmpd under index sub10969mig. the term thiamine is an international non-proprietary name or inn (see who inn reference publication, volume 32, no 10 1978, list 18). world health organization schedules thiamine in its anatomical therapeutic chemical (atc) classification. thiamine is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule thiamine under hs 29362200 and sitc 54113. as of q4 2014, thiamine remains the us fda preferred term for this commodity. thiamine bears us nlm identifiers umls id c0039840 and nci concept code c874. smiles: cc1=c(sc=[n+]1cc2=cn=c(n=c2n)c)cco.. "
"nutritional therapy products. this classification denotes products in capsule, tablet or liquid form that provide essential nutrients, such as a vitamin, an essential mineral, a protein, an herb, or similar nutritional substance.. idebenone. this classification denotes an antioxidant, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier hb6pn45w4j. european medicines agency schedules idebenone in its extended eudravigilance medicinal product dictionary or xevmpd under index sub08114mig. idebenone generally arises in the molecular formula c19h30o5. the term idebenone is an international nomenclature of cosmetic ingredients designation. idebenone is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule idebenone under hs 29146990 and sitc 51629. as of q4 2014, idebenone remains the us fda preferred term for this commodity. idebenone bears us nlm identifiers umls id c0123163 and nci concept code c74158. smiles: occccccccccc1=c(c(=o)c(=c(oc)c1=o)oc)c.. "
"nutritional therapy products. this classification denotes products in capsule, tablet or liquid form that provide essential nutrients, such as a vitamin, an essential mineral, a protein, an herb, or similar nutritional substance.. acitretin. this classification denotes a retinoic acid agent with the molecular formula c21h26o3, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier lch760e9t7, chemically known as 2,4,6,8-nonatetraenoic acid, 9-(4-methoxy-2,3,6-trimethylphenyl)-3,7-dimethyl-, (all-e)- but generally known as acitretin, which bears us nih compound identifier 5284513. european medicines agency schedules acitretin in its extended eudravigilance medicinal product dictionary or xevmpd under index sub05240mig. the term acitretin is an international non-proprietary name or inn (see who inn reference publication, volume 1, no. 4, 1987, list 27). world health organization schedules acitretin in its anatomical therapeutic chemical (atc) classification. acitretin is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule acitretin under hs 29189900 and sitc 51396. as of q4 2014, acitretin remains the us fda preferred term for this commodity. acitretin bears us nlm identifiers umls id c0678135 and nci concept code c985. smiles: o(c1c(c(c(c(c1)c)/c=c/c(=c/c=c/c(=c/c(=o)o)c)c)c)c)c.. "
"nutritional therapy products. this classification denotes products in capsule, tablet or liquid form that provide essential nutrients, such as a vitamin, an essential mineral, a protein, an herb, or similar nutritional substance.. calcium glucoheptonate or calcium gluceptate. this classification denotes an electrolyte replacement agent, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier l11651398j. european medicines agency schedules calcium gluceptate in its extended eudravigilance medicinal product dictionary or xevmpd under index sub13175mig. calcium gluceptate generally arises in the molecular formula c14h26cao16. the term calcium gluceptate is a european pharmacopoeia designation. calcium glucoheptonate or calcium gluceptate bears us nlm identifiers umls id c0108111 and nci concept code c65279. smiles: c(c(c(c(c(c(c(=o)[o-])o)o)o)o)o)o.c(c(c(c(c(c(c(=o)[o-])o)o)o)o)o)o.[ca+2].. "
"nutritional therapy products. this classification denotes products in capsule, tablet or liquid form that provide essential nutrients, such as a vitamin, an essential mineral, a protein, an herb, or similar nutritional substance.. calcium gluconate. this classification denotes an electrolyte replacement agent with the molecular formula 2c6h11o7.ca, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier sqe6vb453k, chemically known as gluconic acid, calcium salt but generally known as calcium gluconate, which bears us nih compound identifier 9290. european medicines agency schedules calcium gluconate in its extended eudravigilance medicinal product dictionary or xevmpd under index sub13176mig. world health organization schedules calcium gluconate in its anatomical therapeutic chemical (atc) classification. as of q4 2014, calcium gluconate remains the us fda preferred term for this commodity. calcium gluconate bears us nlm identifiers umls id c0006699 and nci concept code c336. smiles: c(c(c(c(c(c(=o)[o-])o)o)o)o)o.c(c(c(c(c(c(=o)[o-])o)o)o)o)o.[ca+2].. "
"nutritional therapy products. this classification denotes products in capsule, tablet or liquid form that provide essential nutrients, such as a vitamin, an essential mineral, a protein, an herb, or similar nutritional substance.. dihydrotachysterol. this classification denotes a vitamin d analog with the molecular formula c28h46o, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier r5lm3h112r, chemically known as 9,10-secoergosta-5,7,22-trien-3-ol, (3beta,5e,7e,10alpha,22e)- but generally known as dihydrotachysterol, which bears us nih compound identifier 5281010. european medicines agency schedules dihydrotachysterol in its extended eudravigilance medicinal product dictionary or xevmpd under index sub07141mig. the term dihydrotachysterol is an international non-proprietary name. world health organization schedules dihydrotachysterol in its anatomical therapeutic chemical (atc) classification. dihydrotachysterol is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule dihydrotachysterol under hs 29061900 and sitc 51231. as of q4 2014, dihydrotachysterol remains the us fda preferred term for this commodity. dihydrotachysterol bears us nlm identifiers umls id c0012319 and nci concept code c87290. smiles: oc1cc(=c\\c=c2\\c3c(c(cc3)c(c)/c=c/c(c(c)c)c)(ccc2)c)\\c(cc1)c.. "
"nutritional therapy products. this classification denotes products in capsule, tablet or liquid form that provide essential nutrients, such as a vitamin, an essential mineral, a protein, an herb, or similar nutritional substance.. ferrous sulfate. this classification denotes a nutritional supplement with the molecular formula feo4s; a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 2idp3x9oud; chemically known as vanadium sulfate; vso4 but generally known as ferrous sulfate; which bears us national institutes of health compound identifier 1118 european medicines agency schedules ferrous sulfate in its extended eudravigilance medicinal product dictionary or xevmpd under index sub13877mig world health organization schedules ferrous sulfate in its anatomical therapeutic chemical (atc) classification as of q4 2014, ferrous sulfate remains the us fda preferred term for this commodity. ferrous sulfate bears us nlm identifiers umls id c0060282 and nci concept code c29049. smiles: s(=o)(=o)(o)o.. "
"nutritional therapy products. this classification denotes products in capsule, tablet or liquid form that provide essential nutrients, such as a vitamin, an essential mineral, a protein, an herb, or similar nutritional substance.. folic acid. this classification denotes a b vitamin with the molecular formula c19h19n7o6, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 935e97boy8, chemically known as 4-pteridinol, 2-amino-6-((p-((1, 3-dicarboxypropyl)carbamoyl)anilino)methyl)- but generally known as folic acid, which bears us nih compound identifier 3405. european medicines agency schedules folic acid in its extended eudravigilance medicinal product dictionary or xevmpd under index sub07774mig. the term folic acid is an international non-proprietary name or inn (see who inn reference publication, volume 13, no. 12, 1959, list 3). world health organization schedules folic acid in its anatomical therapeutic chemical (atc) classification. most nations schedule folic acid under hs 29362900 and sitc 54116. as of q4 2014, folic acid remains the us fda preferred term for this commodity. folic acid bears us nlm identifiers umls id c0016410 and nci concept code c510. smiles: oc(=o)c(nc(=o)c1ccc(ncc2nc3c([nh]c(nc3=o)n)nc2)cc1)ccc(=o)o.. "
"nutritional therapy products. this classification denotes products in capsule, tablet or liquid form that provide essential nutrients, such as a vitamin, an essential mineral, a protein, an herb, or similar nutritional substance.. iron sucrose. this classification denotes a nutritional supplement, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier fz7nyf5n8l. european medicines agency schedules iron sucrose in its extended eudravigilance medicinal product dictionary or xevmpd under index sub16439mig. iron sucrose generally arises in the molecular formula c12h22o11.5fe.2na.8o.ho.3h2o. the term iron sucrose is a japanese accepted name designation. as of q4 2014, iron sucrose remains the us fda preferred term for this commodity. iron sucrose bears us nlm identifiers umls id c0060241 and nci concept code c65963. smiles: c(c1c(c(c(c(o1)oc2(c(c(c(o2)co)o)o)co)o)o)o)o.[o-2].[o-2].[o-2].[fe+3].[fe+3].. "
"nutritional therapy products. this classification denotes products in capsule, tablet or liquid form that provide essential nutrients, such as a vitamin, an essential mineral, a protein, an herb, or similar nutritional substance.. niacinamide or nicotinamide. this classification denotes a b vitamin with the molecular formula c6h6n2o, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 25x51i8rd4, chemically known as pyridine, 3-carbamoyl- but generally known as niacinamide, which bears us nih compound identifier 936. european medicines agency schedules niacinamide in its extended eudravigilance medicinal product dictionary or xevmpd under index sub20661. the term nicotinamide is an international non-proprietary name or inn (see who inn reference publication, volume 13, no. 12, 1959, list 3). world health organization schedules niacinamide in its anatomical therapeutic chemical (atc) classification. most nations schedule niacinamide under hs 29362900 and sitc 54116. as of q4 2014, niacinamide remains the us fda preferred term for this commodity. niacinamide bears us nlm identifiers umls id c0028027 and nci concept code c2327. smiles: o=c(n)c1cccnc1.. "
"nutritional therapy products. this classification denotes products in capsule, tablet or liquid form that provide essential nutrients, such as a vitamin, an essential mineral, a protein, an herb, or similar nutritional substance.. nicorandil. this classification denotes a vasodilating agent with the molecular formula c8h9n3o4, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 260456ham0, chemically known as 3-pyridinecarboxamide, n-(2-(nitroxy)ethyl)- but generally known as nicorandil, which bears us nih compound identifier 47528. european medicines agency schedules nicorandil in its extended eudravigilance medicinal product dictionary or xevmpd under index sub09244mig. the term nicorandil is an international non-proprietary name or inn (see who inn reference publication, volume 39, no. 5, 1985, list 25). world health organization schedules nicorandil in its anatomical therapeutic chemical (atc) classification. nicorandil is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule nicorandil under hs 29333999 and sitc 51574. as of q4 2014, nicorandil remains the us fda preferred term for this commodity. nicorandil bears us nlm identifiers umls id c0068700 and nci concept code c84012. smiles: o([n](=o)o)ccnc(=o)c1cccnc1.. "
"nutritional therapy products. this classification denotes products in capsule, tablet or liquid form that provide essential nutrients, such as a vitamin, an essential mineral, a protein, an herb, or similar nutritional substance.. tocofersolan. this classification denotes an antioxidant with the molecular formula c33h54o5(c2h4o)n, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier o03s90u1f2, chemically known as poly(oxy-1,2-ethanediyl), alpha-(4-((3,4-dihydro-2,5,7,8-tetramethyl-2-(4,8,12-trimethyltridecyl)-2h-1-benzopyran-6-yl)oxy)-1,4-dioxobutyl)-omega-hydroxy- but generally known as tocofersolan, which bears us nih compound identifier 71406. european medicines agency schedules tocofersolan in its extended eudravigilance medicinal product dictionary or xevmpd under index sub11139mig. the term tocofersolan is an international non-proprietary name. world health organization schedules tocofersolan in its anatomical therapeutic chemical (atc) classification. tocofersolan is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule tocofersolan under hs 29362800 and sitc 54115. smiles: cc1=c2c(=c(c(=c1c)oc(=o)ccc(=o)occo)c)ccc(o2)(c)cccc(c)cccc(c)cccc(c)c.. "
"nutritional therapy products. this classification denotes products in capsule, tablet or liquid form that provide essential nutrients, such as a vitamin, an essential mineral, a protein, an herb, or similar nutritional substance.. tretinoin. this classification denotes a retinoic acid agent with the molecular formula c20h28o2, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 5688utc01r, chemically known as 3,7-dimethyl-9-(2,6,6-trimethyl-1-cyclohexenyl)-nona-2,4,6,8-tetraenoic acid but generally known as retinoic acid, which bears us nih compound identifier 5538. european medicines agency schedules retinoic acid in its extended eudravigilance medicinal product dictionary or xevmpd under index sub20680. the term tretinoin is an international non-proprietary name or inn (see who inn reference publication, volume 25 , no. 10 1971, list 11). world health organization schedules retinoic acid in its anatomical therapeutic chemical (atc) classification. most nations schedule tretinoin under hs 29362100 and sitc 54112. as of q4 2014, tretinoin remains the us fda preferred term for this commodity. tretinoin bears us nlm identifiers umls id c0040845 and nci concept code c900. smiles: oc(=o)/c=c(/c=c/c=c(/c=c/c1=c(cccc1(c)c)c)c)c.. "
"nutritional therapy products. this classification denotes products in capsule, tablet or liquid form that provide essential nutrients, such as a vitamin, an essential mineral, a protein, an herb, or similar nutritional substance.. ademetionine. this classification denotes an amino acid with the molecular formula c15h22n6o5s, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 7lp2mpo46s, chemically known as methionine, s-adenosyl- (6ci) active methionine but generally known as ademetionine, which bears us nih compound identifier 34755. european medicines agency schedules ademetionine in its extended eudravigilance medicinal product dictionary or xevmpd under index sub05266mig. the term ademetionine is an international non-proprietary name or inn (see who inn reference publication, volume 1, no. 4, 1987, list 27). world health organization schedules ademetionine in its anatomical therapeutic chemical (atc) classification. ademetionine is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule ademetionine under hs 29349990 and sitc 51579. as of q4 2014, ademetionine remains the us fda preferred term for this commodity. ademetionine bears us nlm identifiers umls id cl434401 and nci concept code c100098. smiles: [s](cc1oc(n2c3ncnc(n)c3nc2)c(o)c1o)(ccc(n)c(=o)o)c.. "
"nutritional therapy products. this classification denotes products in capsule, tablet or liquid form that provide essential nutrients, such as a vitamin, an essential mineral, a protein, an herb, or similar nutritional substance.. fluoride. this classification denotes a dietary fluorine with the molecular formula f, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier q80vpu408o, chemically known as drinking water,fluoride treated but generally known as fluoride, which bears us nih compound identifier 28179. european medicines agency schedules fluoride in its extended eudravigilance medicinal product dictionary or xevmpd under index sub21927. world health organization schedules fluoride in its anatomical therapeutic chemical (atc) classification.. "
"nutritional therapy products. this classification denotes products in capsule, tablet or liquid form that provide essential nutrients, such as a vitamin, an essential mineral, a protein, an herb, or similar nutritional substance.. hydroxydecyl ubiquinone or idebenone. this classification denotes an antioxidant, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier hb6pn45w4j. european medicines agency schedules idebenone in its extended eudravigilance medicinal product dictionary or xevmpd under index sub08114mig. idebenone generally arises in the molecular formula c19h30o5. the term idebenone is an international nomenclature of cosmetic ingredients designation. idebenone is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. hydroxydecyl ubiquinone or idebenone bears us nlm identifiers umls id c0123163 and nci concept code c74158.. "
"nutritional therapy products. this classification denotes products in capsule, tablet or liquid form that provide essential nutrients, such as a vitamin, an essential mineral, a protein, an herb, or similar nutritional substance.. acetylcarnitine. this classification denotes a nutritional supplement, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 6dh1w9vh8q. european medicines agency schedules acetylcarnitine in its extended eudravigilance medicinal product dictionary or xevmpd under index sub12716mig. acetylcarnitine generally arises in the molecular formula c8h16clno4. the term acetylcarnitine is a hazardous substances data bank designation. as of q4 2014, acetylcarnitine remains the us fda preferred term for this commodity. acetylcarnitine bears us nlm identifiers umls id c0001040 and nci concept code c87329. smiles: o(c(c[n](c)(c)c)cc(=o)o)c(=o)c.. "
"nutritional therapy products. this classification denotes products in capsule, tablet or liquid form that provide essential nutrients, such as a vitamin, an essential mineral, a protein, an herb, or similar nutritional substance.. niacinamide hydrochloride. this classification denotes a b vitamin with the molecular formula c6h6n2o.clh, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 4d16eof1qw. most nations, for tariff and trade purposes, schedule niacinamide hydrochloride under hs 29362900. as of q4 2014, niacinamide hydrochloride remains us fdas preferred term for this commodity. smiles: c1cc(cnc1)c(=o)n.cl.. "
"nutritional therapy products. this classification denotes products in capsule, tablet or liquid form that provide essential nutrients, such as a vitamin, an essential mineral, a protein, an herb, or similar nutritional substance.. thiamine bromide. this classification denotes a b vitamin with the molecular formula c12h17n4os.br, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier jij7b8t57f, chemically known as 3-((4-amino-2-methyl-5-pyrimidinyl)methyl)-5-(2-hydroxyethyl)-4-methylthiazolium bromide, but more generally known as thiamine bromide, which bears us nih compound identifier 71284. european medicines agency schedules thiamine bromide or its base in its extended eudravigilance medicinal product dictionary or xevmpd under index sub10969mig. most nations, for tariff purposes, schedule thiamine bromide under hs 29362200. smiles: cc1c(sc[n+]1cc2cnc(nc2n)c)cco.[br-].. "
"nutritional therapy products. this classification denotes products in capsule, tablet or liquid form that provide essential nutrients, such as a vitamin, an essential mineral, a protein, an herb, or similar nutritional substance.. thiamine chloride hydrochloride. this classification denotes a b vitamin with the molecular formula c12h17n4os.cl.clh, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier m572600e5p, chemically known as thiazolium, 3-((4-amino-2-methyl-5-pyrimidinyl)methyl)-5-(2-hydroxyethyl)-4-methyl-, chloride, monohydrochloride, but more generally known as thiamine chloride hydrochloride, which bears us nih compound identifier 1130. european medicines agency schedules thiamine chloride hydrochloride or its base in its extended eudravigilance medicinal product dictionary or xevmpd under index sub10969mig. most nations, for tariff purposes, schedule thiamine chloride hydrochloride under hs 29362200. smiles: cc1c(sc[n+]1cc2cnc(nc2n)c)cco.cl.[cl-].. "
"nutritional therapy products. this classification denotes products in capsule, tablet or liquid form that provide essential nutrients, such as a vitamin, an essential mineral, a protein, an herb, or similar nutritional substance.. thiamine disulfide. this classification denotes a b vitamin c24h34n8o4s2, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier ujv8k21ykl, chemically known as n,n-(dithiobis(2-(2-hydroxyethyl)-1-methyl-2,1-ethenediyl))bis(n-((4-amino-2-methyl-5-pyrimidinyl)methyl)formamide), but more generally known as thiamine disulfide, which bears us nih compound identifier 5432. european medicines agency schedules thiamine disulfide in its extended eudravigilance medicinal product dictionary or xevmpd under index sub04797mig. most nations, for tariff and trade purposes, schedule thiamine disulfide under hs 29362200 and sitc 54113. as of q4 2014, thiamine disulfide remains us fdas preferred term for this commodity. smiles: cc1nc(c(cn1)cn(/c(=c(\\ss/c(=c(\\n(c=o)cc2c(nc(nc2)c)n)/c)/cco)/cco)/c)c=o)n.. "
"nutritional therapy products. this classification denotes products in capsule, tablet or liquid form that provide essential nutrients, such as a vitamin, an essential mineral, a protein, an herb, or similar nutritional substance.. thiamine disulfide nitrate. this classification denotes a b vitamin c24h34n8o4s2.2hno3, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 0z281voq5o, chemically known as formamide, n,n-(dithiobis(2-(2-hydroxyethyl)-1-methyl-2,1-ethenediyl))bis(n-((4-amino-2-methyl-5-pyrimidinyl)methyl)-, (z,z)-, dinitrate (salt), but more generally known as thiamine disulfide nitrate, which bears us nih compound identifier 44630506. most nations, for tariff and trade purposes, schedule thiamine disulfide nitrate under hs 29362200 and sitc 54113. as of q4 2014, thiamine disulfide nitrate remains us fdas preferred term for this commodity. smiles: cc1nc(c(cn1)cn(/c(=c(\\ss/c(=c(\\n(c=o)cc2c(nc(nc2)c)n)/c)/cco)/cco)/c)c=o)n.[n+](=o)([o-])o.[n+](=o)([o-])o.. "
"nutritional therapy products. this classification denotes products in capsule, tablet or liquid form that provide essential nutrients, such as a vitamin, an essential mineral, a protein, an herb, or similar nutritional substance.. thiamine disulfide phosphate. this classification denotes a b vitamin c24h36n8o10p2s2, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier hix040uvaz, chemically known as formamide, n,n-(dithiobis[1-methyl-2-(2-(phosphonooxy)ethyl]-2,1-ethenediyl))bis(n-((4-amino-2-methyl-5-pyrimidinyl)methyl)-, but more generally known as thiamine disulfide phosphate, which bears us nih compound identifier 3034217. european medicines agency schedules thiamine disulfide phosphate in its extended eudravigilance medicinal product dictionary or xevmpd under index sub22636. most nations, for tariff and trade purposes, schedule thiamine disulfide phosphate under hs 29362200 and sitc 54113. as of q4 2014, thiamine disulfide phosphate remains us fdas preferred term for this commodity. smiles: cc1nc(c(cn1)cn(/c(=c(\\ss/c(=c(\\n(c=o)cc2c(nc(nc2)c)n)/c)/ccop(=o)(o)o)/ccop(=o)(o)o)/c)c=o)n.. "
"nutritional therapy products. this classification denotes products in capsule, tablet or liquid form that provide essential nutrients, such as a vitamin, an essential mineral, a protein, an herb, or similar nutritional substance.. thiamine hydrochloride. this classification denotes a b vitamin with the molecular formula c12h17n4os.cl.clh, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier m572600e5p, chemically known as 67-03-8 (chloride, hcl) but more generally known as thiamine hcl, which bears us nih compound identifier 1130. european medicines agency schedules thiamine hcl in its extended eudravigilance medicinal product dictionary or xevmpd under index sub04798mig. most nations, for tariff and trade purposes, schedule thiamine hydrochloride under hs 29362200 and sitc 54113. as of q4 2014, thiamine hydrochloride remains us fdas preferred term for this commodity. thiamine hydrochloride bears us nlm identifiers umls id c0770309 and nci concept code c48025. smiles: cc1c(sc[n+]1cc2cnc(nc2n)c)cco.cl.[cl-].. "
"nutritional therapy products. this classification denotes products in capsule, tablet or liquid form that provide essential nutrients, such as a vitamin, an essential mineral, a protein, an herb, or similar nutritional substance.. thiamine monochloride. this classification denotes a b vitamin with the molecular formula c12h17n4os.cl, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier x66nso3n35, chemically known as thiazolium, 3-((4-amino-2-methyl-5-pyrimidinyl)methyl)-5-(2-hydroxyethyl)-4-methyl- chloride (1:1), but more generally known as thiamine monochloride, which bears us nih compound identifier 6042. european medicines agency schedules thiamine monochloride or its base in its extended eudravigilance medicinal product dictionary or xevmpd under index sub10969mig. most nations, for tariff purposes, schedule thiamine monochloride under hs 29362200. smiles: cc1c(sc[n+]1cc2cnc(nc2n)c)cco.[cl-].. "
"nutritional therapy products. this classification denotes products in capsule, tablet or liquid form that provide essential nutrients, such as a vitamin, an essential mineral, a protein, an herb, or similar nutritional substance.. thiamine mononitrate. this classification denotes a b vitamin with the molecular formula c12h17n4os.no3, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 8k0i04919x, chemically known as 3-(4-amino-2-methylpyrimidyl-5-methyl)-4-methyl-5,beta-hydroxyethylthiazolium nitrate but more generally known as thiamine mononitrate, which bears us nih compound identifier 10762. european medicines agency schedules thiamine mononitrate in its extended eudravigilance medicinal product dictionary or xevmpd under index sub15528mig. most nations, for tariff and trade purposes, schedule thiamine mononitrate under hs 29362200 and sitc 54113. as of q4 2014, thiamine mononitrate remains us fdas preferred term for this commodity. thiamine mononitrate bears us nlm identifiers umls id c0039844 and nci concept code c87669. smiles: cc1c(sc[n+]1cc2cnc(nc2n)c)cco.[n+](=o)([o-])[o-].. "
"nutritional therapy products. this classification denotes products in capsule, tablet or liquid form that provide essential nutrients, such as a vitamin, an essential mineral, a protein, an herb, or similar nutritional substance.. thiamine monophosphate chloride. this classification denotes a b vitamin with the molecular formula c12h18n4o4ps.cl, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier p712t71q3t, chemically known as thiazolium, 3-((4-amino-2-methyl-5-pyrimidinyl)methyl)-4-methyl-5-(2-(phosphonooxy)ethyl)-, chloride (1:1), but more generally known as thiamine monophosphate chloride, which bears us nih compound identifier 10761. european medicines agency schedules thiamine monophosphate chloride or its base in its extended eudravigilance medicinal product dictionary or xevmpd under index sub10969mig. most nations, for tariff purposes, schedule thiamine monophosphate chloride under hs 29362200. smiles: cc1c(sc[n+]1cc2cnc(nc2n)c)ccop(=o)(o)o.[cl-].. "
"nutritional therapy products. this classification denotes products in capsule, tablet or liquid form that provide essential nutrients, such as a vitamin, an essential mineral, a protein, an herb, or similar nutritional substance.. thiamine monophosphate disulfide. this classification denotes a b vitamin with the molecular formula c24h36n8o10p2s2, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier hix040uvaz, chemically known as formamide, n,n-(dithiobis[1-methyl-2-(2-(phosphonooxy)ethyl]-2,1-ethenediyl))bis(n-((4-amino-2-methyl-5-pyrimidinyl)methyl)-, but more generally known as thiamine monophosphate disulfide, which bears us nih compound identifier 3034217. european medicines agency schedules thiamine monophosphate disulfide or its base in its extended eudravigilance medicinal product dictionary or xevmpd under index sub10969mig. most nations, for tariff purposes, schedule thiamine monophosphate disulfide under hs 29362200. smiles: cc1nc(c(cn1)cn(/c(=c(\\ss/c(=c(\\n(c=o)cc2c(nc(nc2)c)n)/c)/ccop(=o)(o)o)/ccop(=o)(o)o)/c)c=o)n.. "
"nutritional therapy products. this classification denotes products in capsule, tablet or liquid form that provide essential nutrients, such as a vitamin, an essential mineral, a protein, an herb, or similar nutritional substance.. thiamine nitrate. this classification denotes a b vitamin with the molecular formula c12h17n4os.no3, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 8k0i04919x, chemically known as 3-(4-amino-2-methylpyrimidyl-5-methyl)-4-methyl-5,beta-hydroxyethylthiazolium nitrate but more generally known as thiamine mononitrate, which bears us nih compound identifier 10762. european medicines agency schedules thiamine mononitrate in its extended eudravigilance medicinal product dictionary or xevmpd under index sub15528mig. most nations, for tariff and trade purposes, schedule thiamine nitrate under hs 29362200. smiles: cc1c(sc[n+]1cc2cnc(nc2n)c)cco.[n+](=o)([o-])[o-].. "
"nutritional therapy products. this classification denotes products in capsule, tablet or liquid form that provide essential nutrients, such as a vitamin, an essential mineral, a protein, an herb, or similar nutritional substance.. thiamine propyl disulfide. this classification denotes a b vitamin with the molecular formula c15h24n4o2s2, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier ui32mm3xe3, chemically known as n-((4-amino-2-methyl-5-pyrimidinyl)methyl)-n-(4-hydroxy-1-methyl-2-(propyldithio)-1-butenyl)formamide, but more generally known as thiamine propyl disulfide, which bears us nih compound identifier 4963. european medicines agency schedules thiamine propyl disulfide or its base in its extended eudravigilance medicinal product dictionary or xevmpd under index sub10969mig. most nations, for tariff purposes, schedule thiamine propyl disulfide under hs 29362200. smiles: cccss/c(=c(\\c)/n(cc1cnc(nc1n)c)c=o)/cco.. "
"nutritional therapy products. this classification denotes products in capsule, tablet or liquid form that provide essential nutrients, such as a vitamin, an essential mineral, a protein, an herb, or similar nutritional substance.. thiamine pyrophosphate chloride. this classification denotes a b vitamin with the molecular formula c12h19n4o7p2s.cl, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier xmk8k8eviu, chemically known as thiazolium, 3-((4-amino-2-methyl-5-pyrimidinyl)methyl)-4-methyl-5-(4,6,6-trihydroxy-4,6-dioxido-3,5-dioxa-4,6-diphosphahex-1-yl)-, chloride (1:1), but more generally known as thiamine pyrophosphate chloride, which bears us nih compound identifier 9068. european medicines agency schedules thiamine pyrophosphate chloride or its base in its extended eudravigilance medicinal product dictionary or xevmpd under index sub10969mig. most nations, for tariff purposes, schedule thiamine pyrophosphate chloride under hs 29362200. smiles: cc1c(sc[n+]1cc2cnc(nc2n)c)ccop(=o)(o)op(=o)(o)o.[cl-].. "
"nutritional therapy products. this classification denotes products in capsule, tablet or liquid form that provide essential nutrients, such as a vitamin, an essential mineral, a protein, an herb, or similar nutritional substance.. thiamine tetrahydrofurfuryl disulfide hydrochloride. this classification denotes a b vitamin with the molecular formula c17h26n4o3s2.clh, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier t3557lwb27, chemically known as n-((4-amino-2-methylpyrimidin-5-yl)methyl)-n-((1e)-4-hydroxy-1-methyl-2-((tetrahydrofuran-2-ylmethyl)disulfanyl)but-1-en-1-yl)formamide hydrochloride, but more generally known as thiamine tetrahydrofurfuryl disulfide hydrochloride, which bears us nih compound identifier 3036228. european medicines agency schedules thiamine tetrahydrofurfuryl disulfide hydrochloride or its base in its extended eudravigilance medicinal product dictionary or xevmpd under index sub10969mig. most nations, for tariff purposes, schedule thiamine tetrahydrofurfuryl disulfide hydrochloride under hs 29362200. smiles: cc1ncc(c(n1)n)cn(c=o)/c(=c(\\cco)/sscc2ccco2)/c.cl.. "
"nutritional therapy products. this classification denotes products in capsule, tablet or liquid form that provide essential nutrients, such as a vitamin, an essential mineral, a protein, an herb, or similar nutritional substance.. thiamine triphosphate. this classification denotes a b vitamin with the molecular formula c12h19n4o10p3s, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 464m6aq7iv, chemically known as thiazolium, 3-((4-amino-2-methyl-5-pyrimidinyl)methyl)-4-methyl-5-(4,6,8,8-tetrahydroxy-3,5,7-trioxa-4,6,8-triphosphaoct-1-yl)-, inner salt, p,p,p-trioxide, but more generally known as thiamine triphosphate, which bears us nih compound identifier 511. european medicines agency schedules thiamine triphosphate or its base in its extended eudravigilance medicinal product dictionary or xevmpd under index sub10969mig. most nations, for tariff purposes, schedule thiamine triphosphate under hs 29362200. smiles: cc1c(sc[n+]1cc2cnc(nc2n)c)ccop(=o)([o-])op(=o)(o)op(=o)(o)o.. "
"nutritional therapy products. this classification denotes products in capsule, tablet or liquid form that provide essential nutrients, such as a vitamin, an essential mineral, a protein, an herb, or similar nutritional substance.. thiamine triphosphorate. this classification denotes a b vitamin with the molecular formula c12h19n4o10p3s, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 464m6aq7iv, chemically known as thiazolium, 3-((4-amino-2-methyl-5-pyrimidinyl)methyl)-4-methyl-5-(4,6,8,8-tetrahydroxy-3,5,7-trioxa-4,6,8-triphosphaoct-1-yl)-, inner salt, p,p,p-trioxide, but more generally known as thiamine triphosphorate, which bears us nih compound identifier 18989. european medicines agency schedules thiamine triphosphorate or its base in its extended eudravigilance medicinal product dictionary or xevmpd under index sub10969mig. most nations, for tariff purposes, schedule thiamine triphosphorate under hs 29362200. smiles: cc1c(sc[n+]1cc2cnc(nc2n)c)ccop(=o)([o-])op(=o)(o)op(=o)(o)o.. "
"nutritional therapy products. this classification denotes products in capsule, tablet or liquid form that provide essential nutrients, such as a vitamin, an essential mineral, a protein, an herb, or similar nutritional substance.. tretinoin tocoferil. this classification denotes a differentiation inducer with the molecular formula c49h76o3, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier ctd060b1ss, chemically known as (+-)-(2r*)-2,5,7,8-tetramethyl-2-((4r*,8r*)-4,8,12-trimethyltridecyl)-6-chromanyl retinoate but more generally known as tocoretinate, which bears us nih compound identifier 5282180. european medicines agency schedules tretinoin tocoferil in its extended eudravigilance medicinal product dictionary or xevmpd under index sub11247mig. the term tretinoin tocoferil is an international non-proprietary name or inn (see world health organization inn reference publication, volume 6, no, 3 1992, list 32). most nations, for tariff and trade purposes, schedule tretinoin tocoferil under hs 29362800 and sitc 54115. as of q4 2014, tretinoin tocoferil remains us fdas preferred term for this commodity. tretinoin tocoferil bears us nlm identifiers umls id c0289588 and nci concept code c66628. smiles: cc1c(c(c(c2c1o[c@](cc2)(c)ccc[c@h](c)ccc[c@h](c)cccc(c)c)c)oc(=o)/c=c(\\c)/c=c/c=c(\\c)/c=c/c3=c(cccc3(c)c)c)c.. "
"nutritional therapy products. this classification denotes products in capsule, tablet or liquid form that provide essential nutrients, such as a vitamin, an essential mineral, a protein, an herb, or similar nutritional substance.. sterile water for ingestion. sterilized water used to supplement nutrition and for g-tube flushes.. "
"nutritional therapy products. this classification denotes products in capsule, tablet or liquid form that provide essential nutrients, such as a vitamin, an essential mineral, a protein, an herb, or similar nutritional substance.. ferrous gluconate. iron supplement.. "
"antigout drugs. this classification denotes agents that increase uric acid excretion by the kidney, decrease uric acid production (antihyperuricemics), or alleviate the pain and inflammation of acute attacks of gout.. . "
"antigout drugs. this classification denotes agents that increase uric acid excretion by the kidney, decrease uric acid production (antihyperuricemics), or alleviate the pain and inflammation of acute attacks of gout.. allopurinol. this classification denotes a xanthine oxidase inhibitor and uricosuric agent with the molecular formula c5h4n4o, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 63cz7gjn5i, chemically known as 1,5-dihydro-4h-pyrazolo(3,4-d)pyrimidine-4-one but generally known as allopurinol, which bears us nih compound identifier 2094. allopurinol comes in various forms, including di-methyl, ribonucleoside, riboside, riboside 5-monophosphate, and sodium. european medicines agency schedules allopurinol in its extended eudravigilance medicinal product dictionary or xevmpd under index sub05338mig. the term allopurinol is an international non-proprietary name or inn (see who inn reference publication, volume 33, no. 10 1979, list 19). world health organization schedules allopurinol in its anatomical therapeutic chemical (atc) classification. allopurinol is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule allopurinol under hs 29335995 and sitc 51576. as of q4 2014, allopurinol remains the us fda preferred term for this commodity. allopurinol bears us nlm identifiers umls id c0002144 and nci concept code c224. smiles: c1=c2c(=nc=nc2=o)nn1.. "
"antigout drugs. this classification denotes agents that increase uric acid excretion by the kidney, decrease uric acid production (antihyperuricemics), or alleviate the pain and inflammation of acute attacks of gout.. colchicine. this classification denotes a colchicine-site binding agent with the molecular formula c22h25no6, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier sml2y3j35t, chemically known as colchicine, (+)- but generally known as colchicine, which bears us nih compound identifier 2833. european medicines agency schedules colchicine in its extended eudravigilance medicinal product dictionary or xevmpd under index sub01420mig. world health organization schedules colchicine in its anatomical therapeutic chemical (atc) classification. most nations schedule colchicine under hs 29399990 and sitc 54149. as of q4 2014, colchicine remains the us fda preferred term for this commodity. colchicine bears us nlm identifiers umls id c0009262 and nci concept code c385. smiles: o(c1c2c(ccc(nc(=o)c)c3c2ccc(oc)c(=o)c3)cc(oc)c1oc)c.. "
"antigout drugs. this classification denotes agents that increase uric acid excretion by the kidney, decrease uric acid production (antihyperuricemics), or alleviate the pain and inflammation of acute attacks of gout.. probenecid. this classification denotes a uricosuric agent with the molecular formula c13h19no4s, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier po572z7917, chemically known as 4-(n,n-dipropylsulfamoyl)benzoesaeure but generally known as probenecid, which bears us nih compound identifier 4911. european medicines agency schedules probenecid in its extended eudravigilance medicinal product dictionary or xevmpd under index sub10053mig. the term probenecid is an international non-proprietary name or inn (see who inn reference publication, volume 13, no. 12, 1959, list 3). world health organization schedules probenecid in its anatomical therapeutic chemical (atc) classification. probenecid is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule probenecid under hs 29350090 and sitc 51580. as of q4 2014, probenecid remains the us fda preferred term for this commodity. probenecid bears us nlm identifiers umls id c0033209 and nci concept code c772. smiles: s(=o)(=o)(n(ccc)ccc)c1ccc(cc1)c(=o)o.. "
"antigout drugs. this classification denotes agents that increase uric acid excretion by the kidney, decrease uric acid production (antihyperuricemics), or alleviate the pain and inflammation of acute attacks of gout.. sulfinpyrazone. this classification denotes a uricosuric agent with the molecular formula c23h20n2o3s, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier v6ofu47k3w, chemically known as 3,5-pyrazolidinedione, 1,2-diphenyl-4-(2-(phenylsulfinyl)ethyl)- but generally known as sulfinpyrazone, which bears us nih compound identifier 5342. european medicines agency schedules sulfinpyrazone in its extended eudravigilance medicinal product dictionary or xevmpd under index sub10737mig. the term sulfinpyrazone is an international non-proprietary name or inn (see who inn reference publication, volume 16, no. 3 1962, list 4). world health organization schedules sulfinpyrazone in its anatomical therapeutic chemical (atc) classification. sulfinpyrazone is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule sulfinpyrazone under hs 29331990 and sitc 51571. as of q4 2014, sulfinpyrazone remains the us fda preferred term for this commodity. sulfinpyrazone bears us nlm identifiers umls id c0038742 and nci concept code c47739. smiles: s(=o)(ccc1c(=o)n(n(c1=o)c1ccccc1)c1ccccc1)c1ccccc1.. "
"antigout drugs. this classification denotes agents that increase uric acid excretion by the kidney, decrease uric acid production (antihyperuricemics), or alleviate the pain and inflammation of acute attacks of gout.. benzbromarone. this classification denotes a uricosuric agent with the molecular formula c17h12br2o3, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 4pog0rl69o, chemically known as 3,5-dibromo-4-hydroxyphenyl-2-ethyl-3-benzofuranyl ketone but generally known as benzbromarone, which bears us nih compound identifier 2333. european medicines agency schedules benzbromarone in its extended eudravigilance medicinal product dictionary or xevmpd under index sub05743mig. the term benzbromarone is an international non-proprietary name or inn (see who inn reference publication, volume 19 1975, list 5). world health organization schedules benzbromarone in its anatomical therapeutic chemical (atc) classification. benzbromarone is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule benzbromarone under hs 29329985 and sitc 51569. as of q4 2014, benzbromarone remains the us fda preferred term for this commodity. benzbromarone bears us nlm identifiers umls id c0005035 and nci concept code c74412. smiles: brc1cc(c(=o)c2c3c(oc2cc)cccc3)cc(br)c1o.. "
"antigout drugs. this classification denotes agents that increase uric acid excretion by the kidney, decrease uric acid production (antihyperuricemics), or alleviate the pain and inflammation of acute attacks of gout.. neocinchophen. this classification denotes a uricosuric agent and analgesic agent with the molecular formula c19h17no2, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 539m941y9o, chemically known as 6-methylcinchophen, ethyl ester but generally known as neocinchophen, which bears us nih compound identifier 68089. european medicines agency schedules neocinchophen in its extended eudravigilance medicinal product dictionary or xevmpd under index sub09194mig. the term neocinchophen is an international non-proprietary name or inn (see who inn reference publication, volume 12 no. 2 1999, list 40). neocinchophen is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule neocinchophen under hs 29334910 and sitc 51575. as of q4 2014, neocinchophen remains the us fda preferred term for this commodity. neocinchophen bears us nlm identifiers umls id c0301393 and nci concept code c75068. smiles: o(c(=o)c1c2c(nc(c1)c1ccccc1)ccc(c2)c)cc.. "
"antigout drugs. this classification denotes agents that increase uric acid excretion by the kidney, decrease uric acid production (antihyperuricemics), or alleviate the pain and inflammation of acute attacks of gout.. amflutizole. this classification denotes a xanthine oxidase inhibitor with the molecular formula c11h7f3n2o2s, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 83n680m457, chemically known as 5-isothiazolecarboxylic acid, 4-amino-3-(3-(trifluoromethyl)phenyl)- but generally known as amflutizole, which bears us nih compound identifier 54833. european medicines agency schedules amflutizole in its extended eudravigilance medicinal product dictionary or xevmpd under index sub05420mig. the term amflutizole is an international non-proprietary name or inn (see who inn reference publication, volume 38, no. 6, 1984, list 24). amflutizole is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule amflutizole under hs 29341000 and sitc 51579. as of q4 2014, amflutizole remains the us fda preferred term for this commodity. amflutizole bears us nlm identifiers umls id c0051573 and nci concept code c91009. smiles: c1=cc(=cc(=c1)c(f)(f)f)c2=nsc(=c2n)c(=o)o.. "
"antigout drugs. this classification denotes agents that increase uric acid excretion by the kidney, decrease uric acid production (antihyperuricemics), or alleviate the pain and inflammation of acute attacks of gout.. febuxostat. this classification denotes a xanthine oxidase inhibitor and uricosuric agent with the molecular formula c16h16n2o3s, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 101v0r1n2e, chemically known as 5-thiazolecarboxylic acid, 2-(3-cyano-4-(2-methylpropoxy)phenyl)-4-methyl- but generally known as febuxostat, which bears us nih compound identifier 134018. european medicines agency schedules febuxostat in its extended eudravigilance medicinal product dictionary or xevmpd under index sub25382. the term febuxostat is an international non-proprietary name or inn (see who inn reference publication, volume 16., no. 1.2002, list 47). world health organization schedules febuxostat in its anatomical therapeutic chemical (atc) classification. most nations schedule febuxostat under hs 29341000 and sitc 51579. as of q4 2014, febuxostat remains the us fda preferred term for this commodity. febuxostat bears us nlm identifiers umls id c2683462 and nci concept code c65629. smiles: s1c(nc(c1c(=o)o)c)c1cc(c(occ(c)c)cc1)c#n.. "
"antigout drugs. this classification denotes agents that increase uric acid excretion by the kidney, decrease uric acid production (antihyperuricemics), or alleviate the pain and inflammation of acute attacks of gout.. halofenate. this classification denotes a uricosuric agent and anti-lipidemic agent with the molecular formula c19h17clf3no4, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier k9tzk4mno6, chemically known as (p-chlorophenyl)((alpha,alpha,alpha-trifluoro-m-tolyl)oxy)acetic acid ester with n-(2-hydroxyethyl)acetamide but generally known as halofenate, which bears us nih compound identifier 33584. european medicines agency schedules halofenate in its extended eudravigilance medicinal product dictionary or xevmpd under index sub07999mig. the term halofenate is an international non-proprietary name or inn (see who inn reference publication, volume 23, no. 10 1969, list 9). halofenate is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule halofenate under hs 29242995 and sitc 51479. as of q4 2014, halofenate remains the us fda preferred term for this commodity. halofenate bears us nlm identifiers umls id c0018541 and nci concept code c83805. smiles: clc1ccc(c(oc2cc(ccc2)c(f)(f)f)c(=o)occnc(=o)c)cc1.. "
"antigout drugs. this classification denotes agents that increase uric acid excretion by the kidney, decrease uric acid production (antihyperuricemics), or alleviate the pain and inflammation of acute attacks of gout.. irtemazole. this classification denotes a uricosuric agent with the molecular formula c18h16n4, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier aak27wy74i, chemically known as 1h-benzimidazole, 5-(1h-imidazol-1-ylphenylmethyl)-2-methyl-, (+-)- but generally known as irtemazole, which bears us nih compound identifier 71330. european medicines agency schedules irtemazole in its extended eudravigilance medicinal product dictionary or xevmpd under index sub08300mig. the term irtemazole is an international non-proprietary name or inn (see who inn reference publication, volume 3, no. 3, 1989, list 29). irtemazole is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule irtemazole under hs 29332990 and sitc 51573. as of q4 2014, irtemazole remains the us fda preferred term for this commodity. irtemazole bears us nlm identifiers umls id c0063880 and nci concept code c65965. smiles: n1(c(c2cc3[nh]c(nc3cc2)c)c2ccccc2)ccnc1.. "
"antigout drugs. this classification denotes agents that increase uric acid excretion by the kidney, decrease uric acid production (antihyperuricemics), or alleviate the pain and inflammation of acute attacks of gout.. isobromindione. this classification denotes a uricosuric agent with the molecular formula c15h9bro2, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier j1j87p409k, chemically known as 1,3-indandione, 5-bromo-2-phenyl- but generally known as isobromindione, which bears us nih compound identifier 68953. european medicines agency schedules isobromindione in its extended eudravigilance medicinal product dictionary or xevmpd under index sub08311mig. the term isobromindione is an international non-proprietary name or inn (see who inn reference publication, volume 39, no. 5, 1985, list 25). world health organization schedules isobromindione in its anatomical therapeutic chemical (atc) classification. isobromindione is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule isobromindione under hs 29147000 and sitc 51629. as of q4 2014, isobromindione remains the us fda preferred term for this commodity. isobromindione bears us nlm identifiers umls id c1881274 and nci concept code c65971. smiles: brc1cc2c(c(=o)c(c2=o)c2ccccc2)cc1.. "
"antigout drugs. this classification denotes agents that increase uric acid excretion by the kidney, decrease uric acid production (antihyperuricemics), or alleviate the pain and inflammation of acute attacks of gout.. nicoxamat. this classification denotes a uricosuric agent with the molecular formula c6h6n2o2, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier z3h2d4mf7a, chemically known as 3-pyridinecarboxamide, n-hydroxy- but generally known as nicoxamat, which bears us nih compound identifier 71211. european medicines agency schedules nicoxamat in its extended eudravigilance medicinal product dictionary or xevmpd under index sub09249mig. the term nicoxamat is an international non-proprietary name or inn (see who inn reference publication, volume 35, no. 5 1981, list 21). nicoxamat is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule nicoxamat under hs 29333999 and sitc 51574. as of q4 2014, nicoxamat remains the us fda preferred term for this commodity. nicoxamat bears us nlm identifiers umls id c2698465 and nci concept code c77068. smiles: o=c(no)c1cccnc1.. "
"antigout drugs. this classification denotes agents that increase uric acid excretion by the kidney, decrease uric acid production (antihyperuricemics), or alleviate the pain and inflammation of acute attacks of gout.. oxipurinol or oxypurinol. this classification denotes a xanthine oxidase inhibitor with the molecular formula c5h4n4o2, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier g97oze5068, chemically known as 4,6-dihydroxypyrazolo(3,4-d)pyrimidine but generally known as oxipurinol, which bears us nih compound identifier 4644. european medicines agency schedules oxipurinol in its extended eudravigilance medicinal product dictionary or xevmpd under index sub09535mig. the term oxipurinol is an international non-proprietary name or inn (see who inn reference publication, volume 22, no. 10, 1968, list 8). oxipurinol is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. oxipurinol or oxypurinol bears us nlm identifiers umls id c0030086 and nci concept code c87294. smiles: o=c1[nh]c(=o)nc2[nh][nh]cc12.. "
"antigout drugs. this classification denotes agents that increase uric acid excretion by the kidney, decrease uric acid production (antihyperuricemics), or alleviate the pain and inflammation of acute attacks of gout.. rasburicase. this classification denotes a uricosuric agent with the molecular formula c1521h2381n417o461s7, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 08gy9k1euo, more generally known as rasburicase. european medicines agency schedules rasburicase in its extended eudravigilance medicinal product dictionary or xevmpd under index sub04204mig. the term rasburicase is an international non-proprietary name or inn (see who inn reference publication, volume 14, no. 1, 2000, list 43. most nations schedule rasburicase under hs 35079090 and sitc 51691. smiles:. as of q4 2014, rasburicase remains the us fda preferred term for this commodity. . rasburicase bears us nlm identifiers umls id c0937932 and nci concept code c2404.. "
"antigout drugs. this classification denotes agents that increase uric acid excretion by the kidney, decrease uric acid production (antihyperuricemics), or alleviate the pain and inflammation of acute attacks of gout.. seclazone. this classification denotes a uricosuric agent with the molecular formula c10h8clno3, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier jw3uz4i1a8, chemically known as 3,3a-dihydro-7-chloro-2h,9h-isoxazolo(3,2-b)(1,3)benzoxazin-9-one but generally known as seclazone, which bears us nih compound identifier 34443. european medicines agency schedules seclazone in its extended eudravigilance medicinal product dictionary or xevmpd under index sub10466mig. the term seclazone is an international non-proprietary name or inn (see who inn reference publication, volume 27, no. 10 1973, list 13). seclazone is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule seclazone under hs 29349990 and sitc 51579. as of q4 2014, seclazone remains the us fda preferred term for this commodity. seclazone bears us nlm identifiers umls id c0644512 and nci concept code c73105. smiles: c1con2c1oc3=c(c2=o)c=c(c=c3)cl.. "
"antigout drugs. this classification denotes agents that increase uric acid excretion by the kidney, decrease uric acid production (antihyperuricemics), or alleviate the pain and inflammation of acute attacks of gout.. thiopurinol or tisopurine. this classification denotes a xanthine oxidase inhibitor and uricosuric agent with the molecular formula c5h4n4s, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 79f9i2r16m, chemically known as 5h-pyrazolo(3,4-d)pyrimidine-4-thione but generally known as tisopurine, which bears us nih compound identifier 667510. european medicines agency schedules tisopurine in its extended eudravigilance medicinal product dictionary or xevmpd under index sub11121mig. the term tisopurine is an international non-proprietary name or inn (see who inn reference publication, volume 30, no. 10 1976, list 16). world health organization schedules tisopurine in its anatomical therapeutic chemical (atc) classification. tisopurine is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. thiopurinol or tisopurine bears us nlm identifiers umls id c0076516 and nci concept code c80872. smiles: c1=c2c(=nc=nc2=s)nn1.. "
"antigout drugs. this classification denotes agents that increase uric acid excretion by the kidney, decrease uric acid production (antihyperuricemics), or alleviate the pain and inflammation of acute attacks of gout.. pegloticase. this classification denotes an uricase covalently attached to polyethylene glycol and immobilized enzyme with the chemical formula c1549h2430n408o448s8, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier r581ot55ea, chemically known as des-(1-6)-(7-threonine,46-threonine,291-lysine,301-serine)uricase (ec 1.7.3.3, urate oxidase) but generally known as pegloticase. european medicines agency schedules pegloticase in its extended eudravigilance medicinal product dictionary or xevmpd under index sub32159. the term pegloticase is an international non-proprietary name or inn (see who inn reference publication, volume 22, no. 3, 2008, list 60.) as of q4 2014, pegloticase remains the us fda preferred term for this commodity.. "
"antigout drugs. this classification denotes agents that increase uric acid excretion by the kidney, decrease uric acid production (antihyperuricemics), or alleviate the pain and inflammation of acute attacks of gout.. allopurinol riboside. this classification denotes a xanthine oxidase inhibitor and uricosuric agent with the molecular formula c10h12n4o5, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier wzs8452sec, chemically known as 4h-pyrazolo(3,4-d)pyrimidin-4-one, 1,5-dihydro-1-.beta.-d-ribofuranosyl-, but more generally known as allopurinol riboside, which bears us nih compound identifier 85337. european medicines agency schedules allopurinol riboside or its base in its extended eudravigilance medicinal product dictionary or xevmpd under index sub05338mig. most nations, for tariff purposes, schedule allopurinol riboside under hs 29335995. smiles: c1c2c(=o)[nh]cnc2n(n1)[c@h]3[c@@h]([c@@h]([c@h](o3)co)o)o.. "
"antigout drugs. this classification denotes agents that increase uric acid excretion by the kidney, decrease uric acid production (antihyperuricemics), or alleviate the pain and inflammation of acute attacks of gout.. allopurinol sodium. this classification denotes a xanthine oxidase inhibitor and uricosuric agen with the molecular formula c5h3n4o.na, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 428673rc2z, chemically known as 1,5-dihydro-4h-pyrazolo(3,4-d)pyrimidine-4-one but more generally known as allopurinol sodium, which bears us nih compound identifier 2094. the base compound, allopurinol, comes in other forms, including di-methyl, ribonucleoside, riboside, riboside, and 5-monophosphate. european medicines agency schedules allopurinol sodium in its extended eudravigilance medicinal product dictionary or xevmpd under index sub30291. most nations, for tariff and trade purposes, schedule allopurinol sodium under hs 29335995 and sitc 51576. as of q4 2014, allopurinol sodium remains us fdas preferred term for this commodity. allopurinol sodium bears us nlm identifiers umls id c0278766 and nci concept code c2564. smiles: c1c2c(=o)[nh]cnc2[n-]n1.[na+].. "
"antigout drugs. this classification denotes agents that increase uric acid excretion by the kidney, decrease uric acid production (antihyperuricemics), or alleviate the pain and inflammation of acute attacks of gout.. probenecid sodium. this classification denotes a uricosuric agent with the molecular formula c13h18no4s.na, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier fxb45q4zvk, chemically known as sodium 4-((dipropylamino)sulfonyl)benzoate, but more generally known as probenecid sodium, which bears us nih compound identifier 32095. european medicines agency schedules probenecid sodium or its base in its extended eudravigilance medicinal product dictionary or xevmpd under index sub10053mig. most nations, for tariff purposes, schedule probenecid sodium under hs 29350090. smiles: cccn(ccc)s(=o)(=o)c1ccc(cc1)c(=o)[o-].[na+].. "
"antigout drugs. this classification denotes agents that increase uric acid excretion by the kidney, decrease uric acid production (antihyperuricemics), or alleviate the pain and inflammation of acute attacks of gout.. lesinurad. a type of urat1 inhibitor.. "
"combination antigout agents. this classification denotes combination drugs that increase uric acid excretion by the kidney, decrease uric acid production, or alleviate the pain and inflammation of acute attacks of a hereditary metabolic disorder characterized by recurrent acute arthritis, hyperuricemia, and deposition of sodium urate, called gout, hence the term antigout agents. typical combination antigout agent constituents are colchicine and probenecid.. . "
"combination antigout agents. this classification denotes combination drugs that increase uric acid excretion by the kidney, decrease uric acid production, or alleviate the pain and inflammation of acute attacks of a hereditary metabolic disorder characterized by recurrent acute arthritis, hyperuricemia, and deposition of sodium urate, called gout, hence the term antigout agents. typical combination antigout agent constituents are colchicine and probenecid.. colchicine/probenecid. this classification denotes a combination drug defined by the u.s. department of veterans affairs in its (vas) national drug file (ndf), which falls under va drug class ms400. this va drug class (ms400) classifies this compound as belonging to the group antigout agents.. "
"combination diuretics. this classification denotes combination drugs and preparations that promote excretion of urine by influencing human kidney function, commonly known as diuretics. the major diuretic types include osmotic (diuretics that increase urine volume by increasing osmotically-active urine solute); potassium sparing (diuretics that limit potassium secretion in urine); sodium chloride symporter inhibitors; and sodium potassium chloride symporter inhibitors. diuretics, that is, operate by stimulating he nervous system, by alleviating kidney congestion, by increasing blood pressure, or by increasing or improving liquid transport. typical combination diuretic constituents are hydrochlorothiazide, potassium chloride, spironolactone, and triamterene.. . "
"combination diuretics. this classification denotes combination drugs and preparations that promote excretion of urine by influencing human kidney function, commonly known as diuretics. the major diuretic types include osmotic (diuretics that increase urine volume by increasing osmotically-active urine solute); potassium sparing (diuretics that limit potassium secretion in urine); sodium chloride symporter inhibitors; and sodium potassium chloride symporter inhibitors. diuretics, that is, operate by stimulating he nervous system, by alleviating kidney congestion, by increasing blood pressure, or by increasing or improving liquid transport. typical combination diuretic constituents are hydrochlorothiazide, potassium chloride, spironolactone, and triamterene.. amiloride/hydrochlorothiazide. this classification denotes a combination drug defined by the u.s. department of veterans affairs in its (vas) national drug file (ndf), which falls under va drug class cv704. this va drug class (cv704) classifies this compound as belonging to the group potassium sparing/combinations diuretics.. "
"combination diuretics. this classification denotes combination drugs and preparations that promote excretion of urine by influencing human kidney function, commonly known as diuretics. the major diuretic types include osmotic (diuretics that increase urine volume by increasing osmotically-active urine solute); potassium sparing (diuretics that limit potassium secretion in urine); sodium chloride symporter inhibitors; and sodium potassium chloride symporter inhibitors. diuretics, that is, operate by stimulating he nervous system, by alleviating kidney congestion, by increasing blood pressure, or by increasing or improving liquid transport. typical combination diuretic constituents are hydrochlorothiazide, potassium chloride, spironolactone, and triamterene.. bendroflumethiazide/potassium chloride. this classification denotes a combination drug defined by the u.s. department of veterans affairs in its (vas) national drug file (ndf), which falls under va drug class cv701. this va drug class (cv701) classifies this compound as belonging to the group thiazides/related diuretics.. "
"combination diuretics. this classification denotes combination drugs and preparations that promote excretion of urine by influencing human kidney function, commonly known as diuretics. the major diuretic types include osmotic (diuretics that increase urine volume by increasing osmotically-active urine solute); potassium sparing (diuretics that limit potassium secretion in urine); sodium chloride symporter inhibitors; and sodium potassium chloride symporter inhibitors. diuretics, that is, operate by stimulating he nervous system, by alleviating kidney congestion, by increasing blood pressure, or by increasing or improving liquid transport. typical combination diuretic constituents are hydrochlorothiazide, potassium chloride, spironolactone, and triamterene.. hydrochlorothiazide/spironolactone. this classification denotes a combination drug defined by the u.s. department of veterans affairs in its (vas) national drug file (ndf), which falls under va drug class cv704. this va drug class (cv704) classifies this compound as belonging to the group potassium sparing/combinations diuretics.. "
"combination diuretics. this classification denotes combination drugs and preparations that promote excretion of urine by influencing human kidney function, commonly known as diuretics. the major diuretic types include osmotic (diuretics that increase urine volume by increasing osmotically-active urine solute); potassium sparing (diuretics that limit potassium secretion in urine); sodium chloride symporter inhibitors; and sodium potassium chloride symporter inhibitors. diuretics, that is, operate by stimulating he nervous system, by alleviating kidney congestion, by increasing blood pressure, or by increasing or improving liquid transport. typical combination diuretic constituents are hydrochlorothiazide, potassium chloride, spironolactone, and triamterene.. hydrochlorothiazide/triamterene. this classification denotes a combination drug defined by the u.s. department of veterans affairs in its (vas) national drug file (ndf), which falls under va drug class cv704. this va drug class (cv704) classifies this compound as belonging to the group potassium sparing/combinations diuretics.. "
"combination electrolytes/minerals. this classification denotes combination drugs and preparations that dissociate into two or more ions in water, often used in fluid therapy, or resotoration of both volume and composition of body fluids, hence the term electrolytes; or b) combination drugs and preparations that consist of native, inorganic or fossilized organic substances having a definite chemical composition, called minerals. typical combination electrolyte/mineral constituents are calcium, chloride, chromium, copper, cupric chloride, cupric sulfate, magnesium, potassium, potassium citrate, sodium chloride, and sodium fluoride.. . "
"combination electrolytes/minerals. this classification denotes combination drugs and preparations that dissociate into two or more ions in water, often used in fluid therapy, or resotoration of both volume and composition of body fluids, hence the term electrolytes; or b) combination drugs and preparations that consist of native, inorganic or fossilized organic substances having a definite chemical composition, called minerals. typical combination electrolyte/mineral constituents are calcium, chloride, chromium, copper, cupric chloride, cupric sulfate, magnesium, potassium, potassium citrate, sodium chloride, and sodium fluoride.. chromic chloride/cupric sulfate/manganese sulfate/zinc sulfate. this classification denotes a combination drug defined by the u.s. department of veterans affairs in its (vas) national drug file (ndf), which falls under va drug class tn490. this va drug class (tn490) classifies this compound as belonging to the group electrolytes/minerals, combinations.. "
"combination electrolytes/minerals. this classification denotes combination drugs and preparations that dissociate into two or more ions in water, often used in fluid therapy, or resotoration of both volume and composition of body fluids, hence the term electrolytes; or b) combination drugs and preparations that consist of native, inorganic or fossilized organic substances having a definite chemical composition, called minerals. typical combination electrolyte/mineral constituents are calcium, chloride, chromium, copper, cupric chloride, cupric sulfate, magnesium, potassium, potassium citrate, sodium chloride, and sodium fluoride.. acetate/calcium/chloride/gluconate/magnesium/potassium/sodium. this classification denotes a combination drug defined by the u.s. department of veterans affairs in its (vas) national drug file (ndf), which falls under va drug class tn490. this va drug class (tn490) classifies this compound as belonging to the group electrolytes/minerals, combinations.. "
"combination electrolytes/minerals. this classification denotes combination drugs and preparations that dissociate into two or more ions in water, often used in fluid therapy, or resotoration of both volume and composition of body fluids, hence the term electrolytes; or b) combination drugs and preparations that consist of native, inorganic or fossilized organic substances having a definite chemical composition, called minerals. typical combination electrolyte/mineral constituents are calcium, chloride, chromium, copper, cupric chloride, cupric sulfate, magnesium, potassium, potassium citrate, sodium chloride, and sodium fluoride.. acetate/calcium/chloride/gluconate/magnesium/potassium/sodium/sugar. this classification denotes a combination drug defined by the u.s. department of veterans affairs in its (vas) national drug file (ndf), which falls under va drug class tn490. this va drug class (tn490) classifies this compound as belonging to the group electrolytes/minerals, combinations.. "
"combination electrolytes/minerals. this classification denotes combination drugs and preparations that dissociate into two or more ions in water, often used in fluid therapy, or resotoration of both volume and composition of body fluids, hence the term electrolytes; or b) combination drugs and preparations that consist of native, inorganic or fossilized organic substances having a definite chemical composition, called minerals. typical combination electrolyte/mineral constituents are calcium, chloride, chromium, copper, cupric chloride, cupric sulfate, magnesium, potassium, potassium citrate, sodium chloride, and sodium fluoride.. ammonium chloride/potassium citrate/potassium gluconate. this classification denotes a combination drug defined by the u.s. department of veterans affairs in its (vas) national drug file (ndf), which falls under va drug class tn490. this va drug class (tn490) classifies this compound as belonging to the group electrolytes/minerals, combinations.. "
"combination electrolytes/minerals. this classification denotes combination drugs and preparations that dissociate into two or more ions in water, often used in fluid therapy, or resotoration of both volume and composition of body fluids, hence the term electrolytes; or b) combination drugs and preparations that consist of native, inorganic or fossilized organic substances having a definite chemical composition, called minerals. typical combination electrolyte/mineral constituents are calcium, chloride, chromium, copper, cupric chloride, cupric sulfate, magnesium, potassium, potassium citrate, sodium chloride, and sodium fluoride.. calcium carbonate/sodium fluoride. this classification denotes a combination drug defined by the u.s. department of veterans affairs in its (vas) national drug file (ndf), which falls under va drug class tn490. this va drug class (tn490) classifies this compound as belonging to the group electrolytes/minerals, combinations.. "
"combination electrolytes/minerals. this classification denotes combination drugs and preparations that dissociate into two or more ions in water, often used in fluid therapy, or resotoration of both volume and composition of body fluids, hence the term electrolytes; or b) combination drugs and preparations that consist of native, inorganic or fossilized organic substances having a definite chemical composition, called minerals. typical combination electrolyte/mineral constituents are calcium, chloride, chromium, copper, cupric chloride, cupric sulfate, magnesium, potassium, potassium citrate, sodium chloride, and sodium fluoride.. calcium/chloride/gluconate/magnesium/potassium/sodium/sulfate. this classification denotes a combination drug defined by the u.s. department of veterans affairs in its (vas) national drug file (ndf), which falls under va drug class tn490. this va drug class (tn490) classifies this compound as belonging to the group electrolytes/minerals, combinations.. "
"combination electrolytes/minerals. this classification denotes combination drugs and preparations that dissociate into two or more ions in water, often used in fluid therapy, or resotoration of both volume and composition of body fluids, hence the term electrolytes; or b) combination drugs and preparations that consist of native, inorganic or fossilized organic substances having a definite chemical composition, called minerals. typical combination electrolyte/mineral constituents are calcium, chloride, chromium, copper, cupric chloride, cupric sulfate, magnesium, potassium, potassium citrate, sodium chloride, and sodium fluoride.. chromic chloride/cupric chloride/manganese chloride/selenium/zinc chloride. this classification denotes a combination drug defined by the u.s. department of veterans affairs in its (vas) national drug file (ndf), which falls under va drug class tn490. this va drug class (tn490) classifies this compound as belonging to the group electrolytes/minerals, combinations.. "
"combination electrolytes/minerals. this classification denotes combination drugs and preparations that dissociate into two or more ions in water, often used in fluid therapy, or resotoration of both volume and composition of body fluids, hence the term electrolytes; or b) combination drugs and preparations that consist of native, inorganic or fossilized organic substances having a definite chemical composition, called minerals. typical combination electrolyte/mineral constituents are calcium, chloride, chromium, copper, cupric chloride, cupric sulfate, magnesium, potassium, potassium citrate, sodium chloride, and sodium fluoride.. chromic chloride/cupric chloride/manganese chloride/zinc chloride. this classification denotes a combination drug defined by the u.s. department of veterans affairs in its (vas) national drug file (ndf), which falls under va drug class tn490. this va drug class (tn490) classifies this compound as belonging to the group electrolytes/minerals, combinations.. "
"combination electrolytes/minerals. this classification denotes combination drugs and preparations that dissociate into two or more ions in water, often used in fluid therapy, or resotoration of both volume and composition of body fluids, hence the term electrolytes; or b) combination drugs and preparations that consist of native, inorganic or fossilized organic substances having a definite chemical composition, called minerals. typical combination electrolyte/mineral constituents are calcium, chloride, chromium, copper, cupric chloride, cupric sulfate, magnesium, potassium, potassium citrate, sodium chloride, and sodium fluoride.. chromic chloride/cupric chloride/manganese sulfate/selenium/zinc. this classification denotes a combination drug defined by the u.s. department of veterans affairs in its (vas) national drug file (ndf), which falls under va drug class tn490. this va drug class (tn490) classifies this compound as belonging to the group electrolytes/minerals, combinations.. "
"combination electrolytes/minerals. this classification denotes combination drugs and preparations that dissociate into two or more ions in water, often used in fluid therapy, or resotoration of both volume and composition of body fluids, hence the term electrolytes; or b) combination drugs and preparations that consist of native, inorganic or fossilized organic substances having a definite chemical composition, called minerals. typical combination electrolyte/mineral constituents are calcium, chloride, chromium, copper, cupric chloride, cupric sulfate, magnesium, potassium, potassium citrate, sodium chloride, and sodium fluoride.. chromic chloride/cupric sulfate/manganese sulfate/selenium/zinc. this classification denotes a combination drug defined by the u.s. department of veterans affairs in its (vas) national drug file (ndf), which falls under va drug class tn490. this va drug class (tn490) classifies this compound as belonging to the group electrolytes/minerals, combinations.. "
"combination electrolytes/minerals. this classification denotes combination drugs and preparations that dissociate into two or more ions in water, often used in fluid therapy, or resotoration of both volume and composition of body fluids, hence the term electrolytes; or b) combination drugs and preparations that consist of native, inorganic or fossilized organic substances having a definite chemical composition, called minerals. typical combination electrolyte/mineral constituents are calcium, chloride, chromium, copper, cupric chloride, cupric sulfate, magnesium, potassium, potassium citrate, sodium chloride, and sodium fluoride.. chromic sulfate/cupric sulfate/manganese sulfate/selenium/zinc. this classification denotes a combination drug defined by the u.s. department of veterans affairs in its (vas) national drug file (ndf), which falls under va drug class tn490. this va drug class (tn490) classifies this compound as belonging to the group electrolytes/minerals, combinations.. "
"combination electrolytes/minerals. this classification denotes combination drugs and preparations that dissociate into two or more ions in water, often used in fluid therapy, or resotoration of both volume and composition of body fluids, hence the term electrolytes; or b) combination drugs and preparations that consist of native, inorganic or fossilized organic substances having a definite chemical composition, called minerals. typical combination electrolyte/mineral constituents are calcium, chloride, chromium, copper, cupric chloride, cupric sulfate, magnesium, potassium, potassium citrate, sodium chloride, and sodium fluoride.. chromic sulfate/cupric sulfate/manganese sulfate/zinc sulfate. this classification denotes a combination drug defined by the u.s. department of veterans affairs in its (vas) national drug file (ndf), which falls under va drug class tn490. this va drug class (tn490) classifies this compound as belonging to the group electrolytes/minerals, combinations.. "
"combination electrolytes/minerals. this classification denotes combination drugs and preparations that dissociate into two or more ions in water, often used in fluid therapy, or resotoration of both volume and composition of body fluids, hence the term electrolytes; or b) combination drugs and preparations that consist of native, inorganic or fossilized organic substances having a definite chemical composition, called minerals. typical combination electrolyte/mineral constituents are calcium, chloride, chromium, copper, cupric chloride, cupric sulfate, magnesium, potassium, potassium citrate, sodium chloride, and sodium fluoride.. potassium chloride/sodium chloride. this classification denotes a combination drug defined by the u.s. department of veterans affairs in its (vas) national drug file (ndf), which falls under va drug class tn102. this va drug class (tn102) classifies this compound as belonging to the group iv solutions with electrolytes.. "
"combination electrolytes/minerals. this classification denotes combination drugs and preparations that dissociate into two or more ions in water, often used in fluid therapy, or resotoration of both volume and composition of body fluids, hence the term electrolytes; or b) combination drugs and preparations that consist of native, inorganic or fossilized organic substances having a definite chemical composition, called minerals. typical combination electrolyte/mineral constituents are calcium, chloride, chromium, copper, cupric chloride, cupric sulfate, magnesium, potassium, potassium citrate, sodium chloride, and sodium fluoride.. potassium chloride/sodium chloride/tromethamine. this classification denotes a combination drug defined by the u.s. department of veterans affairs in its (vas) national drug file (ndf), which falls under va drug class tn900. this va drug class (tn900) classifies this compound as belonging to the group therapeutic nutrients/minerals/electrolyes, other.. "
"combination electrolytes/minerals. this classification denotes combination drugs and preparations that dissociate into two or more ions in water, often used in fluid therapy, or resotoration of both volume and composition of body fluids, hence the term electrolytes; or b) combination drugs and preparations that consist of native, inorganic or fossilized organic substances having a definite chemical composition, called minerals. typical combination electrolyte/mineral constituents are calcium, chloride, chromium, copper, cupric chloride, cupric sulfate, magnesium, potassium, potassium citrate, sodium chloride, and sodium fluoride.. potassium chloride/water. electrolyte replacement solution of potassium chloride in water.. "
"combination electrolytes/minerals. this classification denotes combination drugs and preparations that dissociate into two or more ions in water, often used in fluid therapy, or resotoration of both volume and composition of body fluids, hence the term electrolytes; or b) combination drugs and preparations that consist of native, inorganic or fossilized organic substances having a definite chemical composition, called minerals. typical combination electrolyte/mineral constituents are calcium, chloride, chromium, copper, cupric chloride, cupric sulfate, magnesium, potassium, potassium citrate, sodium chloride, and sodium fluoride.. potassium chloride/sodium chloride/dextrose. electrolyte replacement solutions containing potassium chloride, sodium chloride and dextrose.. "
"combination nutritional therapy products. this classification denotes combination drugs and preparations that consist in whole or part of a) native, inorganic or fossilized organic substances having a definite chemical composition and formed by inorganic reactions, which bear the name minerals; and/or b) organic substances that are required in small amounts for maintenance and growth, but which cannot be manufactured by the human body, which, as vital amines, bear the name vitamins. typical combination minerals and vitamin constituents are ascorbic acid, beta carotene, calcium, cholecalciferol, ferrous fumarate, folic acid, iron, magnesium oxide, minerals, multivitamins, niacin, pyridoxine, and vitamin a.. . "
"combination nutritional therapy products. this classification denotes combination drugs and preparations that consist in whole or part of a) native, inorganic or fossilized organic substances having a definite chemical composition and formed by inorganic reactions, which bear the name minerals; and/or b) organic substances that are required in small amounts for maintenance and growth, but which cannot be manufactured by the human body, which, as vital amines, bear the name vitamins. typical combination minerals and vitamin constituents are ascorbic acid, beta carotene, calcium, cholecalciferol, ferrous fumarate, folic acid, iron, magnesium oxide, minerals, multivitamins, niacin, pyridoxine, and vitamin a.. ascorbic acid/cyanocobalamin/ferrous gluconate/intrinsic factor. this classification denotes a combination drug defined by the u.s. department of veterans affairs in its (vas) national drug file (ndf), which falls under va drug class vt802. this va drug class (vt802) classifies this compound as belonging to the group multivitamins with minerals.. "
"combination nutritional therapy products. this classification denotes combination drugs and preparations that consist in whole or part of a) native, inorganic or fossilized organic substances having a definite chemical composition and formed by inorganic reactions, which bear the name minerals; and/or b) organic substances that are required in small amounts for maintenance and growth, but which cannot be manufactured by the human body, which, as vital amines, bear the name vitamins. typical combination minerals and vitamin constituents are ascorbic acid, beta carotene, calcium, cholecalciferol, ferrous fumarate, folic acid, iron, magnesium oxide, minerals, multivitamins, niacin, pyridoxine, and vitamin a.. alanine/glutamic acid/glycine/thiamine. this classification denotes a combination drug defined by the u.s. department of veterans affairs in its (vas) national drug file (ndf), which falls under va drug class vt809. this va drug class (vt809) classifies this compound as belonging to the group vitamin combinations, other.. "
"combination nutritional therapy products. this classification denotes combination drugs and preparations that consist in whole or part of a) native, inorganic or fossilized organic substances having a definite chemical composition and formed by inorganic reactions, which bear the name minerals; and/or b) organic substances that are required in small amounts for maintenance and growth, but which cannot be manufactured by the human body, which, as vital amines, bear the name vitamins. typical combination minerals and vitamin constituents are ascorbic acid, beta carotene, calcium, cholecalciferol, ferrous fumarate, folic acid, iron, magnesium oxide, minerals, multivitamins, niacin, pyridoxine, and vitamin a.. aluminum hydroxide/ferrous sulfate/magnesium hydroxide. this classification denotes a combination drug defined by the u.s. department of veterans affairs in its (vas) national drug file (ndf), which falls under va drug class tn410. this va drug class (tn410) classifies this compound as belonging to the group iron.. "
"combination nutritional therapy products. this classification denotes combination drugs and preparations that consist in whole or part of a) native, inorganic or fossilized organic substances having a definite chemical composition and formed by inorganic reactions, which bear the name minerals; and/or b) organic substances that are required in small amounts for maintenance and growth, but which cannot be manufactured by the human body, which, as vital amines, bear the name vitamins. typical combination minerals and vitamin constituents are ascorbic acid, beta carotene, calcium, cholecalciferol, ferrous fumarate, folic acid, iron, magnesium oxide, minerals, multivitamins, niacin, pyridoxine, and vitamin a.. ascorbic acid/bioflavonoids. this classification denotes a combination drug defined by the u.s. department of veterans affairs in its (vas) national drug file (ndf), which falls under va drug class vt801. this va drug class (vt801) classifies this compound as belonging to the group multivitamins.. "
"combination nutritional therapy products. this classification denotes combination drugs and preparations that consist in whole or part of a) native, inorganic or fossilized organic substances having a definite chemical composition and formed by inorganic reactions, which bear the name minerals; and/or b) organic substances that are required in small amounts for maintenance and growth, but which cannot be manufactured by the human body, which, as vital amines, bear the name vitamins. typical combination minerals and vitamin constituents are ascorbic acid, beta carotene, calcium, cholecalciferol, ferrous fumarate, folic acid, iron, magnesium oxide, minerals, multivitamins, niacin, pyridoxine, and vitamin a.. ascorbic acid/bioflavonoids/calcium. this classification denotes a combination drug defined by the u.s. department of veterans affairs in its (vas) national drug file (ndf), which falls under va drug class vt801. this va drug class (vt801) classifies this compound as belonging to the group multivitamins.. "
"combination nutritional therapy products. this classification denotes combination drugs and preparations that consist in whole or part of a) native, inorganic or fossilized organic substances having a definite chemical composition and formed by inorganic reactions, which bear the name minerals; and/or b) organic substances that are required in small amounts for maintenance and growth, but which cannot be manufactured by the human body, which, as vital amines, bear the name vitamins. typical combination minerals and vitamin constituents are ascorbic acid, beta carotene, calcium, cholecalciferol, ferrous fumarate, folic acid, iron, magnesium oxide, minerals, multivitamins, niacin, pyridoxine, and vitamin a.. ascorbic acid/citrus bioflavonoids/hesperidin complex/rutin. this classification denotes a combination drug defined by the u.s. department of veterans affairs in its (vas) national drug file (ndf), which falls under va drug class vt400. this va drug class (vt400) classifies this compound as belonging to the group vitamin c.. "
"combination nutritional therapy products. this classification denotes combination drugs and preparations that consist in whole or part of a) native, inorganic or fossilized organic substances having a definite chemical composition and formed by inorganic reactions, which bear the name minerals; and/or b) organic substances that are required in small amounts for maintenance and growth, but which cannot be manufactured by the human body, which, as vital amines, bear the name vitamins. typical combination minerals and vitamin constituents are ascorbic acid, beta carotene, calcium, cholecalciferol, ferrous fumarate, folic acid, iron, magnesium oxide, minerals, multivitamins, niacin, pyridoxine, and vitamin a.. ascorbic acid/cyanocobalamin/ferrous fumarate. this classification denotes a combination drug defined by the u.s. department of veterans affairs in its (vas) national drug file (ndf), which falls under va drug class vt802. this va drug class (vt802) classifies this compound as belonging to the group multivitamins with minerals.. "
"combination nutritional therapy products. this classification denotes combination drugs and preparations that consist in whole or part of a) native, inorganic or fossilized organic substances having a definite chemical composition and formed by inorganic reactions, which bear the name minerals; and/or b) organic substances that are required in small amounts for maintenance and growth, but which cannot be manufactured by the human body, which, as vital amines, bear the name vitamins. typical combination minerals and vitamin constituents are ascorbic acid, beta carotene, calcium, cholecalciferol, ferrous fumarate, folic acid, iron, magnesium oxide, minerals, multivitamins, niacin, pyridoxine, and vitamin a.. ascorbic acid/cyanocobalamin/ferrous fumarate/folic acid/intrins. this classification denotes a combination drug defined by the u.s. department of veterans affairs in its (vas) national drug file (ndf), which falls under va drug class vt802. this va drug class (vt802) classifies this compound as belonging to the group multivitamins with minerals.. "
"combination nutritional therapy products. this classification denotes combination drugs and preparations that consist in whole or part of a) native, inorganic or fossilized organic substances having a definite chemical composition and formed by inorganic reactions, which bear the name minerals; and/or b) organic substances that are required in small amounts for maintenance and growth, but which cannot be manufactured by the human body, which, as vital amines, bear the name vitamins. typical combination minerals and vitamin constituents are ascorbic acid, beta carotene, calcium, cholecalciferol, ferrous fumarate, folic acid, iron, magnesium oxide, minerals, multivitamins, niacin, pyridoxine, and vitamin a.. ascorbic acid/cyanocobalamin/ferrous gluconate/folic acid/gold. this classification denotes a combination drug defined by the u.s. department of veterans affairs in its (vas) national drug file (ndf), which falls under va drug class vt802. this va drug class (vt802) classifies this compound as belonging to the group multivitamins with minerals.. "
"combination nutritional therapy products. this classification denotes combination drugs and preparations that consist in whole or part of a) native, inorganic or fossilized organic substances having a definite chemical composition and formed by inorganic reactions, which bear the name minerals; and/or b) organic substances that are required in small amounts for maintenance and growth, but which cannot be manufactured by the human body, which, as vital amines, bear the name vitamins. typical combination minerals and vitamin constituents are ascorbic acid, beta carotene, calcium, cholecalciferol, ferrous fumarate, folic acid, iron, magnesium oxide, minerals, multivitamins, niacin, pyridoxine, and vitamin a.. ascorbic acid/niacin. this classification denotes a combination drug defined by the u.s. department of veterans affairs in its (vas) national drug file (ndf), which falls under va drug class vt801. this va drug class (vt801) classifies this compound as belonging to the group multivitamins.. "
"combination nutritional therapy products. this classification denotes combination drugs and preparations that consist in whole or part of a) native, inorganic or fossilized organic substances having a definite chemical composition and formed by inorganic reactions, which bear the name minerals; and/or b) organic substances that are required in small amounts for maintenance and growth, but which cannot be manufactured by the human body, which, as vital amines, bear the name vitamins. typical combination minerals and vitamin constituents are ascorbic acid, beta carotene, calcium, cholecalciferol, ferrous fumarate, folic acid, iron, magnesium oxide, minerals, multivitamins, niacin, pyridoxine, and vitamin a.. ascorbic acid/cyanocobalamin/folic acid/iron. this classification denotes a combination drug defined by the u.s. department of veterans affairs in its (vas) national drug file (ndf), which falls under va drug class vt802. this va drug class (vt802) classifies this compound as belonging to the group multivitamins with minerals.. "
"combination nutritional therapy products. this classification denotes combination drugs and preparations that consist in whole or part of a) native, inorganic or fossilized organic substances having a definite chemical composition and formed by inorganic reactions, which bear the name minerals; and/or b) organic substances that are required in small amounts for maintenance and growth, but which cannot be manufactured by the human body, which, as vital amines, bear the name vitamins. typical combination minerals and vitamin constituents are ascorbic acid, beta carotene, calcium, cholecalciferol, ferrous fumarate, folic acid, iron, magnesium oxide, minerals, multivitamins, niacin, pyridoxine, and vitamin a.. ascorbic acid/docusate/ferrous fumarate. this classification denotes a combination drug defined by the u.s. department of veterans affairs in its (vas) national drug file (ndf), which falls under va drug class vt809. this va drug class (vt809) classifies this compound as belonging to the group vitamin combinations, other.. "
"combination nutritional therapy products. this classification denotes combination drugs and preparations that consist in whole or part of a) native, inorganic or fossilized organic substances having a definite chemical composition and formed by inorganic reactions, which bear the name minerals; and/or b) organic substances that are required in small amounts for maintenance and growth, but which cannot be manufactured by the human body, which, as vital amines, bear the name vitamins. typical combination minerals and vitamin constituents are ascorbic acid, beta carotene, calcium, cholecalciferol, ferrous fumarate, folic acid, iron, magnesium oxide, minerals, multivitamins, niacin, pyridoxine, and vitamin a.. ascorbic acid/ferrous fumarate. this classification denotes a combination drug defined by the u.s. department of veterans affairs in its (vas) national drug file (ndf), which falls under va drug class vt802. this va drug class (vt802) classifies this compound as belonging to the group multivitamins with minerals.. "
"combination nutritional therapy products. this classification denotes combination drugs and preparations that consist in whole or part of a) native, inorganic or fossilized organic substances having a definite chemical composition and formed by inorganic reactions, which bear the name minerals; and/or b) organic substances that are required in small amounts for maintenance and growth, but which cannot be manufactured by the human body, which, as vital amines, bear the name vitamins. typical combination minerals and vitamin constituents are ascorbic acid, beta carotene, calcium, cholecalciferol, ferrous fumarate, folic acid, iron, magnesium oxide, minerals, multivitamins, niacin, pyridoxine, and vitamin a.. ascorbic acid/ferrous fumarate/folic acid. this classification denotes a combination drug defined by the u.s. department of veterans affairs in its (vas) national drug file (ndf), which falls under va drug class vt802. this va drug class (vt802) classifies this compound as belonging to the group multivitamins with minerals.. "
"combination nutritional therapy products. this classification denotes combination drugs and preparations that consist in whole or part of a) native, inorganic or fossilized organic substances having a definite chemical composition and formed by inorganic reactions, which bear the name minerals; and/or b) organic substances that are required in small amounts for maintenance and growth, but which cannot be manufactured by the human body, which, as vital amines, bear the name vitamins. typical combination minerals and vitamin constituents are ascorbic acid, beta carotene, calcium, cholecalciferol, ferrous fumarate, folic acid, iron, magnesium oxide, minerals, multivitamins, niacin, pyridoxine, and vitamin a.. ascorbic acid/ferrous sulfate. this classification denotes a combination drug defined by the u.s. department of veterans affairs in its (vas) national drug file (ndf), which falls under va drug class vt802. this va drug class (vt802) classifies this compound as belonging to the group multivitamins with minerals.. "
"combination nutritional therapy products. this classification denotes combination drugs and preparations that consist in whole or part of a) native, inorganic or fossilized organic substances having a definite chemical composition and formed by inorganic reactions, which bear the name minerals; and/or b) organic substances that are required in small amounts for maintenance and growth, but which cannot be manufactured by the human body, which, as vital amines, bear the name vitamins. typical combination minerals and vitamin constituents are ascorbic acid, beta carotene, calcium, cholecalciferol, ferrous fumarate, folic acid, iron, magnesium oxide, minerals, multivitamins, niacin, pyridoxine, and vitamin a.. ascorbic acid/ferrous sulfate/folic acid. this classification denotes a combination drug defined by the u.s. department of veterans affairs in its (vas) national drug file (ndf), which falls under va drug class vt802. this va drug class (vt802) classifies this compound as belonging to the group multivitamins with minerals.. "
"combination nutritional therapy products. this classification denotes combination drugs and preparations that consist in whole or part of a) native, inorganic or fossilized organic substances having a definite chemical composition and formed by inorganic reactions, which bear the name minerals; and/or b) organic substances that are required in small amounts for maintenance and growth, but which cannot be manufactured by the human body, which, as vital amines, bear the name vitamins. typical combination minerals and vitamin constituents are ascorbic acid, beta carotene, calcium, cholecalciferol, ferrous fumarate, folic acid, iron, magnesium oxide, minerals, multivitamins, niacin, pyridoxine, and vitamin a.. ascorbic acid/folic acid/iron. this classification denotes a combination drug defined by the u.s. department of veterans affairs in its (vas) national drug file (ndf), which falls under va drug class vt809. this va drug class (vt809) classifies this compound as belonging to the group vitamin combinations, other.. "
"combination nutritional therapy products. this classification denotes combination drugs and preparations that consist in whole or part of a) native, inorganic or fossilized organic substances having a definite chemical composition and formed by inorganic reactions, which bear the name minerals; and/or b) organic substances that are required in small amounts for maintenance and growth, but which cannot be manufactured by the human body, which, as vital amines, bear the name vitamins. typical combination minerals and vitamin constituents are ascorbic acid, beta carotene, calcium, cholecalciferol, ferrous fumarate, folic acid, iron, magnesium oxide, minerals, multivitamins, niacin, pyridoxine, and vitamin a.. ascorbic acid/hesperidin. this classification denotes a combination drug defined by the u.s. department of veterans affairs in its (vas) national drug file (ndf), which falls under va drug class vt809. this va drug class (vt809) classifies this compound as belonging to the group vitamin combinations, other.. "
"combination nutritional therapy products. this classification denotes combination drugs and preparations that consist in whole or part of a) native, inorganic or fossilized organic substances having a definite chemical composition and formed by inorganic reactions, which bear the name minerals; and/or b) organic substances that are required in small amounts for maintenance and growth, but which cannot be manufactured by the human body, which, as vital amines, bear the name vitamins. typical combination minerals and vitamin constituents are ascorbic acid, beta carotene, calcium, cholecalciferol, ferrous fumarate, folic acid, iron, magnesium oxide, minerals, multivitamins, niacin, pyridoxine, and vitamin a.. ascorbic acid/iron. this classification denotes a combination drug defined by the u.s. department of veterans affairs in its (vas) national drug file (ndf), which falls under va drug class vt802. this va drug class (vt802) classifies this compound as belonging to the group multivitamins with minerals.. "
"combination nutritional therapy products. this classification denotes combination drugs and preparations that consist in whole or part of a) native, inorganic or fossilized organic substances having a definite chemical composition and formed by inorganic reactions, which bear the name minerals; and/or b) organic substances that are required in small amounts for maintenance and growth, but which cannot be manufactured by the human body, which, as vital amines, bear the name vitamins. typical combination minerals and vitamin constituents are ascorbic acid, beta carotene, calcium, cholecalciferol, ferrous fumarate, folic acid, iron, magnesium oxide, minerals, multivitamins, niacin, pyridoxine, and vitamin a.. calcium citrate/glutamic acid. this classification denotes a combination drug defined by the u.s. department of veterans affairs in its (vas) national drug file (ndf), which falls under va drug class tn420. this va drug class (tn420) classifies this compound as belonging to the group calcium.. "
"combination nutritional therapy products. this classification denotes combination drugs and preparations that consist in whole or part of a) native, inorganic or fossilized organic substances having a definite chemical composition and formed by inorganic reactions, which bear the name minerals; and/or b) organic substances that are required in small amounts for maintenance and growth, but which cannot be manufactured by the human body, which, as vital amines, bear the name vitamins. typical combination minerals and vitamin constituents are ascorbic acid, beta carotene, calcium, cholecalciferol, ferrous fumarate, folic acid, iron, magnesium oxide, minerals, multivitamins, niacin, pyridoxine, and vitamin a.. ascorbic acid/rose hips. this classification denotes a combination drug defined by the u.s. department of veterans affairs in its (vas) national drug file (ndf), which falls under va drug class vt400. this va drug class (vt400) classifies this compound as belonging to the group vitamin c.. "
"combination nutritional therapy products. this classification denotes combination drugs and preparations that consist in whole or part of a) native, inorganic or fossilized organic substances having a definite chemical composition and formed by inorganic reactions, which bear the name minerals; and/or b) organic substances that are required in small amounts for maintenance and growth, but which cannot be manufactured by the human body, which, as vital amines, bear the name vitamins. typical combination minerals and vitamin constituents are ascorbic acid, beta carotene, calcium, cholecalciferol, ferrous fumarate, folic acid, iron, magnesium oxide, minerals, multivitamins, niacin, pyridoxine, and vitamin a.. ascorbic acid/zinc. this classification denotes a combination drug defined by the u.s. department of veterans affairs in its (vas) national drug file (ndf), which falls under va drug class vt802. this va drug class (vt802) classifies this compound as belonging to the group multivitamins with minerals.. "
"combination nutritional therapy products. this classification denotes combination drugs and preparations that consist in whole or part of a) native, inorganic or fossilized organic substances having a definite chemical composition and formed by inorganic reactions, which bear the name minerals; and/or b) organic substances that are required in small amounts for maintenance and growth, but which cannot be manufactured by the human body, which, as vital amines, bear the name vitamins. typical combination minerals and vitamin constituents are ascorbic acid, beta carotene, calcium, cholecalciferol, ferrous fumarate, folic acid, iron, magnesium oxide, minerals, multivitamins, niacin, pyridoxine, and vitamin a.. beta carotene/vitamin a. this classification denotes a combination drug defined by the u.s. department of veterans affairs in its (vas) national drug file (ndf), which falls under va drug class vt050. this va drug class (vt050) classifies this compound as belonging to the group vitamin a.. "
"combination nutritional therapy products. this classification denotes combination drugs and preparations that consist in whole or part of a) native, inorganic or fossilized organic substances having a definite chemical composition and formed by inorganic reactions, which bear the name minerals; and/or b) organic substances that are required in small amounts for maintenance and growth, but which cannot be manufactured by the human body, which, as vital amines, bear the name vitamins. typical combination minerals and vitamin constituents are ascorbic acid, beta carotene, calcium, cholecalciferol, ferrous fumarate, folic acid, iron, magnesium oxide, minerals, multivitamins, niacin, pyridoxine, and vitamin a.. calciuim lactate/thiamine. this classification denotes a combination drug defined by the u.s. department of veterans affairs in its (vas) national drug file (ndf), which falls under va drug class vt802. this va drug class (vt802) classifies this compound as belonging to the group multivitamins with minerals.. "
"combination nutritional therapy products. this classification denotes combination drugs and preparations that consist in whole or part of a) native, inorganic or fossilized organic substances having a definite chemical composition and formed by inorganic reactions, which bear the name minerals; and/or b) organic substances that are required in small amounts for maintenance and growth, but which cannot be manufactured by the human body, which, as vital amines, bear the name vitamins. typical combination minerals and vitamin constituents are ascorbic acid, beta carotene, calcium, cholecalciferol, ferrous fumarate, folic acid, iron, magnesium oxide, minerals, multivitamins, niacin, pyridoxine, and vitamin a.. calcium carbonate/calcium gluconate/calciucm lactate/vitamin d. this classification denotes a combination drug defined by the u.s. department of veterans affairs in its (vas) national drug file (ndf), which falls under va drug class vt802. this va drug class (vt802) classifies this compound as belonging to the group multivitamins with minerals.. "
"combination nutritional therapy products. this classification denotes combination drugs and preparations that consist in whole or part of a) native, inorganic or fossilized organic substances having a definite chemical composition and formed by inorganic reactions, which bear the name minerals; and/or b) organic substances that are required in small amounts for maintenance and growth, but which cannot be manufactured by the human body, which, as vital amines, bear the name vitamins. typical combination minerals and vitamin constituents are ascorbic acid, beta carotene, calcium, cholecalciferol, ferrous fumarate, folic acid, iron, magnesium oxide, minerals, multivitamins, niacin, pyridoxine, and vitamin a.. calcium carbonate/ferrous fumarate/vitamin d. this classification denotes a combination drug defined by the u.s. department of veterans affairs in its (vas) national drug file (ndf), which falls under va drug class vt802. this va drug class (vt802) classifies this compound as belonging to the group multivitamins with minerals.. "
"combination nutritional therapy products. this classification denotes combination drugs and preparations that consist in whole or part of a) native, inorganic or fossilized organic substances having a definite chemical composition and formed by inorganic reactions, which bear the name minerals; and/or b) organic substances that are required in small amounts for maintenance and growth, but which cannot be manufactured by the human body, which, as vital amines, bear the name vitamins. typical combination minerals and vitamin constituents are ascorbic acid, beta carotene, calcium, cholecalciferol, ferrous fumarate, folic acid, iron, magnesium oxide, minerals, multivitamins, niacin, pyridoxine, and vitamin a.. calcium carbonate/magnesium carbonate/vitamin d. this classification denotes a combination drug defined by the u.s. department of veterans affairs in its (vas) national drug file (ndf), which falls under va drug class vt802. this va drug class (vt802) classifies this compound as belonging to the group multivitamins with minerals.. "
"combination nutritional therapy products. this classification denotes combination drugs and preparations that consist in whole or part of a) native, inorganic or fossilized organic substances having a definite chemical composition and formed by inorganic reactions, which bear the name minerals; and/or b) organic substances that are required in small amounts for maintenance and growth, but which cannot be manufactured by the human body, which, as vital amines, bear the name vitamins. typical combination minerals and vitamin constituents are ascorbic acid, beta carotene, calcium, cholecalciferol, ferrous fumarate, folic acid, iron, magnesium oxide, minerals, multivitamins, niacin, pyridoxine, and vitamin a.. calcium carbonate/minerals/vitamin d. this classification denotes a combination drug defined by the u.s. department of veterans affairs in its (vas) national drug file (ndf), which falls under va drug class vt809. this va drug class (vt809) classifies this compound as belonging to the group vitamin combinations, other.. "
"combination nutritional therapy products. this classification denotes combination drugs and preparations that consist in whole or part of a) native, inorganic or fossilized organic substances having a definite chemical composition and formed by inorganic reactions, which bear the name minerals; and/or b) organic substances that are required in small amounts for maintenance and growth, but which cannot be manufactured by the human body, which, as vital amines, bear the name vitamins. typical combination minerals and vitamin constituents are ascorbic acid, beta carotene, calcium, cholecalciferol, ferrous fumarate, folic acid, iron, magnesium oxide, minerals, multivitamins, niacin, pyridoxine, and vitamin a.. calcium carbonate/vitamin d. this classification denotes a combination drug defined by the u.s. department of veterans affairs in its (vas) national drug file (ndf), which falls under va drug class vt802. this va drug class (vt802) classifies this compound as belonging to the group multivitamins with minerals.. "
"combination nutritional therapy products. this classification denotes combination drugs and preparations that consist in whole or part of a) native, inorganic or fossilized organic substances having a definite chemical composition and formed by inorganic reactions, which bear the name minerals; and/or b) organic substances that are required in small amounts for maintenance and growth, but which cannot be manufactured by the human body, which, as vital amines, bear the name vitamins. typical combination minerals and vitamin constituents are ascorbic acid, beta carotene, calcium, cholecalciferol, ferrous fumarate, folic acid, iron, magnesium oxide, minerals, multivitamins, niacin, pyridoxine, and vitamin a.. cyanocobalamin/intrinsic factor. this classification denotes a combination drug defined by the u.s. department of veterans affairs in its (vas) national drug file (ndf), which falls under va drug class vt801. this va drug class (vt801) classifies this compound as belonging to the group multivitamins.. "
"combination nutritional therapy products. this classification denotes combination drugs and preparations that consist in whole or part of a) native, inorganic or fossilized organic substances having a definite chemical composition and formed by inorganic reactions, which bear the name minerals; and/or b) organic substances that are required in small amounts for maintenance and growth, but which cannot be manufactured by the human body, which, as vital amines, bear the name vitamins. typical combination minerals and vitamin constituents are ascorbic acid, beta carotene, calcium, cholecalciferol, ferrous fumarate, folic acid, iron, magnesium oxide, minerals, multivitamins, niacin, pyridoxine, and vitamin a.. calcium citrate/vitamin a/vitamin d. this classification denotes a combination drug defined by the u.s. department of veterans affairs in its (vas) national drug file (ndf), which falls under va drug class vt802. this va drug class (vt802) classifies this compound as belonging to the group multivitamins with minerals.. "
"combination nutritional therapy products. this classification denotes combination drugs and preparations that consist in whole or part of a) native, inorganic or fossilized organic substances having a definite chemical composition and formed by inorganic reactions, which bear the name minerals; and/or b) organic substances that are required in small amounts for maintenance and growth, but which cannot be manufactured by the human body, which, as vital amines, bear the name vitamins. typical combination minerals and vitamin constituents are ascorbic acid, beta carotene, calcium, cholecalciferol, ferrous fumarate, folic acid, iron, magnesium oxide, minerals, multivitamins, niacin, pyridoxine, and vitamin a.. calcium glycerophosphate/calcium levulinate. this classification denotes a combination drug defined by the u.s. department of veterans affairs in its (vas) national drug file (ndf), which falls under va drug class tn420. this va drug class (tn420) classifies this compound as belonging to the group calcium.. "
"combination nutritional therapy products. this classification denotes combination drugs and preparations that consist in whole or part of a) native, inorganic or fossilized organic substances having a definite chemical composition and formed by inorganic reactions, which bear the name minerals; and/or b) organic substances that are required in small amounts for maintenance and growth, but which cannot be manufactured by the human body, which, as vital amines, bear the name vitamins. typical combination minerals and vitamin constituents are ascorbic acid, beta carotene, calcium, cholecalciferol, ferrous fumarate, folic acid, iron, magnesium oxide, minerals, multivitamins, niacin, pyridoxine, and vitamin a.. cholecalciferol/fish oil. this classification denotes a combination drug defined by the u.s. department of veterans affairs in its (vas) national drug file (ndf), which falls under va drug class vt809. this va drug class (vt809) classifies this compound as belonging to the group vitamin combinations, other.. "
"combination nutritional therapy products. this classification denotes combination drugs and preparations that consist in whole or part of a) native, inorganic or fossilized organic substances having a definite chemical composition and formed by inorganic reactions, which bear the name minerals; and/or b) organic substances that are required in small amounts for maintenance and growth, but which cannot be manufactured by the human body, which, as vital amines, bear the name vitamins. typical combination minerals and vitamin constituents are ascorbic acid, beta carotene, calcium, cholecalciferol, ferrous fumarate, folic acid, iron, magnesium oxide, minerals, multivitamins, niacin, pyridoxine, and vitamin a.. citric acid/potassium citrate/sodium citrate. this classification denotes a combination drug defined by the u.s. department of veterans affairs in its (vas) national drug file (ndf), which falls under va drug class tn478. this va drug class (tn478) classifies this compound as belonging to the group citrates.. "
"combination nutritional therapy products. this classification denotes combination drugs and preparations that consist in whole or part of a) native, inorganic or fossilized organic substances having a definite chemical composition and formed by inorganic reactions, which bear the name minerals; and/or b) organic substances that are required in small amounts for maintenance and growth, but which cannot be manufactured by the human body, which, as vital amines, bear the name vitamins. typical combination minerals and vitamin constituents are ascorbic acid, beta carotene, calcium, cholecalciferol, ferrous fumarate, folic acid, iron, magnesium oxide, minerals, multivitamins, niacin, pyridoxine, and vitamin a.. cyanocobalamin/folic acid. this classification denotes a combination drug defined by the u.s. department of veterans affairs in its (vas) national drug file (ndf), which falls under va drug class vt109. this va drug class (vt109) classifies this compound as belonging to the group vitamin b, other.. "
"combination nutritional therapy products. this classification denotes combination drugs and preparations that consist in whole or part of a) native, inorganic or fossilized organic substances having a definite chemical composition and formed by inorganic reactions, which bear the name minerals; and/or b) organic substances that are required in small amounts for maintenance and growth, but which cannot be manufactured by the human body, which, as vital amines, bear the name vitamins. typical combination minerals and vitamin constituents are ascorbic acid, beta carotene, calcium, cholecalciferol, ferrous fumarate, folic acid, iron, magnesium oxide, minerals, multivitamins, niacin, pyridoxine, and vitamin a.. cyanocobalamin/folic acid/iron. this classification denotes a combination drug defined by the u.s. department of veterans affairs in its (vas) national drug file (ndf), which falls under va drug class vt802. this va drug class (vt802) classifies this compound as belonging to the group multivitamins with minerals.. "
"combination nutritional therapy products. this classification denotes combination drugs and preparations that consist in whole or part of a) native, inorganic or fossilized organic substances having a definite chemical composition and formed by inorganic reactions, which bear the name minerals; and/or b) organic substances that are required in small amounts for maintenance and growth, but which cannot be manufactured by the human body, which, as vital amines, bear the name vitamins. typical combination minerals and vitamin constituents are ascorbic acid, beta carotene, calcium, cholecalciferol, ferrous fumarate, folic acid, iron, magnesium oxide, minerals, multivitamins, niacin, pyridoxine, and vitamin a.. cyanocobalamin/folic acid/liver. this classification denotes a combination drug defined by the u.s. department of veterans affairs in its (vas) national drug file (ndf), which falls under va drug class vt109. this va drug class (vt109) classifies this compound as belonging to the group vitamin b, other.. "
"combination nutritional therapy products. this classification denotes combination drugs and preparations that consist in whole or part of a) native, inorganic or fossilized organic substances having a definite chemical composition and formed by inorganic reactions, which bear the name minerals; and/or b) organic substances that are required in small amounts for maintenance and growth, but which cannot be manufactured by the human body, which, as vital amines, bear the name vitamins. typical combination minerals and vitamin constituents are ascorbic acid, beta carotene, calcium, cholecalciferol, ferrous fumarate, folic acid, iron, magnesium oxide, minerals, multivitamins, niacin, pyridoxine, and vitamin a.. cyanocobalamin/folic acid/pyridoxine. this classification denotes a combination drug defined by the u.s. department of veterans affairs in its (vas) national drug file (ndf), which falls under va drug class vt801. this va drug class (vt801) classifies this compound as belonging to the group multivitamins.. "
"combination nutritional therapy products. this classification denotes combination drugs and preparations that consist in whole or part of a) native, inorganic or fossilized organic substances having a definite chemical composition and formed by inorganic reactions, which bear the name minerals; and/or b) organic substances that are required in small amounts for maintenance and growth, but which cannot be manufactured by the human body, which, as vital amines, bear the name vitamins. typical combination minerals and vitamin constituents are ascorbic acid, beta carotene, calcium, cholecalciferol, ferrous fumarate, folic acid, iron, magnesium oxide, minerals, multivitamins, niacin, pyridoxine, and vitamin a.. glycine/niacin. this classification denotes a combination drug defined by the u.s. department of veterans affairs in its (vas) national drug file (ndf), which falls under va drug class vt809. this va drug class (vt809) classifies this compound as belonging to the group vitamin combinations, other.. "
"combination nutritional therapy products. this classification denotes combination drugs and preparations that consist in whole or part of a) native, inorganic or fossilized organic substances having a definite chemical composition and formed by inorganic reactions, which bear the name minerals; and/or b) organic substances that are required in small amounts for maintenance and growth, but which cannot be manufactured by the human body, which, as vital amines, bear the name vitamins. typical combination minerals and vitamin constituents are ascorbic acid, beta carotene, calcium, cholecalciferol, ferrous fumarate, folic acid, iron, magnesium oxide, minerals, multivitamins, niacin, pyridoxine, and vitamin a.. cyanocobalamin/iron/liver. this classification denotes a combination drug defined by the u.s. department of veterans affairs in its (vas) national drug file (ndf), which falls under va drug class vt109. this va drug class (vt109) classifies this compound as belonging to the group vitamin b, other.. "
"combination nutritional therapy products. this classification denotes combination drugs and preparations that consist in whole or part of a) native, inorganic or fossilized organic substances having a definite chemical composition and formed by inorganic reactions, which bear the name minerals; and/or b) organic substances that are required in small amounts for maintenance and growth, but which cannot be manufactured by the human body, which, as vital amines, bear the name vitamins. typical combination minerals and vitamin constituents are ascorbic acid, beta carotene, calcium, cholecalciferol, ferrous fumarate, folic acid, iron, magnesium oxide, minerals, multivitamins, niacin, pyridoxine, and vitamin a.. cyanocobalamin/thiamine. this classification denotes a combination drug defined by the u.s. department of veterans affairs in its (vas) national drug file (ndf), which falls under va drug class vt109. this va drug class (vt109) classifies this compound as belonging to the group vitamin b, other.. "
"combination nutritional therapy products. this classification denotes combination drugs and preparations that consist in whole or part of a) native, inorganic or fossilized organic substances having a definite chemical composition and formed by inorganic reactions, which bear the name minerals; and/or b) organic substances that are required in small amounts for maintenance and growth, but which cannot be manufactured by the human body, which, as vital amines, bear the name vitamins. typical combination minerals and vitamin constituents are ascorbic acid, beta carotene, calcium, cholecalciferol, ferrous fumarate, folic acid, iron, magnesium oxide, minerals, multivitamins, niacin, pyridoxine, and vitamin a.. ferrous fumarate/folic acid. this classification denotes a combination drug defined by the u.s. department of veterans affairs in its (vas) national drug file (ndf), which falls under va drug class vt802. this va drug class (vt802) classifies this compound as belonging to the group multivitamins with minerals.. "
"combination nutritional therapy products. this classification denotes combination drugs and preparations that consist in whole or part of a) native, inorganic or fossilized organic substances having a definite chemical composition and formed by inorganic reactions, which bear the name minerals; and/or b) organic substances that are required in small amounts for maintenance and growth, but which cannot be manufactured by the human body, which, as vital amines, bear the name vitamins. typical combination minerals and vitamin constituents are ascorbic acid, beta carotene, calcium, cholecalciferol, ferrous fumarate, folic acid, iron, magnesium oxide, minerals, multivitamins, niacin, pyridoxine, and vitamin a.. ferrous sulfate/folic acid. this classification denotes a combination drug defined by the u.s. department of veterans affairs in its (vas) national drug file (ndf), which falls under va drug class vt802. this va drug class (vt802) classifies this compound as belonging to the group multivitamins with minerals.. "
"combination nutritional therapy products. this classification denotes combination drugs and preparations that consist in whole or part of a) native, inorganic or fossilized organic substances having a definite chemical composition and formed by inorganic reactions, which bear the name minerals; and/or b) organic substances that are required in small amounts for maintenance and growth, but which cannot be manufactured by the human body, which, as vital amines, bear the name vitamins. typical combination minerals and vitamin constituents are ascorbic acid, beta carotene, calcium, cholecalciferol, ferrous fumarate, folic acid, iron, magnesium oxide, minerals, multivitamins, niacin, pyridoxine, and vitamin a.. fluoride/iron/vitamin a/vitamin c/vitamin d. this classification denotes a combination drug defined by the u.s. department of veterans affairs in its (vas) national drug file (ndf), which falls under va drug class vt802. this va drug class (vt802) classifies this compound as belonging to the group multivitamins with minerals.. "
"combination nutritional therapy products. this classification denotes combination drugs and preparations that consist in whole or part of a) native, inorganic or fossilized organic substances having a definite chemical composition and formed by inorganic reactions, which bear the name minerals; and/or b) organic substances that are required in small amounts for maintenance and growth, but which cannot be manufactured by the human body, which, as vital amines, bear the name vitamins. typical combination minerals and vitamin constituents are ascorbic acid, beta carotene, calcium, cholecalciferol, ferrous fumarate, folic acid, iron, magnesium oxide, minerals, multivitamins, niacin, pyridoxine, and vitamin a.. folic acid/iron. this classification denotes a combination drug defined by the u.s. department of veterans affairs in its (vas) national drug file (ndf), which falls under va drug class vt802. this va drug class (vt802) classifies this compound as belonging to the group multivitamins with minerals.. "
"combination nutritional therapy products. this classification denotes combination drugs and preparations that consist in whole or part of a) native, inorganic or fossilized organic substances having a definite chemical composition and formed by inorganic reactions, which bear the name minerals; and/or b) organic substances that are required in small amounts for maintenance and growth, but which cannot be manufactured by the human body, which, as vital amines, bear the name vitamins. typical combination minerals and vitamin constituents are ascorbic acid, beta carotene, calcium, cholecalciferol, ferrous fumarate, folic acid, iron, magnesium oxide, minerals, multivitamins, niacin, pyridoxine, and vitamin a.. folic acid/iron/multivitamins. this classification denotes a combination drug defined by the u.s. department of veterans affairs in its (vas) national drug file (ndf), which falls under va drug class vt802. this va drug class (vt802) classifies this compound as belonging to the group multivitamins with minerals.. "
"combination nutritional therapy products. this classification denotes combination drugs and preparations that consist in whole or part of a) native, inorganic or fossilized organic substances having a definite chemical composition and formed by inorganic reactions, which bear the name minerals; and/or b) organic substances that are required in small amounts for maintenance and growth, but which cannot be manufactured by the human body, which, as vital amines, bear the name vitamins. typical combination minerals and vitamin constituents are ascorbic acid, beta carotene, calcium, cholecalciferol, ferrous fumarate, folic acid, iron, magnesium oxide, minerals, multivitamins, niacin, pyridoxine, and vitamin a.. niacin/rice bran. this classification denotes a combination drug defined by the u.s. department of veterans affairs in its (vas) national drug file (ndf), which falls under va drug class vt900. this va drug class (vt900) classifies this compound as belonging to the group vitamins, other.. "
"combination nutritional therapy products. this classification denotes combination drugs and preparations that consist in whole or part of a) native, inorganic or fossilized organic substances having a definite chemical composition and formed by inorganic reactions, which bear the name minerals; and/or b) organic substances that are required in small amounts for maintenance and growth, but which cannot be manufactured by the human body, which, as vital amines, bear the name vitamins. typical combination minerals and vitamin constituents are ascorbic acid, beta carotene, calcium, cholecalciferol, ferrous fumarate, folic acid, iron, magnesium oxide, minerals, multivitamins, niacin, pyridoxine, and vitamin a.. glycine/niacin/pyridoxine. this classification denotes a combination drug defined by the u.s. department of veterans affairs in its (vas) national drug file (ndf), which falls under va drug class vt809. this va drug class (vt809) classifies this compound as belonging to the group vitamin combinations, other.. "
"combination nutritional therapy products. this classification denotes combination drugs and preparations that consist in whole or part of a) native, inorganic or fossilized organic substances having a definite chemical composition and formed by inorganic reactions, which bear the name minerals; and/or b) organic substances that are required in small amounts for maintenance and growth, but which cannot be manufactured by the human body, which, as vital amines, bear the name vitamins. typical combination minerals and vitamin constituents are ascorbic acid, beta carotene, calcium, cholecalciferol, ferrous fumarate, folic acid, iron, magnesium oxide, minerals, multivitamins, niacin, pyridoxine, and vitamin a.. iron/multivitamins/procaine. this classification denotes a combination drug defined by the u.s. department of veterans affairs in its (vas) national drug file (ndf), which falls under va drug class vt809. this va drug class (vt809) classifies this compound as belonging to the group vitamin combinations, other.. "
"combination nutritional therapy products. this classification denotes combination drugs and preparations that consist in whole or part of a) native, inorganic or fossilized organic substances having a definite chemical composition and formed by inorganic reactions, which bear the name minerals; and/or b) organic substances that are required in small amounts for maintenance and growth, but which cannot be manufactured by the human body, which, as vital amines, bear the name vitamins. typical combination minerals and vitamin constituents are ascorbic acid, beta carotene, calcium, cholecalciferol, ferrous fumarate, folic acid, iron, magnesium oxide, minerals, multivitamins, niacin, pyridoxine, and vitamin a.. iron/multivitamins/sorbitol. this classification denotes a combination drug defined by the u.s. department of veterans affairs in its (vas) national drug file (ndf), which falls under va drug class vt809. this va drug class (vt809) classifies this compound as belonging to the group vitamin combinations, other.. "
"combination nutritional therapy products. this classification denotes combination drugs and preparations that consist in whole or part of a) native, inorganic or fossilized organic substances having a definite chemical composition and formed by inorganic reactions, which bear the name minerals; and/or b) organic substances that are required in small amounts for maintenance and growth, but which cannot be manufactured by the human body, which, as vital amines, bear the name vitamins. typical combination minerals and vitamin constituents are ascorbic acid, beta carotene, calcium, cholecalciferol, ferrous fumarate, folic acid, iron, magnesium oxide, minerals, multivitamins, niacin, pyridoxine, and vitamin a.. magnesium chloride/sodium chloride. this classification denotes a combination drug defined by the u.s. department of veterans affairs in its (vas) national drug file (ndf), which falls under va drug class tn460. this va drug class (tn460) classifies this compound as belonging to the group magnesium.. "
"combination nutritional therapy products. this classification denotes combination drugs and preparations that consist in whole or part of a) native, inorganic or fossilized organic substances having a definite chemical composition and formed by inorganic reactions, which bear the name minerals; and/or b) organic substances that are required in small amounts for maintenance and growth, but which cannot be manufactured by the human body, which, as vital amines, bear the name vitamins. typical combination minerals and vitamin constituents are ascorbic acid, beta carotene, calcium, cholecalciferol, ferrous fumarate, folic acid, iron, magnesium oxide, minerals, multivitamins, niacin, pyridoxine, and vitamin a.. magnesium oxide/pyridoxine. this classification denotes a combination drug defined by the u.s. department of veterans affairs in its (vas) national drug file (ndf), which falls under va drug class vt802. this va drug class (vt802) classifies this compound as belonging to the group multivitamins with minerals.. "
"combination nutritional therapy products. this classification denotes combination drugs and preparations that consist in whole or part of a) native, inorganic or fossilized organic substances having a definite chemical composition and formed by inorganic reactions, which bear the name minerals; and/or b) organic substances that are required in small amounts for maintenance and growth, but which cannot be manufactured by the human body, which, as vital amines, bear the name vitamins. typical combination minerals and vitamin constituents are ascorbic acid, beta carotene, calcium, cholecalciferol, ferrous fumarate, folic acid, iron, magnesium oxide, minerals, multivitamins, niacin, pyridoxine, and vitamin a.. minerals/multivitamins/testosterone. this classification denotes a combination drug defined by the u.s. department of veterans affairs in its (vas) national drug file (ndf), which falls under va drug class vt809. this va drug class (vt809) classifies this compound as belonging to the group vitamin combinations, other.. "
"combination nutritional therapy products. this classification denotes combination drugs and preparations that consist in whole or part of a) native, inorganic or fossilized organic substances having a definite chemical composition and formed by inorganic reactions, which bear the name minerals; and/or b) organic substances that are required in small amounts for maintenance and growth, but which cannot be manufactured by the human body, which, as vital amines, bear the name vitamins. typical combination minerals and vitamin constituents are ascorbic acid, beta carotene, calcium, cholecalciferol, ferrous fumarate, folic acid, iron, magnesium oxide, minerals, multivitamins, niacin, pyridoxine, and vitamin a.. multivitamins/testosterone. this classification denotes a combination drug defined by the u.s. department of veterans affairs in its (vas) national drug file (ndf), which falls under va drug class vt809. this va drug class (vt809) classifies this compound as belonging to the group vitamin combinations, other.. "
"combination nutritional therapy products. this classification denotes combination drugs and preparations that consist in whole or part of a) native, inorganic or fossilized organic substances having a definite chemical composition and formed by inorganic reactions, which bear the name minerals; and/or b) organic substances that are required in small amounts for maintenance and growth, but which cannot be manufactured by the human body, which, as vital amines, bear the name vitamins. typical combination minerals and vitamin constituents are ascorbic acid, beta carotene, calcium, cholecalciferol, ferrous fumarate, folic acid, iron, magnesium oxide, minerals, multivitamins, niacin, pyridoxine, and vitamin a.. niacin/pantothenic acid/pyridoxine/riboflavin/thiamine. this classification denotes a combination drug defined by the u.s. department of veterans affairs in its (vas) national drug file (ndf), which falls under va drug class vt109. this va drug class (vt109) classifies this compound as belonging to the group vitamin b, other.. "
"combination nutritional therapy products. this classification denotes combination drugs and preparations that consist in whole or part of a) native, inorganic or fossilized organic substances having a definite chemical composition and formed by inorganic reactions, which bear the name minerals; and/or b) organic substances that are required in small amounts for maintenance and growth, but which cannot be manufactured by the human body, which, as vital amines, bear the name vitamins. typical combination minerals and vitamin constituents are ascorbic acid, beta carotene, calcium, cholecalciferol, ferrous fumarate, folic acid, iron, magnesium oxide, minerals, multivitamins, niacin, pyridoxine, and vitamin a.. niacin/riboflavin/thiamine. this classification denotes a combination drug defined by the u.s. department of veterans affairs in its (vas) national drug file (ndf), which falls under va drug class vt109. this va drug class (vt109) classifies this compound as belonging to the group vitamin b, other.. "
"combination nutritional therapy products. this classification denotes combination drugs and preparations that consist in whole or part of a) native, inorganic or fossilized organic substances having a definite chemical composition and formed by inorganic reactions, which bear the name minerals; and/or b) organic substances that are required in small amounts for maintenance and growth, but which cannot be manufactured by the human body, which, as vital amines, bear the name vitamins. typical combination minerals and vitamin constituents are ascorbic acid, beta carotene, calcium, cholecalciferol, ferrous fumarate, folic acid, iron, magnesium oxide, minerals, multivitamins, niacin, pyridoxine, and vitamin a.. pyridoxine/thiamine. this classification denotes a combination drug defined by the u.s. department of veterans affairs in its (vas) national drug file (ndf), which falls under va drug class vt109. this va drug class (vt109) classifies this compound as belonging to the group vitamin b, other.. "
"combination prostaglandins. this classification denotes combination drugs and preparations in at least one constituient derives from unsaturated 20-carbon fatty acids, primarily arachidonic acid, via the cyclooxygenase pathway, so called as prosta-glandins or prostaglandins because scientists first isolated and later synthesized these from the human prostate gland. typical combination prostaglandin constituients are carboprost and tromethamine.. . "
"combination prostaglandins. this classification denotes combination drugs and preparations in at least one constituient derives from unsaturated 20-carbon fatty acids, primarily arachidonic acid, via the cyclooxygenase pathway, so called as prosta-glandins or prostaglandins because scientists first isolated and later synthesized these from the human prostate gland. typical combination prostaglandin constituients are carboprost and tromethamine.. carboprost/tromethamine. this classification denotes a combination drug defined by the u.s. department of veterans affairs in its (vas) national drug file (ndf), which falls under va drug class hs875. this va drug class (hs875) classifies this compound as belonging to the group prostaglandins.. "
"combination protective agents. this classification denotes combination drugs and preparations which are given to prevent a disease or disorder or are used in the process of treating a disease or injury due to a poisonous agent, so, as in the case of chemotherapy treatment which causes damage to kidneys or other organs, such protective agents reduce said damage. typical combination protective agent constituients are amifostine and mannitol.. . "
"combination protective agents. this classification denotes combination drugs and preparations which are given to prevent a disease or disorder or are used in the process of treating a disease or injury due to a poisonous agent, so, as in the case of chemotherapy treatment which causes damage to kidneys or other organs, such protective agents reduce said damage. typical combination protective agent constituients are amifostine and mannitol.. amifostine/mannitol. this classification denotes a combination drug defined by the u.s. department of veterans affairs in its (vas) national drug file (ndf), which falls under va drug class an700. this va drug class (an700) classifies this compound as belonging to the group protective agents.. "
